data_2ofq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ofq _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.027 0.441 . . . . 0.0 110.752 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.57 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.533 ' HB3' HG21 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.506 ' HB2' HG12 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.509 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.471 ' N ' HG13 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.647 HD21 ' H ' ' A' ' 205' ' ' ARG . 10.4 t30 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.647 ' H ' HD21 ' A' ' 203' ' ' ASN . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.437 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.627 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.627 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.527 HG11 HG23 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.527 HG23 HG11 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.415 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.5 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.52 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.406 0.086 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 110.262 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.611 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.51 ' HB3' HG21 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 71.7 mm-40 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.539 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.601 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 212' ' ' PRO . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.52 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.441 ' N ' HG12 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.611 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.405 ' HG1' HG21 ' A' ' 249' ' ' VAL . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.427 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.527 HG23 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.435 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.423 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.512 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.512 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 244' ' ' ILE . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.427 ' N ' HG23 ' A' ' 243' ' ' ILE . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.405 HG21 ' HG1' ' A' ' 207' ' ' THR . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.404 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 23' ' ' PRO . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.503 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.504 0.126 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.528 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.443 HD22 ' H ' ' A' ' 184' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.6 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.613 HE22 ' HA ' ' B' ' 25' ' ' PRO . 16.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.608 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.494 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.527 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.465 ' N ' HG12 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.473 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.52 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.535 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.429 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.535 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.57 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.54 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.541 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.747 0.228 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HA ' HE22 ' A' ' 189' ' ' GLN . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.454 ' H ' ' NE2' ' A' ' 189' ' ' GLN . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.4 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 188' ' ' GLU . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.652 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.527 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.427 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.463 HG21 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.506 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.472 ' N ' HG12 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.463 ' HD3' HG21 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 242' ' ' ASN . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.521 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.608 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.608 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.428 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.422 HG22 HD13 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.522 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 244' ' ' ILE . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.411 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.537 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' A' ' 261' ' ' VAL . 55.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 120.456 0.107 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 1.4 p30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.94 0.4 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.474 ' HG2' HG21 ' B' ' 33' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.452 ' HB2' HE22 ' A' ' 189' ' ' GLN . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.0 OUTLIER -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.464 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.576 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.512 ' HA ' HG11 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.457 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.517 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 2.6 t-20 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.438 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.439 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 242' ' ' ASN . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.442 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.544 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.544 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.424 HG21 HD11 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 240' ' ' ASN . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 238' ' ' GLY . 15.5 m120 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.439 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.479 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.67 0.196 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.479 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 38.4 m-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.465 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.41 ' HE1' ' HA ' ' B' ' 33' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.628 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.535 ' HA ' HG13 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.452 ' N ' HG13 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 231' ' ' LEU . 26.1 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.425 HD13 HE21 ' A' ' 219' ' ' GLN . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.448 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.528 ' HB2' HG13 ' A' ' 261' ' ' VAL . 52.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.515 0.131 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.461 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' B' ' 28' ' ' SER . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 26' ' ' ASP . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.624 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.545 ' HB3' HG23 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.513 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.513 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.468 HH21 ' HB3' ' A' ' 190' ' ' PRO . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.521 ' HA ' HG11 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.411 ' N ' HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.624 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.526 HG23 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.454 ' HD1' HG13 ' A' ' 237' ' ' VAL . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.432 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.504 ' HB ' HG21 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 235' ' ' HIS . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.526 HG12 HG23 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.567 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.501 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HB2' HG13 ' A' ' 261' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--O 1.23 0.1 0 CA-C-O 120.476 0.115 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 185' ' ' VAL . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 188' ' ' GLU . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.951 0.405 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.502 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.473 ' HB2' HE22 ' A' ' 189' ' ' GLN . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.562 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.2 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.531 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.433 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.599 HH11 HG23 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.493 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.599 HG23 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.492 ' HA ' HD21 ' A' ' 217' ' ' LEU . 66.4 m-20 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.52 ' HB ' HG21 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.518 HG12 HG23 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.432 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.452 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.529 ' HB2' HG11 ' A' ' 261' ' ' VAL . 58.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.441 0.101 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.505 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.437 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.452 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.638 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.671 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.5 ' HB2' HE22 ' A' ' 189' ' ' GLN . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' B' ' 31' ' ' VAL . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 187' ' ' SER . 2.7 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.547 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.418 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.478 HG13 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.522 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.443 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.671 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.655 HD21 ' H ' ' A' ' 205' ' ' ARG . 10.3 t30 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.655 ' H ' HD21 ' A' ' 203' ' ' ASN . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.437 ' HB3' HD13 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.428 ' HB3' HD13 ' A' ' 231' ' ' LEU . 15.0 mm100 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.476 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.419 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HG2' HG11 ' A' ' 261' ' ' VAL . 35.0 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.458 0.107 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' B' ' 28' ' ' SER . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 26' ' ' ASP . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.031 0.443 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.417 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.482 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.441 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.482 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.419 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.506 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.528 ' HA ' HG11 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.494 ' N ' HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.48 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.414 ' HG1' HG21 ' A' ' 249' ' ' VAL . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.427 ' HB3' HD13 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.526 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.617 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.44 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.617 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.435 HG22 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.428 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.435 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.414 HG21 ' HG1' ' A' ' 207' ' ' THR . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.661 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.43 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.468 HG12 HG23 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.528 ' HB2' HG13 ' A' ' 261' ' ' VAL . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.499 0.125 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.456 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.531 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.628 ' N ' HD21 ' B' ' 34' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.564 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.523 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.493 ' N ' HG12 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.423 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.589 ' HA ' HD11 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.557 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.591 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.508 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.401 HD13 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.591 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.47 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.449 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 36.5 t30 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.58 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.535 0.139 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.5 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.564 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.581 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.523 ' HE3' ' HA ' ' B' ' 33' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 0.1 OUTLIER -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.458 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.54 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.418 HG21 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.555 ' HA ' HG13 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.461 ' N ' HG13 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.581 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.472 HG21 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG21 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.513 HG23 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.47 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.505 ' HD2' HD11 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.407 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.54 ' HD2' ' HG2' ' A' ' 192' ' ' MET . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.625 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.535 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.504 0.127 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HE3' ' A' ' 192' ' ' MET . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.625 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.491 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.499 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' B' ' 30' ' ' THR . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.427 ' HG3' ' HE1' ' A' ' 192' ' ' MET . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.427 ' HE1' ' HG3' ' A' ' 191' ' ' GLU . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 53.4 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 186' ' ' MET . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.51 ' HA ' HG11 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.478 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.499 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.521 HE21 HD12 ' A' ' 231' ' ' LEU . 15.4 mm100 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.521 HD12 HE21 ' A' ' 219' ' ' GLN . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.423 ' HB3' ' SD ' ' A' ' 222' ' ' MET . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.53 ' HA ' HD12 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.556 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.413 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.448 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.524 ' HB2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.593 0.164 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.554 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' B' ' 33' ' ' VAL . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.027 0.441 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.514 ' HE3' ' HA ' ' B' ' 33' ' ' VAL . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.49 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.516 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.516 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.466 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.489 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG13 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.438 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.514 ' HB3' HD13 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.491 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.507 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.512 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.512 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.566 HG21 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.407 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.2 p30 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.566 ' HB ' HG21 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.601 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.532 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.404 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 261' ' ' VAL . 55.4 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.449 0.104 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.484 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.551 HG11 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' B' ' 31' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 110.709 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.637 HE21 HD22 ' A' ' 266' ' ' ASN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.499 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.526 ' HE1' ' HA ' ' B' ' 33' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.561 HE22 ' HA ' ' B' ' 25' ' ' PRO . 22.1 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.402 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.541 ' HA ' HG11 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.452 ' N ' HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.499 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.497 ' HB3' HD13 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.517 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.446 ' HA ' HD12 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.479 HD11 HG21 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.41 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.41 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.481 HG12 HG23 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.637 HD22 HE21 ' A' ' 183' ' ' GLN . 15.7 t-20 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.558 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 120.663 0.193 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.561 ' HA ' HE22 ' A' ' 189' ' ' GLN . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.443 ' N ' HE22 ' A' ' 189' ' ' GLN . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.437 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.506 ' HB3' HG21 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 7.5 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.42 HG13 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.519 ' HA ' HG13 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.44 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.453 HD11 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.479 ' HA ' HD23 ' A' ' 217' ' ' LEU . 8.3 p30 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.662 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.447 HG12 HG21 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.433 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.452 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.484 0.118 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.469 ' N ' HD21 ' B' ' 34' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.479 ' HG3' HG22 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.499 ' HB2' HG11 ' B' ' 31' ' ' VAL . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.559 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.463 HG21 ' HD3' ' A' ' 212' ' ' PRO . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' HG22 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.463 ' HD3' HG21 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.601 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.462 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.601 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 243' ' ' ILE . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.537 ' HA ' HD12 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 237' ' ' VAL . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.531 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 CA-C-O 120.459 0.108 . . . . 0.0 112.126 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.505 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.55 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.618 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.514 ' H ' HD22 ' B' ' 34' ' ' ASN . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.541 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.541 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.531 ' HA ' HG13 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.429 ' N ' HG13 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.618 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.428 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.472 ' HG1' HG23 ' A' ' 249' ' ' VAL . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 242' ' ' ASN . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.452 ' HB3' HD11 ' A' ' 231' ' ' LEU . 24.8 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.469 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.569 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.532 ' O ' ' HG3' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.569 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.634 ' H ' HD21 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 236' ' ' VAL . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.472 HG23 ' HG1' ' A' ' 207' ' ' THR . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HB2' HG13 ' A' ' 261' ' ' VAL . 39.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.476 0.115 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.504 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' B' ' 27' ' ' TRP . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 184' ' ' TYR . 2.4 p30 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.938 0.399 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.51 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.654 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.507 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.417 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.496 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.439 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.496 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.577 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD22 ' A' ' 217' ' ' LEU . 9.4 p30 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.44 ' HB ' HG21 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' HIS . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.562 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.43 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.562 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.486 0.119 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.493 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.559 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 199' ' ' HIS . 12.9 m120 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.465 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.411 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.587 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.587 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' MET . . . . . 0.608 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.62 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.411 HG21 ' HD3' ' A' ' 212' ' ' PRO . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.44 ' HA ' HG11 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.423 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.411 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.411 ' HD3' HG21 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.484 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.484 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.54 ' HB2' HD21 ' A' ' 242' ' ' ASN . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 240' ' ' ASN . 8.3 p30 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.633 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.506 HG12 HG23 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.586 ' HB2' HG13 ' A' ' 261' ' ' VAL . 59.6 Cg_endo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 120.732 0.221 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.564 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.845 0.355 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.61 -152.51 6.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.505 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.83 113.01 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -101.43 165.28 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -131.41 113.09 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.94 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -120.49 95.28 4.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.57 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.533 ' HB3' HG21 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.506 ' HB2' HG12 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.509 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.471 ' N ' HG13 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.647 HD21 ' H ' ' A' ' 205' ' ' ARG . 10.4 t30 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.647 ' H ' HD21 ' A' ' 203' ' ' ASN . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.437 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.627 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t -64.07 176.88 0.89 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.4 39.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.7 t -81.84 -59.23 2.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.88 -6.21 1.36 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER -103.28 175.17 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.627 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.527 HG11 HG23 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.527 HG23 HG11 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.415 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.5 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.52 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -105.38 81.15 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 175.74 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 40.1 t80 59.41 98.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.024 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 271' ' ' PRO . . . -81.14 -50.46 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.062 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 270' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.38 2.053 . . . . 0.0 112.377 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.173 -0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.13 117.19 3.75 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.237 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo -67.55 -79.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.343 2.028 . . . . 0.0 112.22 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -127.97 104.83 8.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -126.22 -38.75 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.987 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -81.79 -41.2 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.254 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.9 mm 62.22 109.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.116 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -78.89 97.65 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 112.311 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.14 -25.77 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.063 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.0 t70 61.17 101.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.094 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 58.6 m -68.26 139.74 56.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 155.32 146.96 4.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -144.95 126.38 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -144.87 133.86 22.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -114.12 113.61 24.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER -81.68 95.09 7.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.262 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.611 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.51 ' HB3' HG21 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 71.7 mm-40 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.539 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.601 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 212' ' ' PRO . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.52 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.441 ' N ' HG12 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.611 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.405 ' HG1' HG21 ' A' ' 249' ' ' VAL . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.427 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.527 HG23 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.435 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.423 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p -125.66 82.23 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.88 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.212 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p -42.27 -59.32 1.85 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.617 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.48 -7.97 1.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.558 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -62.08 139.86 58.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.512 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.512 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 244' ' ' ILE . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.427 ' N ' HG23 ' A' ' 243' ' ' ILE . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.405 HG21 ' HG1' ' A' ' 207' ' ' THR . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.404 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 23' ' ' PRO . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.503 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.02 81.36 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 178.43 -69.0 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.698 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 49.4 t80 57.91 97.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -80.97 -47.5 1.14 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.973 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 47.2 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.487 2.124 . . . . 0.0 112.332 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.08 -0.392 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.32 157.12 18.86 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.536 2.157 . . . . 0.0 112.236 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo -69.4 -78.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.457 2.105 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.528 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.443 HD22 ' H ' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -150.88 103.21 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' B' ' 32' ' ' PRO . 47.6 mmtm -96.86 -45.57 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 71.4 p -101.84 90.79 4.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.96 130.51 84.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.55 98.82 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.504 2.136 . . . . 0.0 112.286 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.84 -22.01 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t70 60.94 83.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.175 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -55.85 156.35 5.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.302 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.785 0.326 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.543 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.61 116.0 21.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.771 0.319 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -100.23 130.94 46.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -123.09 113.5 19.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.575 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -90.83 94.98 9.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.658 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.6 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.613 HE22 ' HA ' ' B' ' 25' ' ' PRO . 16.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.608 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.494 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.527 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.465 ' N ' HG12 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.473 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.52 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.535 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t -91.21 176.05 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.1 -21.29 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.166 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.0 m -73.37 -30.09 63.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 101.31 15.1 28.69 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.607 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.66 157.32 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.429 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.535 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.57 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.54 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -103.61 81.11 1.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 173.8 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 68.3 t80 56.88 95.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.187 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -127.11 80.17 71.95 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.622 2.215 . . . . 0.0 112.241 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.084 -0.391 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.1 158.18 58.8 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.485 2.123 . . . . 0.0 112.189 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.541 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo -72.36 -50.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.688 2.259 . . . . 0.0 111.987 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HA ' HE22 ' A' ' 189' ' ' GLN . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.454 ' H ' ' NE2' ' A' ' 189' ' ' GLN . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.4 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 188' ' ' GLU . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -122.59 98.15 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.38 -26.57 30.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.716 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 64.5 p -139.32 100.12 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.903 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.23 126.86 57.35 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.075 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.61 98.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.593 2.195 . . . . 0.0 112.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.92 -21.27 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 60.36 98.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 m -105.43 -64.51 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.785 0.326 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.54 100.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.57 135.03 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.452 ' HZ3' ' HB3' ' A' ' 203' ' ' ASN . 68.3 mttm -103.15 139.01 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.11 112.95 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -101.68 95.25 6.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.652 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.527 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.427 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.463 HG21 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.506 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.472 ' N ' HG12 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.452 ' HB3' ' HZ3' ' A' ' 180' ' ' LYS . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.463 ' HD3' HG21 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 242' ' ' ASN . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.521 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.608 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -65.06 176.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.68 30.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.4 m -87.74 -34.26 18.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.14 -8.65 10.43 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.38 175.0 6.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.608 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.428 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.422 HG22 HD13 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.522 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 244' ' ' ILE . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.411 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.537 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 269' ' ' PHE . 38.1 m-80 -117.13 172.26 7.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 267' ' ' ASN . 7.2 t30 75.92 -36.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 267' ' ' ASN . 36.5 t80 52.73 96.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.46 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.21 78.12 13.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.579 2.186 . . . . 0.0 112.34 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.516 ' H3 ' ' HD2' ' B' ' 22' ' ' PRO . 5.9 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 CA-C-O 119.693 -0.211 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.516 ' HD2' ' H3 ' ' B' ' 21' ' ' PRO . 62.5 Cg_exo -52.02 157.43 6.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.096 1.864 . . . . 0.0 112.214 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' A' ' 261' ' ' VAL . 55.8 Cg_endo -70.67 -78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.439 2.093 . . . . 0.0 112.144 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 1.4 p30 -152.88 101.1 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -91.86 -31.24 15.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -111.25 94.63 5.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.07 130.26 26.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.15 97.86 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.93 -26.55 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 64.85 151.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -69.73 143.53 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.939 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.7 69.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.88 121.14 40.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.478 ' HZ2' ' ND2' ' A' ' 203' ' ' ASN . 18.0 ptpt -89.38 138.07 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -117.67 113.5 21.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.471 ' HH ' ' HD2' ' A' ' 180' ' ' LYS . 1.5 m-85 -82.38 95.04 7.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.517 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.474 ' HG2' HG21 ' B' ' 33' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.452 ' HB2' HE22 ' A' ' 189' ' ' GLN . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.0 OUTLIER -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.464 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.576 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.512 ' HA ' HG11 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.457 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.517 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.478 ' ND2' ' HZ2' ' A' ' 180' ' ' LYS . 2.6 t-20 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.438 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.439 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 242' ' ' ASN . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.544 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m -110.42 -165.88 1.04 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.98 165.03 1.98 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.6 m 61.73 9.62 2.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.122 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.69 59.6 10.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 142.08 49.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.544 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.424 HG21 HD11 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 240' ' ' ASN . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 238' ' ' GLY . 15.5 m120 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.439 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.479 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 -101.5 81.06 2.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.0 t30 175.05 142.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.53 115.91 13.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -142.65 75.83 18.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.629 2.219 . . . . 0.0 112.341 179.814 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.157 -0.363 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.49 124.15 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 38.2 Cg_endo -66.2 -77.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.456 2.104 . . . . 0.0 112.234 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.479 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 38.4 m-80 -123.08 -38.96 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 63.29 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -119.82 129.13 54.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.41 . . . . 0.0 110.977 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.43 128.55 93.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.108 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 98.58 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.571 2.18 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 p -115.15 -26.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.75 98.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 72.3 p -111.38 146.1 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.987 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.5 157.63 28.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.545 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.38 124.22 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.26 151.48 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -120.6 113.14 19.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -114.7 95.33 5.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.465 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.41 ' HE1' ' HA ' ' B' ' 33' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.628 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.535 ' HA ' HG13 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.452 ' N ' HG13 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 231' ' ' LEU . 26.1 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m -144.28 147.22 33.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.65 98.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.1 t 62.1 -82.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.98 72.9 0.11 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -129.18 141.57 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.425 HD13 HE21 ' A' ' 219' ' ' GLN . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.448 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -102.12 80.63 2.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 173.82 141.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.85 102.07 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -134.3 78.64 57.35 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.239 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.519 ' H3 ' ' HD2' ' B' ' 22' ' ' PRO . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.78 0 CA-C-O 119.789 -0.171 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.519 ' HD2' ' H3 ' ' B' ' 21' ' ' PRO . 59.3 Cg_exo -52.12 147.06 28.35 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.949 1.766 . . . . 0.0 112.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.528 ' HB2' HG13 ' A' ' 261' ' ' VAL . 52.9 Cg_endo -69.78 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.395 2.063 . . . . 0.0 112.402 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.461 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' B' ' 28' ' ' SER . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 26' ' ' ASP . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.46 100.59 5.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.2 p -106.25 103.74 13.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 50.6 mm -59.25 109.75 2.16 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 19.2 Cg_endo -58.54 96.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.607 2.204 . . . . 0.0 112.169 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.64 -32.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 58.8 -172.69 0.1 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -119.13 143.53 47.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.34 87.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.88 7.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.634 ' HB3' ' HZ1' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -140.12 137.77 34.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -120.22 113.37 20.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 -79.47 95.16 5.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.431 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.624 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.545 ' HB3' HG23 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.513 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.513 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.468 HH21 ' HB3' ' A' ' 190' ' ' PRO . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.521 ' HA ' HG11 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.411 ' N ' HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.624 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.526 HG23 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p -81.83 -178.3 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.41 82.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.2 t -68.48 -52.25 34.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 130.78 45.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -131.05 143.68 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.454 ' HD1' HG13 ' A' ' 237' ' ' VAL . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.432 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.504 ' HB ' HG21 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 235' ' ' HIS . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.526 HG12 HG23 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.567 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.501 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -117.24 172.51 7.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.62 22.56 11.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.456 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -55.05 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.56 79.65 9.45 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.082 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.234 . . . . 0.0 112.237 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 111.069 -0.396 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 159.46 51.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.507 2.138 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HB2' HG13 ' A' ' 261' ' ' VAL . 33.6 Cg_endo -64.75 -73.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.579 2.186 . . . . 0.0 112.176 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 185' ' ' VAL . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 188' ' ' GLU . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.454 ' HB3' HG12 ' B' ' 37' ' ' ILE . 7.3 m120 -90.5 -67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.79 -82.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.804 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 7.6 t -103.14 -33.91 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' B' ' 34' ' ' ASN . 59.5 mt 67.49 129.19 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.35 101.28 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.522 2.148 . . . . 0.0 112.349 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.466 ' O ' HG21 ' B' ' 39' ' ' VAL . 9.3 p -164.07 35.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.335 0.588 . . . . 0.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -48.25 135.94 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -69.32 -38.51 78.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.829 0.347 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.42 -44.91 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.565 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.73 147.56 22.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.37 131.65 54.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.06 113.02 25.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.625 ' HH ' ' HD3' ' B' ' 38' ' ' PRO . 4.4 p90 -118.89 95.51 4.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.628 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.502 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.473 ' HB2' HE22 ' A' ' 189' ' ' GLN . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.562 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.2 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.531 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.433 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.599 HH11 HG23 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.493 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m -122.23 -165.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.2 153.36 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.113 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 t 61.73 11.03 3.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.113 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.44 78.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.654 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.12 143.09 40.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.599 HG23 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.492 ' HA ' HD21 ' A' ' 217' ' ' LEU . 66.4 m-20 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.52 ' HB ' HG21 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.518 HG12 HG23 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.432 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.452 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -103.86 81.08 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.574 HD22 ' HB1' ' A' ' 270' ' ' ALA . 4.7 t30 175.19 -56.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 t80 57.25 96.04 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.574 ' HB1' HD22 ' A' ' 268' ' ' ASN . . . -120.66 80.75 32.0 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.621 2.214 . . . . 0.0 112.255 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' HD2' ' B' ' 22' ' ' PRO . 2.6 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' B' ' 21' ' ' PRO . 2.8 Cg_endo -43.3 -48.74 7.95 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.902 2.401 . . . . 0.0 113.343 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.529 ' HB2' HG11 ' A' ' 261' ' ' VAL . 58.5 Cg_endo -71.4 -78.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.847 1.698 . . . . 0.0 112.235 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.505 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.437 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.452 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -98.87 -78.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.02 -71.39 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 57.2 m -49.98 -76.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.939 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 46.6 mm 66.6 129.06 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.625 ' HD3' ' HH ' ' A' ' 182' ' ' TYR . 6.1 Cg_exo -78.96 110.44 2.77 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.804 2.336 . . . . 0.0 112.017 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.0 -34.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.232 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.18 98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -93.26 -16.87 24.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.739 0.304 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.4 174.13 34.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 59.42 -177.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 180' ' ' LYS . 10.1 mptt -120.43 173.92 6.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -104.35 113.01 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.638 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER -130.18 95.16 3.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.98 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.671 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.5 ' HB2' HE22 ' A' ' 189' ' ' GLN . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' B' ' 31' ' ' VAL . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 187' ' ' SER . 2.7 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.547 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.418 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.478 HG13 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.522 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.443 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.671 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.655 HD21 ' H ' ' A' ' 205' ' ' ARG . 10.3 t30 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.655 ' H ' HD21 ' A' ' 203' ' ' ASN . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.437 ' HB3' HD13 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.428 ' HB3' HD13 ' A' ' 231' ' ' LEU . 15.0 mm100 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.476 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t -125.07 -171.73 2.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -53.89 155.68 3.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 37.1 t 61.86 11.48 4.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.056 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.16 76.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.684 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -136.29 141.55 43.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.419 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.55 ' HB ' HG22 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.599 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -100.94 81.41 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 175.36 -64.7 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 2.4 t80 59.14 96.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.545 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -77.12 -47.79 2.62 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.899 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 33.5 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.432 2.088 . . . . 0.0 112.317 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.484 0.938 0 N-CA-C 111.191 -0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 156.98 61.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.221 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HG2' HG11 ' A' ' 261' ' ' VAL . 35.0 Cg_endo -65.73 -74.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.445 2.097 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' B' ' 28' ' ' SER . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 26' ' ' ASP . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -124.08 114.45 19.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -136.91 -39.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.975 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 87.8 m -74.1 -52.69 11.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm 64.07 117.62 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.97 98.93 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.461 2.107 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.52 -37.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.033 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 57.09 96.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -104.3 130.68 52.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -165.35 155.89 27.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.564 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -148.19 173.39 13.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.46 ' HZ2' HD22 ' A' ' 203' ' ' ASN . 96.2 mttt -111.01 178.52 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.818 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -130.26 113.14 14.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -125.69 95.24 4.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.417 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.482 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.441 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.482 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.419 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.506 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.528 ' HA ' HG11 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.494 ' N ' HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.48 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.46 HD22 ' HZ2' ' A' ' 180' ' ' LYS . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.414 ' HG1' HG21 ' A' ' 249' ' ' VAL . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.427 ' HB3' HD13 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.526 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.617 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m -76.36 -164.93 0.44 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -63.97 176.54 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t 62.28 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 165.63 51.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.606 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.19 141.61 40.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.44 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.617 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.435 HG22 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.428 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.435 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.414 HG21 ' HG1' ' A' ' 207' ' ' THR . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.661 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.43 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.468 HG12 HG23 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 82.5 m-20 -117.57 80.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 63.7 t30 161.62 26.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.807 0.692 . . . . 0.0 110.466 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -53.49 106.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.189 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.99 69.86 6.33 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.031 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.711 2.274 . . . . 0.0 112.511 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.36 153.31 41.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 112.253 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.528 ' HB2' HG13 ' A' ' 261' ' ' VAL . 43.9 Cg_endo -68.3 -75.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.456 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.531 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.628 ' N ' HD21 ' B' ' 34' ' ' ASN . 0.8 OUTLIER -108.03 126.3 52.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.02 -38.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.206 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 10.5 t -105.36 -25.51 12.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.181 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.8 mm 67.11 132.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.84 104.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.921 2.414 . . . . 0.0 112.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.98 -22.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 60.26 -176.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' THR . . . . . 0.422 ' HG1' ' HG2' ' B' ' 42' ' ' GLN . 70.5 p -125.75 -51.23 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.422 ' HG2' ' HG1' ' B' ' 41' ' ' THR . 17.7 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.748 0.309 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.95 77.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.43 172.04 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -98.62 167.5 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.76 113.33 14.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.19 95.45 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.81 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.564 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.523 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.493 ' N ' HG12 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.423 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.589 ' HA ' HD11 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.557 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.591 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -79.59 -172.46 3.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.54 171.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.104 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.2 m 62.56 9.84 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.232 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.07 52.99 50.11 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.821 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -138.04 140.92 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.508 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.401 HD13 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.591 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.47 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.449 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 36.5 t30 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 2.3 m-20 -103.05 80.84 1.9 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 3.0 t-20 172.61 -25.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.716 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.79 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.415 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 50.74 54.81 15.97 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.253 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.512 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 111.105 -0.383 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.51 156.94 60.36 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.539 2.159 . . . . 0.0 112.263 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.58 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo -65.68 -76.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.528 2.152 . . . . 0.0 112.305 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.5 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.564 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -143.62 114.38 7.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -106.93 -33.94 7.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' B' ' 37' ' ' ILE . 38.6 p -58.64 -74.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.349 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.42 ' H ' ' HG1' ' B' ' 36' ' ' THR . 50.5 mm 64.36 131.55 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.369 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 37' ' ' ILE . 5.9 Cg_exo -77.91 110.62 2.95 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.753 2.302 . . . . 0.0 112.128 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.49 -70.39 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 56.53 24.86 9.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m 59.94 99.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -155.96 68.19 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -150.29 113.42 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 203' ' ' ASN . 67.4 mttm -135.75 144.99 46.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -99.39 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 -116.74 95.41 5.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.682 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.581 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.523 ' HE3' ' HA ' ' B' ' 33' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 0.1 OUTLIER -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.458 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.54 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.418 HG21 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.555 ' HA ' HG13 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.461 ' N ' HG13 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.581 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 180' ' ' LYS . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.472 HG21 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG21 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.513 HG23 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.47 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t -143.68 139.86 29.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 60.58 102.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.225 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t 63.07 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.11 51.36 0.2 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.452 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -104.37 141.39 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.505 ' HD2' HD11 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.407 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.54 ' HD2' ' HG2' ' A' ' 192' ' ' MET . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.625 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 37.2 m-80 -117.1 80.32 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 55.0 t30 173.06 28.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.71 108.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.944 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.89 80.93 9.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.722 2.281 . . . . 0.0 112.305 179.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.498 ' H3 ' ' HD2' ' B' ' 22' ' ' PRO . 43.9 Cg_exo . . . . . 0 N--CA 1.485 1.021 0 CA-C-O 119.872 -0.137 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.498 ' HD2' ' H3 ' ' B' ' 21' ' ' PRO . 73.9 Cg_endo -75.55 114.35 3.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.936 1.757 . . . . 0.0 112.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.535 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 14.7 Cg_endo -57.2 -67.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HE3' ' A' ' 192' ' ' MET . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.625 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -95.58 150.73 20.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -135.38 -45.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -123.55 97.18 5.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.052 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.24 128.41 57.64 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.072 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.88 98.16 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.534 2.156 . . . . 0.0 112.188 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.5 -28.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.009 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.0 t70 59.27 98.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.6 m -67.26 112.36 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.46 54.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.46 32.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -151.09 153.34 34.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -123.3 113.35 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.02 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.491 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 -105.78 95.3 5.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.613 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.499 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' B' ' 30' ' ' THR . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.427 ' HG3' ' HE1' ' A' ' 192' ' ' MET . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.427 ' HE1' ' HG3' ' A' ' 191' ' ' GLU . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 53.4 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.41 ' O ' ' HE3' ' A' ' 186' ' ' MET . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.51 ' HA ' HG11 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.478 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.499 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.521 HE21 HD12 ' A' ' 231' ' ' LEU . 15.4 mm100 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p -124.53 -164.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.11 157.5 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.196 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.9 m 62.04 10.25 3.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.36 74.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -138.23 141.85 39.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.521 HD12 HE21 ' A' ' 219' ' ' GLN . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.423 ' HB3' ' SD ' ' A' ' 222' ' ' MET . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.53 ' HA ' HD12 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.556 ' HB ' HG22 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.413 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.42 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.448 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -97.97 80.91 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 174.81 137.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.524 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.24 98.92 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -126.14 80.52 68.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.143 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.562 2.175 . . . . 0.0 112.278 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 111.171 -0.357 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.28 156.17 55.3 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.422 2.081 . . . . 0.0 112.262 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.524 ' HB2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo -67.82 -74.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.285 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.554 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' B' ' 33' ' ' VAL . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 -105.27 -59.93 1.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 66.13 -4.69 0.64 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.077 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.467 ' H ' ' C ' ' B' ' 34' ' ' ASN . 40.0 p -148.59 95.58 2.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.839 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.44 128.33 28.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.51 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.732 2.288 . . . . 0.0 112.257 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.28 -30.76 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 59.43 99.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 66.0 m -73.3 -38.74 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.56 73.67 0.3 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -139.21 17.95 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.65 145.87 24.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.64 113.42 14.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 95.11 7.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.514 ' HE3' ' HA ' ' B' ' 33' ' ' VAL . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.49 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.516 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.516 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.466 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.489 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG13 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.438 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.514 ' HB3' HD13 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.491 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m -91.23 -178.37 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.54 -22.5 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t -85.74 -21.01 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.23 4.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -122.59 142.96 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.507 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.512 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.512 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.566 HG21 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.407 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.2 p30 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.566 ' HB ' HG21 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.601 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.532 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.404 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.59 172.14 7.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 61.11 29.59 18.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.53 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.87 107.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.062 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -123.88 81.55 55.93 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.179 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.72 2.28 . . . . 0.0 112.211 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 111.092 -0.388 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.52 156.01 58.66 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.467 2.111 . . . . 0.0 112.225 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 261' ' ' VAL . 55.4 Cg_endo -69.76 -77.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.513 2.142 . . . . 0.0 112.341 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.484 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.551 HG11 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' B' ' 31' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -94.49 102.28 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' B' ' 35' ' ' LYS . 3.6 mptp? -79.41 -63.95 1.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 69.5 p -96.72 102.41 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.04 124.91 88.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.48 100.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.686 2.257 . . . . 0.0 112.223 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.7 -30.8 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.225 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.4 -173.58 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.0 m -129.86 -49.05 1.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.01 58.13 0.42 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.49 -172.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.859 0.362 . . . . 0.0 111.218 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.653 ' HZ2' ' HB3' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -146.91 163.59 35.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.36 113.64 25.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -106.21 95.24 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.709 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.637 HE21 HD22 ' A' ' 266' ' ' ASN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.499 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.526 ' HE1' ' HA ' ' B' ' 33' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.561 HE22 ' HA ' ' B' ' 25' ' ' PRO . 22.1 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.402 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.541 ' HA ' HG11 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.452 ' N ' HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.499 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.497 ' HB3' HD13 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.517 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t -140.1 175.82 9.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.77 -84.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.4 m -147.57 -14.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 161.52 30.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.446 ' HA ' HD12 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.479 HD11 HG21 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.41 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.41 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.481 HG12 HG23 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.558 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.637 HD22 HE21 ' A' ' 183' ' ' GLN . 15.7 t-20 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 84.6 m-20 -117.54 82.59 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.565 ' HB3' ' HG3' ' A' ' 183' ' ' GLN . 7.0 t30 163.51 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.257 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 65.8 t80 57.03 98.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.311 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -138.16 78.46 34.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.975 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.346 0.402 0 C-N-CA 122.597 2.198 . . . . 0.0 112.297 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.148 -0.366 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.71 157.25 55.98 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.498 2.132 . . . . 0.0 112.248 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.558 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo -78.43 -57.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.884 2.389 . . . . 0.0 112.005 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.561 ' HA ' HE22 ' A' ' 189' ' ' GLN . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.443 ' N ' HE22 ' A' ' 189' ' ' GLN . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.437 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -107.46 97.25 7.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' HE2' ' A' ' 199' ' ' HIS . 61.0 mttp -99.14 -34.59 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -127.72 98.66 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -63.8 130.11 94.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.74 99.22 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.529 2.153 . . . . 0.0 112.337 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.89 -30.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 59.33 98.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.3 t -95.18 -5.63 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -163.43 -171.92 30.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.42 ' HA ' ' HZ1' ' A' ' 180' ' ' LYS . . . -138.96 -176.91 4.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.332 . . . . 0.0 111.08 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.663 ' HZ2' ' HB3' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -131.24 157.36 43.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -95.81 113.83 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -80.54 94.7 6.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.181 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.506 ' HB3' HG21 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 7.5 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.42 HG13 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.519 ' HA ' HG13 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.44 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t -60.87 172.29 1.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.33 -14.42 62.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.1 m -77.25 -62.34 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 141.5 31.56 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -137.86 145.84 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.495 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.453 HD11 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.479 ' HA ' HD23 ' A' ' 217' ' ' LEU . 8.3 p30 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.662 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.447 HG12 HG21 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.433 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.452 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.659 HD22 ' H ' ' A' ' 269' ' ' PHE . 6.4 t30 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 -117.06 81.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -179.86 -60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.728 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.659 ' H ' HD22 ' A' ' 266' ' ' ASN . 51.0 t80 57.97 95.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.206 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -117.1 81.78 13.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.683 2.256 . . . . 0.0 112.249 179.751 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.484 ' H3 ' ' HD2' ' B' ' 22' ' ' PRO . 45.0 Cg_exo . . . . . 0 N--CA 1.485 0.996 0 CA-C-O 119.834 -0.152 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.484 ' HD2' ' H3 ' ' B' ' 21' ' ' PRO . 73.6 Cg_endo -75.5 155.4 40.64 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.933 1.756 . . . . 0.0 112.307 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.512 ' HB2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo -74.5 -80.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.459 2.106 . . . . 0.0 112.251 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.469 ' N ' HD21 ' B' ' 34' ' ' ASN . 0.9 OUTLIER -95.61 -72.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' B' ' 35' ' ' LYS . 0.0 OUTLIER 61.12 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 76.7 p -102.78 103.78 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mm -73.54 126.75 89.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.021 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.54 102.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.834 2.356 . . . . 0.0 112.305 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 -32.36 35.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.183 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 60.68 104.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.3 p -59.25 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.191 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.9 2.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.57 144.3 25.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.345 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -129.81 149.64 51.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.45 113.48 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER -90.87 95.19 10.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.479 ' HG3' HG22 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.499 ' HB2' HG11 ' B' ' 31' ' ' VAL . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.559 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.463 HG21 ' HD3' ' A' ' 212' ' ' PRO . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' HG22 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.463 ' HD3' HG21 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.601 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t -67.86 177.5 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.57 4.47 24.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -95.2 -22.6 17.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 104.34 13.08 27.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -128.6 147.0 50.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.462 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.601 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 243' ' ' ILE . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.537 ' HA ' HD12 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 237' ' ' VAL . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.578 HG13 ' HG2' ' A' ' 271' ' ' PRO . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.531 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -117.1 171.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.6 t30 59.18 17.95 6.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.074 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -53.14 98.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.44 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 271' ' ' PRO . . . -94.21 -50.54 0.26 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.775 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.578 ' HG2' HG13 ' A' ' 249' ' ' VAL . 73.5 Cg_endo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.449 2.099 . . . . 0.0 112.377 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.656 ' H3 ' ' HD2' ' B' ' 22' ' ' PRO . 5.6 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 CA-C-O 119.866 -0.139 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.656 ' HD2' ' H3 ' ' B' ' 21' ' ' PRO . 71.7 Cg_endo -74.08 158.75 45.34 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.947 1.765 . . . . 0.0 112.283 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo -72.5 -81.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.529 2.152 . . . . 0.0 112.126 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.505 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.55 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -96.34 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -94.84 -36.98 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -132.18 108.46 9.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.26 127.1 91.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.926 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.37 101.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.838 2.359 . . . . 0.0 112.361 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -94.23 91.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 p30 44.2 28.62 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 63.5 m -72.25 130.26 40.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.759 0.314 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.8 147.64 18.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.421 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.6 18.99 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.047 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -78.85 141.99 37.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -131.94 113.11 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.618 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER -115.09 95.29 5.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.717 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.514 ' H ' HD22 ' B' ' 34' ' ' ASN . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.541 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.541 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.531 ' HA ' HG13 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.429 ' N ' HG13 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.618 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.428 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.472 ' HG1' HG23 ' A' ' 249' ' ' VAL . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 242' ' ' ASN . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.452 ' HB3' HD11 ' A' ' 231' ' ' LEU . 24.8 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.469 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.569 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 -178.63 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.55 85.97 1.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -173.49 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 131.46 15.59 1.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -130.47 166.34 20.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.532 ' O ' ' HG3' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.569 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.634 ' H ' HD21 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 236' ' ' VAL . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.472 HG23 ' HG1' ' A' ' 207' ' ' THR . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -110.78 81.37 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.5 t30 177.19 -42.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 26.7 t80 62.66 118.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.251 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -112.85 81.34 4.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.189 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.724 2.283 . . . . 0.0 112.234 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 111.154 -0.364 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.91 126.0 10.33 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.495 2.13 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HB2' HG13 ' A' ' 261' ' ' VAL . 39.4 Cg_endo -67.33 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.371 2.047 . . . . 0.0 112.18 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.504 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' B' ' 27' ' ' TRP . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 184' ' ' TYR . 2.4 p30 -131.61 99.05 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' B' ' 35' ' ' LYS . 3.8 mppt? -113.44 -23.37 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.639 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 62.6 m -80.16 -48.78 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm 63.8 119.73 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.525 ' HD2' ' HH ' ' A' ' 182' ' ' TYR . 91.1 Cg_endo -79.41 98.27 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.413 2.076 . . . . 0.0 112.291 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 -53.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 t70 59.94 90.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.632 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.8 m -60.34 -65.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.079 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.841 0.353 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.88 -113.05 2.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.7 137.6 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.344 . . . . 0.0 111.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.01 151.51 19.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -129.95 112.9 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.683 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.32 95.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.354 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.51 ' HH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.654 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.507 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.417 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.496 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' HH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.439 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.496 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.577 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -74.63 -165.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.4 177.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.109 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.5 m 63.54 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.082 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 162.8 51.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.665 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -138.01 159.94 40.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD22 ' A' ' 217' ' ' LEU . 9.4 p30 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.44 ' HB ' HG21 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 235' ' ' HIS . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.562 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.43 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -99.44 80.9 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.1 t30 174.03 134.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.438 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -143.98 99.45 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.389 . . . . 0.0 110.941 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.57 81.93 18.9 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.716 2.277 . . . . 0.0 112.209 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.484 0.935 0 N-CA-C 111.194 -0.348 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.44 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 75.0 Cg_exo -49.04 -48.04 19.62 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.639 2.226 . . . . 0.0 113.279 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.562 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo -73.83 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.935 1.757 . . . . 0.0 112.285 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.493 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.559 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 199' ' ' HIS . 12.9 m120 -97.56 143.72 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.35 -30.48 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 65.5 p -70.53 -63.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.459 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 49.8 mm 60.29 104.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.224 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 9.6 Cg_endo -50.78 102.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' B' ' 40' ' ' ASP . 1.0 OUTLIER -117.25 -63.65 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.22 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' B' ' 39' ' ' VAL . 3.1 p30 179.89 -174.97 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.5 p -140.73 -39.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.154 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.59 78.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.399 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -141.0 128.87 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -141.09 142.25 34.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -123.74 113.39 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.356 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.465 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 -81.19 95.24 6.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.411 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.587 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.587 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.608 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.62 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.411 HG21 ' HD3' ' A' ' 212' ' ' PRO . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.44 ' HA ' HG11 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.423 ' N ' HG11 ' B' ' 33' ' ' VAL . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.411 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.411 ' HD3' HG21 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 242' ' ' ASN . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m -144.19 -179.52 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.14 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.365 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -147.53 -12.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 159.03 37.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -103.52 139.63 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.484 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.484 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.54 ' HB2' HD21 ' A' ' 242' ' ' ASN . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 240' ' ' ASN . 8.3 p30 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.633 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.506 HG12 HG23 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.634 HD22 ' H ' ' A' ' 269' ' ' PHE . 7.2 t30 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.77 81.68 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.495 HD22 ' HB2' ' A' ' 270' ' ' ALA . 3.2 t30 179.74 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.634 ' H ' HD22 ' A' ' 266' ' ' ASN . 28.3 t80 57.96 97.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.216 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.495 ' HB2' HD22 ' A' ' 268' ' ' ASN . . . -130.16 80.9 69.9 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 C--N 1.346 0.435 0 C-N-CA 122.631 2.221 . . . . 0.0 112.305 179.747 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.101 -0.384 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.52 143.95 97.54 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.474 2.116 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.586 ' HB2' HG13 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -85.13 179.51 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.765 2.31 . . . . 0.0 112.059 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.564 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HE3' ' A' ' 186' ' ' MET . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -82.42 -15.48 52.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 61.13 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -89.83 96.43 10.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.51 124.17 90.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.06 99.18 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.502 2.135 . . . . 0.0 112.281 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.69 -26.11 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.993 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.4 t -113.04 -16.78 12.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.079 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.027 0.441 . . . . 0.0 110.752 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.462 ' HB2' HG13 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.599 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.599 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.689 ' HA ' HG12 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.648 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.463 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 207' ' ' THR . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.436 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.495 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.613 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.406 0.086 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.613 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 110.262 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.463 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 10.7 mm100 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.545 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.633 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.433 HG12 ' ND1' ' A' ' 199' ' ' HIS . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.709 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.428 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.751 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.441 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.428 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.495 HG12 ' H ' ' B' ' 24' ' ' GLU . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.597 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.596 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.504 0.126 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.597 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.636 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.655 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 15.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.612 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 199' ' ' HIS . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.718 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.631 HG23 HG11 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.444 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.597 ' SD ' HG23 ' A' ' 230' ' ' THR . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.597 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.56 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 241' ' ' ARG . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.418 ' HG3' ' HB ' ' A' ' 236' ' ' VAL . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.546 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.747 0.228 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.668 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' B' ' 28' ' ' SER . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.419 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.46 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 1.1 p30 -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 182' ' ' TYR . 93.8 m-20 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.652 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.451 HG23 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.662 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.451 ' HD3' HG23 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 244' ' ' ILE . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.64 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.64 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 243' ' ' ILE . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.558 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.424 HD12 HG23 ' A' ' 237' ' ' VAL . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.635 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 38.1 m-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.506 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 120.456 0.107 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.635 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 189' ' ' GLN . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.5 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.94 0.4 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.491 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.621 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 9.7 mp0 -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.621 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.454 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.604 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.67 ' HA ' HG12 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.525 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.479 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.564 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.556 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.556 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.55 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.479 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.447 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.511 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.546 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.67 0.196 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 261' ' ' VAL . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.511 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HE3' ' B' ' 27' ' ' TRP . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.465 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.419 ' HB3' HG22 ' A' ' 264' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 189' ' ' GLN . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.651 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.708 ' HA ' HG12 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.455 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.469 ' HA ' HD21 ' A' ' 217' ' ' LEU . 24.8 p-10 -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.493 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 253' ' ' TRP . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.407 ' CZ3' HG11 ' A' ' 246' ' ' VAL . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 218' ' ' PRO . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.568 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 186' ' ' MET . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' A' ' 261' ' ' VAL . 52.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.515 0.131 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 199' ' ' HIS . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.641 HG23 HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.437 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.496 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.449 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.456 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.537 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.521 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.8 m120 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG2' HG12 ' A' ' 261' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--O 1.23 0.1 0 CA-C-O 120.476 0.115 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.658 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.532 ' HE3' HG22 ' B' ' 30' ' ' THR . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.532 HG22 ' HE3' ' B' ' 27' ' ' TRP . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.951 0.405 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.588 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 11.7 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.594 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 262' ' ' VAL . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.404 HG12 ' ND1' ' A' ' 199' ' ' HIS . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.738 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.448 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.602 HH11 HG21 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.405 ' HA ' HD13 ' A' ' 257' ' ' LEU . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.602 HG21 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.527 ' HA ' HD21 ' A' ' 217' ' ' LEU . 10.9 m120 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 218' ' ' PRO . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 197' ' ' PRO . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.513 ' HG2' HG12 ' A' ' 261' ' ' VAL . 58.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.441 0.101 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.49 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 ' HE3' ' B' ' 27' ' ' TRP . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 188' ' ' GLU . 2.2 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.579 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.422 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.502 HG12 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.739 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.682 HG23 HG11 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.477 ' HB3' HD11 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.419 ' HB3' HD11 ' A' ' 231' ' ' LEU . 28.8 mm-40 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.423 ' HA ' HD21 ' A' ' 217' ' ' LEU . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.693 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.488 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.6 ' HG2' HG12 ' A' ' 261' ' ' VAL . 35.0 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.458 0.107 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.693 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 188' ' ' GLU . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.031 0.443 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB3' HG22 ' A' ' 264' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.521 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.484 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.428 ' HA ' HG21 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.429 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.727 ' HA ' HG12 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.672 HG23 HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.489 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.538 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.653 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.451 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.653 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.48 HG23 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 240' ' ' ASN . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' A' ' 217' ' ' LEU . 9.3 p30 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.48 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.471 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.462 HG12 HG22 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 261' ' ' VAL . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.499 0.125 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 261' ' ' VAL . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.521 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.541 ' O ' HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 199' ' ' HIS . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.509 HD22 ' HB2' ' A' ' 182' ' ' TYR . 2.3 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.501 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.69 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.562 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.422 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.707 ' HA ' HD13 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.619 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.619 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.49 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.594 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 2.6 t-20 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.624 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.535 0.139 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.594 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.471 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 m120 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.573 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.404 HG23 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.736 ' HA ' HG12 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.69 HG23 HG11 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 244' ' ' ILE . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' HG23 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.481 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 252' ' ' GLU . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' CE1' ' A' ' 211' ' ' PHE . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 223' ' ' ILE . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.574 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.579 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.717 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.439 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.579 ' HG2' HG12 ' A' ' 261' ' ' VAL . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.504 0.127 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.717 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 28' ' ' SER . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 188' ' ' GLU . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.527 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.564 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.458 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 8.2 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 199' ' ' HIS . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.602 ' HA ' HG12 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.527 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 252' ' ' GLU . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HG3' ' HZ3' ' A' ' 253' ' ' TRP . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' HD11 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.57 ' H ' HG12 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.438 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.441 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.646 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.515 ' HG2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.593 0.164 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.463 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 186' ' ' MET . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.027 0.441 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.531 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.443 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.528 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.542 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.405 HG23 HG11 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.403 ' HE1' ' NE ' ' A' ' 208' ' ' ARG . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.441 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.654 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.5 p-10 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.654 ' HB ' HG23 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.552 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.4 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.449 0.104 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.592 HG13 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 199' ' ' HIS . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 110.709 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.51 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.421 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 22.2 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.707 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.696 HG23 HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 202' ' ' ASP . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 244' ' ' ILE . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.53 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.53 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 248' ' ' THR . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.404 ' H ' HG12 ' A' ' 246' ' ' VAL . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.414 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.414 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.456 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 5.6 t30 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.538 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 120.663 0.193 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.464 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.449 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 1.1 p30 -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' A' ' 189' ' ' GLN . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 49.7 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.434 HG12 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.696 ' HA ' HG12 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.568 HG13 HG11 ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 243' ' ' ILE . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.642 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.642 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.424 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.507 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.5 p-10 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 217' ' ' LEU . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.55 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.481 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.571 ' HG2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.484 0.118 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.55 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.441 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' HG23 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 1.3 mp0 -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' A' ' 199' ' ' HIS . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.473 ' CD2' HG12 ' A' ' 198' ' ' VAL . 44.5 m-70 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 243' ' ' ILE . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 244' ' ' ILE . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.509 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.635 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.474 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.635 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 209' ' ' PHE . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 261' ' ' VAL . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.7 m120 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 CA-C-O 120.459 0.108 . . . . 0.0 112.126 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.486 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.5 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.558 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 184' ' ' TYR . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.8 m120 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.603 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 193' ' ' ARG . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.676 HG23 HG11 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.603 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' ILE . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 244' ' ' ILE . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.448 ' HB3' HD11 ' A' ' 231' ' ' LEU . 96.1 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.59 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.552 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.59 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.438 ' HA ' HD21 ' A' ' 217' ' ' LEU . 24.6 p-10 -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 209' ' ' PHE . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.498 ' HG2' HG23 ' A' ' 261' ' ' VAL . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.52 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.601 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.52 ' HG2' HG12 ' A' ' 261' ' ' VAL . 39.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.476 0.115 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.51 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.59 ' H ' ' HB2' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.526 ' H ' HE22 ' A' ' 189' ' ' GLN . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.515 ' HB2' ' ND2' ' B' ' 34' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.938 0.399 . . . . 0.0 110.354 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.425 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 1.2 mp0 -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.425 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.681 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.526 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.404 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.546 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.546 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.477 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.546 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.3 p-10 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 217' ' ' LEU . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' MET . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.486 0.119 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HB ' ' A' ' 185' ' ' VAL . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 182' ' ' TYR . 91.2 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.594 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' MET . . . . . 0.626 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.653 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.405 HG12 ' HD2' ' A' ' 260' ' ' LYS . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TRP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.412 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD3' HG23 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.498 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.507 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.507 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.525 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.5 p-10 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 246' ' ' VAL . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.706 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.411 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.82 ' HB2' HG12 ' A' ' 261' ' ' VAL . 59.6 Cg_endo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 120.732 0.221 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.547 ' O ' HG13 ' B' ' 31' ' ' VAL . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.57 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 199' ' ' HIS . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.845 0.355 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.61 -152.51 6.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.505 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.83 113.01 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.532 ' CD ' HD21 ' A' ' 203' ' ' ASN . 36.3 mtmm -101.43 165.28 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -131.41 113.09 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.94 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -120.49 95.28 4.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.462 ' HB2' HG13 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.599 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.599 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.689 ' HA ' HG12 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.532 HD21 ' CD ' ' A' ' 180' ' ' LYS . 22.8 t-20 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.648 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t -64.07 176.88 0.89 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.4 39.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.7 t -81.84 -59.23 2.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.88 -6.21 1.36 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER -103.28 175.17 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.463 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 207' ' ' THR . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.436 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.495 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.613 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -105.38 81.15 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 175.74 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 40.1 t80 59.41 98.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.024 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 271' ' ' PRO . . . -81.14 -50.46 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.062 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 270' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.38 2.053 . . . . 0.0 112.377 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.173 -0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' B' ' 23' ' ' PRO . 52.8 Cg_exo -55.13 117.19 3.75 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.237 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo -67.55 -79.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.343 2.028 . . . . 0.0 112.22 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.613 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -127.97 104.83 8.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -126.22 -38.75 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.987 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -81.79 -41.2 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.254 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.9 mm 62.22 109.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.116 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -78.89 97.65 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 112.311 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.14 -25.77 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.063 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.0 t70 61.17 101.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.094 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 58.6 m -68.26 139.74 56.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 155.32 146.96 4.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -144.95 126.38 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -144.87 133.86 22.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -114.12 113.61 24.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER -81.68 95.09 7.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.262 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.463 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 10.7 mm100 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.545 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.633 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.433 HG12 ' ND1' ' A' ' 199' ' ' HIS . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.709 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.428 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p -125.66 82.23 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.88 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.212 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p -42.27 -59.32 1.85 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.617 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.48 -7.97 1.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.558 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -62.08 139.86 58.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 271' ' ' PRO . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.751 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.441 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.428 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.495 HG12 ' H ' ' B' ' 24' ' ' GLU . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.597 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.02 81.36 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 178.43 -69.0 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.698 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 49.4 t80 57.91 97.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -80.97 -47.5 1.14 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.973 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 47.2 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.487 2.124 . . . . 0.0 112.332 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.08 -0.392 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.32 157.12 18.86 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.536 2.157 . . . . 0.0 112.236 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.596 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo -69.4 -78.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.457 2.105 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.597 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.636 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.88 103.21 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -96.86 -45.57 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 71.4 p -101.84 90.79 4.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.96 130.51 84.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.55 98.82 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.504 2.136 . . . . 0.0 112.286 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.84 -22.01 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t70 60.94 83.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.175 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -55.85 156.35 5.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.302 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.785 0.326 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.543 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.61 116.0 21.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.771 0.319 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -100.23 130.94 46.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.09 113.5 19.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -90.83 94.98 9.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.658 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.655 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 15.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.612 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 199' ' ' HIS . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.718 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.631 HG23 HG11 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.444 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.597 ' SD ' HG23 ' A' ' 230' ' ' THR . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t -91.21 176.05 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.1 -21.29 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.166 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.0 m -73.37 -30.09 63.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 101.31 15.1 28.69 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.607 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.66 157.32 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.597 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.56 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 241' ' ' ARG . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.418 ' HG3' ' HB ' ' A' ' 236' ' ' VAL . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.546 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -103.61 81.11 1.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.9 t30 173.8 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 68.3 t80 56.88 95.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.187 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -127.11 80.17 71.95 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.622 2.215 . . . . 0.0 112.241 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.084 -0.391 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.1 158.18 58.8 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.485 2.123 . . . . 0.0 112.189 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo -72.36 -50.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.688 2.259 . . . . 0.0 111.987 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.668 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' B' ' 28' ' ' SER . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.419 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.46 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 1.1 p30 -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 182' ' ' TYR . 93.8 m-20 -122.59 98.15 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.38 -26.57 30.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.716 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 64.5 p -139.32 100.12 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.903 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.23 126.86 57.35 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.075 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.61 98.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.593 2.195 . . . . 0.0 112.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.92 -21.27 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 60.36 98.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 m -105.43 -64.51 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.785 0.326 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.54 100.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.57 135.03 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -103.15 139.01 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.11 112.95 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -101.68 95.25 6.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.652 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.464 ' H ' HD21 ' B' ' 34' ' ' ASN . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.451 HG23 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.662 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.451 ' HD3' HG23 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 244' ' ' ILE . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.64 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -65.06 176.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.68 30.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.4 m -87.74 -34.26 18.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.14 -8.65 10.43 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.38 175.0 6.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.64 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 243' ' ' ILE . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.558 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.424 HD12 HG23 ' A' ' 237' ' ' VAL . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.635 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 268' ' ' ASN . 38.1 m-80 -117.13 172.26 7.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' ASN . 7.2 t30 75.92 -36.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 267' ' ' ASN . 36.5 t80 52.73 96.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.46 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.21 78.12 13.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.579 2.186 . . . . 0.0 112.34 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.438 ' HG2' ' HD3' ' B' ' 22' ' ' PRO . 5.9 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 CA-C-O 119.693 -0.211 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.438 ' HD3' ' HG2' ' B' ' 21' ' ' PRO . 62.5 Cg_exo -52.02 157.43 6.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.096 1.864 . . . . 0.0 112.214 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.506 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.8 Cg_endo -70.67 -78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.439 2.093 . . . . 0.0 112.144 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.635 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 189' ' ' GLN . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.464 HD21 ' H ' ' A' ' 184' ' ' TYR . 1.4 p30 -152.88 101.1 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -91.86 -31.24 15.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -111.25 94.63 5.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.07 130.26 26.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.15 97.86 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.93 -26.55 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 64.85 151.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -69.73 143.53 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.939 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.7 69.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.88 121.14 40.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -89.38 138.07 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -117.67 113.5 21.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.5 m-85 -82.38 95.04 7.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.491 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.621 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 9.7 mp0 -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.621 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.454 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.604 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.67 ' HA ' HG12 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.525 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.479 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.564 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.556 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m -110.42 -165.88 1.04 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.98 165.03 1.98 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.6 m 61.73 9.62 2.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.122 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.69 59.6 10.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 142.08 49.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.556 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.55 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.479 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.447 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.511 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 -101.5 81.06 2.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.0 t30 175.05 142.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.53 115.91 13.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -142.65 75.83 18.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.629 2.219 . . . . 0.0 112.341 179.814 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.157 -0.363 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.49 124.15 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.546 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 38.2 Cg_endo -66.2 -77.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.456 2.104 . . . . 0.0 112.234 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 261' ' ' VAL . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.511 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HE3' ' B' ' 27' ' ' TRP . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -123.08 -38.96 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 63.29 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -119.82 129.13 54.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.41 . . . . 0.0 110.977 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.43 128.55 93.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.108 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 98.58 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.571 2.18 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 p -115.15 -26.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.75 98.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 72.3 p -111.38 146.1 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.987 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.5 157.63 28.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.545 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.38 124.22 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.26 151.48 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -120.6 113.14 19.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -114.7 95.33 5.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.465 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.419 ' HB3' HG22 ' A' ' 264' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 189' ' ' GLN . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.651 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.708 ' HA ' HG12 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.455 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m -144.28 147.22 33.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.65 98.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.1 t 62.1 -82.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.98 72.9 0.11 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -129.18 141.57 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.469 ' HA ' HD21 ' A' ' 217' ' ' LEU . 24.8 p-10 -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.493 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 253' ' ' TRP . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.407 ' CZ3' HG11 ' A' ' 246' ' ' VAL . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 218' ' ' PRO . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.568 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 186' ' ' MET . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -102.12 80.63 2.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 173.82 141.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.85 102.07 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -134.3 78.64 57.35 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.239 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.432 ' HG2' ' HD3' ' B' ' 22' ' ' PRO . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.78 0 CA-C-O 119.789 -0.171 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 21' ' ' PRO . 59.3 Cg_exo -52.12 147.06 28.35 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.949 1.766 . . . . 0.0 112.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' A' ' 261' ' ' VAL . 52.9 Cg_endo -69.78 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.395 2.063 . . . . 0.0 112.402 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -132.46 100.59 5.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.2 p -106.25 103.74 13.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 50.6 mm -59.25 109.75 2.16 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 19.2 Cg_endo -58.54 96.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.607 2.204 . . . . 0.0 112.169 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.64 -32.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 58.8 -172.69 0.1 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -119.13 143.53 47.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.34 87.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.88 7.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -140.12 137.77 34.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -120.22 113.37 20.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 -79.47 95.16 5.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.431 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 199' ' ' HIS . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.641 HG23 HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.437 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.496 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p -81.83 -178.3 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.41 82.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.2 t -68.48 -52.25 34.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 130.78 45.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -131.05 143.68 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.449 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.456 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.537 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.521 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.8 m120 -117.24 172.51 7.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.62 22.56 11.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.456 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -55.05 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.56 79.65 9.45 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.082 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.234 . . . . 0.0 112.237 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 111.069 -0.396 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 159.46 51.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.507 2.138 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG2' HG12 ' A' ' 261' ' ' VAL . 33.6 Cg_endo -64.75 -73.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.579 2.186 . . . . 0.0 112.176 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.658 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.532 ' HE3' HG22 ' B' ' 30' ' ' THR . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.532 HG22 ' HE3' ' B' ' 27' ' ' TRP . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' B' ' 37' ' ' ILE . 7.3 m120 -90.5 -67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.79 -82.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.804 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 7.6 t -103.14 -33.91 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' B' ' 34' ' ' ASN . 59.5 mt 67.49 129.19 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.35 101.28 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.522 2.148 . . . . 0.0 112.349 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 39' ' ' VAL . 9.3 p -164.07 35.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.335 0.588 . . . . 0.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -48.25 135.94 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -69.32 -38.51 78.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.829 0.347 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.42 -44.91 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.565 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.73 147.56 22.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.37 131.65 54.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.06 113.02 25.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -118.89 95.51 4.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.628 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.588 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 11.7 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.594 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 262' ' ' VAL . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.404 HG12 ' ND1' ' A' ' 199' ' ' HIS . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.738 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.448 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.602 HH11 HG21 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.405 ' HA ' HD13 ' A' ' 257' ' ' LEU . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m -122.23 -165.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.2 153.36 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.113 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 t 61.73 11.03 3.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.113 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.44 78.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.654 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.12 143.09 40.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.602 HG21 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.527 ' HA ' HD21 ' A' ' 217' ' ' LEU . 10.9 m120 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 218' ' ' PRO . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 197' ' ' PRO . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -103.86 81.08 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 175.19 -56.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.664 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 t80 57.25 96.04 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -120.66 80.75 32.0 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.621 2.214 . . . . 0.0 112.255 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.484 ' HA ' ' HD2' ' B' ' 22' ' ' PRO . 2.6 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' B' ' 21' ' ' PRO . 2.8 Cg_endo -43.3 -48.74 7.95 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.902 2.401 . . . . 0.0 113.343 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.513 ' HG2' HG12 ' A' ' 261' ' ' VAL . 58.5 Cg_endo -71.4 -78.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.847 1.698 . . . . 0.0 112.235 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.49 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 ' HE3' ' B' ' 27' ' ' TRP . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -98.87 -78.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.02 -71.39 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 57.2 m -49.98 -76.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.939 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 46.6 mm 66.6 129.06 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 37' ' ' ILE . 6.1 Cg_exo -78.96 110.44 2.77 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.804 2.336 . . . . 0.0 112.017 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.0 -34.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.232 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.18 98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -93.26 -16.87 24.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.739 0.304 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.4 174.13 34.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 59.42 -177.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 180' ' ' LYS . 10.1 mptt -120.43 173.92 6.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -104.35 113.01 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER -130.18 95.16 3.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.98 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 188' ' ' GLU . 2.2 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.579 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.422 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.502 HG12 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.739 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.682 HG23 HG11 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.748 HD22 ' H ' ' A' ' 205' ' ' ARG . 10.3 t30 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.748 ' H ' HD22 ' A' ' 203' ' ' ASN . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.477 ' HB3' HD11 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.419 ' HB3' HD11 ' A' ' 231' ' ' LEU . 28.8 mm-40 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t -125.07 -171.73 2.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -53.89 155.68 3.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 37.1 t 61.86 11.48 4.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.056 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.16 76.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.684 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -136.29 141.55 43.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.423 ' HA ' HD21 ' A' ' 217' ' ' LEU . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.693 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.488 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -100.94 81.41 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 183' ' ' GLN . 13.4 t-20 175.36 -64.7 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 2.4 t80 59.14 96.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -77.12 -47.79 2.62 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.899 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 33.5 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.432 2.088 . . . . 0.0 112.317 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.484 0.938 0 N-CA-C 111.191 -0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 156.98 61.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.221 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.6 ' HG2' HG12 ' A' ' 261' ' ' VAL . 35.0 Cg_endo -65.73 -74.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.445 2.097 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.693 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 188' ' ' GLU . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -124.08 114.45 19.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -136.91 -39.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.975 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 87.8 m -74.1 -52.69 11.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm 64.07 117.62 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.97 98.93 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.461 2.107 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.52 -37.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.033 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 57.09 96.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -104.3 130.68 52.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -165.35 155.89 27.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.564 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -148.19 173.39 13.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -111.01 178.52 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -130.26 113.14 14.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -125.69 95.24 4.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB3' HG22 ' A' ' 264' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.521 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.484 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.428 ' HA ' HG21 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.429 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.727 ' HA ' HG12 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.672 HG23 HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.489 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.538 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.653 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m -76.36 -164.93 0.44 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -63.97 176.54 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t 62.28 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 165.63 51.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.606 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.19 141.61 40.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.451 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.653 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.48 HG23 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 240' ' ' ASN . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' A' ' 217' ' ' LEU . 9.3 p30 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.48 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.471 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.462 HG12 HG22 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 82.5 m-20 -117.57 80.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 63.7 t30 161.62 26.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.807 0.692 . . . . 0.0 110.466 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -53.49 106.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.189 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.99 69.86 6.33 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.031 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.711 2.274 . . . . 0.0 112.511 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.36 153.31 41.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 112.253 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 261' ' ' VAL . 43.9 Cg_endo -68.3 -75.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 261' ' ' VAL . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.521 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.541 ' O ' HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 199' ' ' HIS . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.509 HD22 ' HB2' ' A' ' 182' ' ' TYR . 2.3 m120 -108.03 126.3 52.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.02 -38.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.206 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 10.5 t -105.36 -25.51 12.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.181 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.8 mm 67.11 132.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.84 104.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.921 2.414 . . . . 0.0 112.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.98 -22.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 60.26 -176.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -125.75 -51.23 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.748 0.309 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.95 77.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.43 172.04 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -98.62 167.5 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.76 113.33 14.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.4 OUTLIER -108.19 95.45 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.81 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.501 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.69 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.562 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.422 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.707 ' HA ' HD13 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.619 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -79.59 -172.46 3.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.54 171.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.104 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.2 m 62.56 9.84 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.232 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.07 52.99 50.11 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.821 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -138.04 140.92 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.619 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.49 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.594 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 2.6 t-20 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 2.3 m-20 -103.05 80.84 1.9 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 28.7 t30 172.61 -25.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.716 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.79 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.415 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 50.74 54.81 15.97 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.253 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.512 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 111.105 -0.383 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.51 156.94 60.36 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.539 2.159 . . . . 0.0 112.263 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.624 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo -65.68 -76.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.528 2.152 . . . . 0.0 112.305 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.594 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.471 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -143.62 114.38 7.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -106.93 -33.94 7.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 38.6 p -58.64 -74.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.349 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.5 mm 64.36 131.55 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.369 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 37' ' ' ILE . 5.9 Cg_exo -77.91 110.62 2.95 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.753 2.302 . . . . 0.0 112.128 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 41' ' ' THR . 13.1 t -98.49 -70.39 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 56.53 24.86 9.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.454 ' H ' HG12 ' B' ' 39' ' ' VAL . 62.9 m 59.94 99.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -155.96 68.19 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -150.29 113.42 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 203' ' ' ASN . 67.4 mttm -135.75 144.99 46.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -99.39 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 -116.74 95.41 5.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.682 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.573 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.404 HG23 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.736 ' HA ' HG12 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.69 HG23 HG11 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 180' ' ' LYS . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 244' ' ' ILE . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' HG23 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.481 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 252' ' ' GLU . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t -143.68 139.86 29.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 60.58 102.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.225 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t 63.07 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.11 51.36 0.2 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.452 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -104.37 141.39 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' CE1' ' A' ' 211' ' ' PHE . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 223' ' ' ILE . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.574 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.579 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.717 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.439 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 37.2 m-80 -117.1 80.32 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 55.0 t30 173.06 28.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.71 108.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.944 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.89 80.93 9.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.722 2.281 . . . . 0.0 112.305 179.813 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.404 ' N ' ' HD2' ' B' ' 22' ' ' PRO . 43.9 Cg_exo . . . . . 0 N--CA 1.485 1.021 0 CA-C-O 119.872 -0.137 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' HD2' ' B' ' 23' ' ' PRO . 73.9 Cg_endo -75.55 114.35 3.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.936 1.757 . . . . 0.0 112.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.579 ' HG2' HG12 ' A' ' 261' ' ' VAL . 14.7 Cg_endo -57.2 -67.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.717 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 28' ' ' SER . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 188' ' ' GLU . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -95.58 150.73 20.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -135.38 -45.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -123.55 97.18 5.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.052 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.24 128.41 57.64 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.072 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.88 98.16 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.534 2.156 . . . . 0.0 112.188 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.5 -28.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.009 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.0 t70 59.27 98.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.6 m -67.26 112.36 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.46 54.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.46 32.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -151.09 153.34 34.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -123.3 113.35 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.02 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.527 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 -105.78 95.3 5.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.613 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.564 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.458 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 8.2 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 199' ' ' HIS . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.602 ' HA ' HG12 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.527 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 252' ' ' GLU . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p -124.53 -164.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.11 157.5 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.196 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.9 m 62.04 10.25 3.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.36 74.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -138.23 141.85 39.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HG3' ' HZ3' ' A' ' 253' ' ' TRP . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' HD11 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.57 ' H ' HG12 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.438 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.441 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.646 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -97.97 80.91 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.8 t30 174.81 137.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.524 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.24 98.92 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -126.14 80.52 68.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.143 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.562 2.175 . . . . 0.0 112.278 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 111.171 -0.357 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.28 156.17 55.3 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.422 2.081 . . . . 0.0 112.262 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.515 ' HG2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo -67.82 -74.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.285 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.463 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 186' ' ' MET . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 -105.27 -59.93 1.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 66.13 -4.69 0.64 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.077 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.432 ' H ' ' C ' ' B' ' 34' ' ' ASN . 40.0 p -148.59 95.58 2.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.839 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.44 128.33 28.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.51 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.732 2.288 . . . . 0.0 112.257 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.28 -30.76 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 59.43 99.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 66.0 m -73.3 -38.74 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.56 73.67 0.3 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -139.21 17.95 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.65 145.87 24.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.64 113.42 14.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 95.11 7.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.531 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.443 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.528 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.542 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.405 HG23 HG11 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.403 ' HE1' ' NE ' ' A' ' 208' ' ' ARG . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.441 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m -91.23 -178.37 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.54 -22.5 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t -85.74 -21.01 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.23 4.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -122.59 142.96 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.654 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.5 p-10 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.654 ' HB ' HG23 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.552 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -117.59 172.14 7.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 61.11 29.59 18.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.53 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.87 107.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.062 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -123.88 81.55 55.93 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.179 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.72 2.28 . . . . 0.0 112.211 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 111.092 -0.388 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.52 156.01 58.66 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.467 2.111 . . . . 0.0 112.225 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.4 Cg_endo -69.76 -77.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.513 2.142 . . . . 0.0 112.341 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.592 HG13 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 199' ' ' HIS . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -94.49 102.28 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' B' ' 35' ' ' LYS . 3.6 mptp? -79.41 -63.95 1.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 69.5 p -96.72 102.41 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.04 124.91 88.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.48 100.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.686 2.257 . . . . 0.0 112.223 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.7 -30.8 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.225 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.4 -173.58 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.0 m -129.86 -49.05 1.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.01 58.13 0.42 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.49 -172.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.859 0.362 . . . . 0.0 111.218 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -146.91 163.59 35.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.36 113.64 25.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -106.21 95.24 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.709 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.579 ' HG3' ' HB3' ' A' ' 268' ' ' ASN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.51 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.421 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 22.2 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.707 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.696 HG23 HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 202' ' ' ASP . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 244' ' ' ILE . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.53 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t -140.1 175.82 9.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.77 -84.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.4 m -147.57 -14.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 161.52 30.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.53 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 248' ' ' THR . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.404 ' H ' HG12 ' A' ' 246' ' ' VAL . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.414 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.414 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.456 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 5.6 t30 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 84.6 m-20 -117.54 82.59 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.579 ' HB3' ' HG3' ' A' ' 183' ' ' GLN . 27.6 t-20 163.51 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.257 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.503 ' H ' ' ND2' ' A' ' 266' ' ' ASN . 65.8 t80 57.03 98.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.311 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -138.16 78.46 34.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.975 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.346 0.402 0 C-N-CA 122.597 2.198 . . . . 0.0 112.297 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.148 -0.366 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' B' ' 23' ' ' PRO . 58.4 Cg_endo -71.71 157.25 55.98 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.498 2.132 . . . . 0.0 112.248 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.538 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo -78.43 -57.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.884 2.389 . . . . 0.0 112.005 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.464 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.449 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 1.1 p30 -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -107.46 97.25 7.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -99.14 -34.59 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -127.72 98.66 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -63.8 130.11 94.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.74 99.22 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.529 2.153 . . . . 0.0 112.337 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.89 -30.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 59.33 98.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.3 t -95.18 -5.63 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -163.43 -171.92 30.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.434 ' C ' ' HZ3' ' A' ' 180' ' ' LYS . . . -138.96 -176.91 4.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.332 . . . . 0.0 111.08 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.659 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -131.24 157.36 43.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -95.81 113.83 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -80.54 94.7 6.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.181 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' A' ' 189' ' ' GLN . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 49.7 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.434 HG12 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.696 ' HA ' HG12 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.568 HG13 HG11 ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 243' ' ' ILE . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.642 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t -60.87 172.29 1.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.33 -14.42 62.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.1 m -77.25 -62.34 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 141.5 31.56 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -137.86 145.84 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.642 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.424 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.507 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.5 p-10 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 217' ' ' LEU . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.55 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.481 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 -117.06 81.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -179.86 -60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.728 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 51.0 t80 57.97 95.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.206 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -117.1 81.78 13.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.683 2.256 . . . . 0.0 112.249 179.751 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.403 ' N ' ' HD2' ' B' ' 22' ' ' PRO . 45.0 Cg_exo . . . . . 0 N--CA 1.485 0.996 0 CA-C-O 119.834 -0.152 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' B' ' 21' ' ' PRO . 73.6 Cg_endo -75.5 155.4 40.64 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.933 1.756 . . . . 0.0 112.307 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.571 ' HG2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo -74.5 -80.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.459 2.106 . . . . 0.0 112.251 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.55 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.441 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.418 HD21 HD11 ' B' ' 37' ' ' ILE . 4.5 m-20 -95.61 -72.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 0.0 OUTLIER 61.12 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 76.7 p -102.78 103.78 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.418 HD11 HD21 ' B' ' 34' ' ' ASN . 50.2 mm -73.54 126.75 89.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.021 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.54 102.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.834 2.356 . . . . 0.0 112.305 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 -32.36 35.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.183 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 60.68 104.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.3 p -59.25 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.191 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.9 2.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.57 144.3 25.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.345 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -129.81 149.64 51.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.45 113.48 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER -90.87 95.19 10.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' HG23 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 1.3 mp0 -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' A' ' 199' ' ' HIS . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.473 ' CD2' HG12 ' A' ' 198' ' ' VAL . 44.5 m-70 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 243' ' ' ILE . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 244' ' ' ILE . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.509 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.635 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t -67.86 177.5 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.57 4.47 24.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -95.2 -22.6 17.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 104.34 13.08 27.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -128.6 147.0 50.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.474 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.635 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 209' ' ' PHE . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.612 HG11 ' HG2' ' A' ' 271' ' ' PRO . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 261' ' ' VAL . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.7 m120 -117.1 171.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 59.18 17.95 6.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.074 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -53.14 98.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.44 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.513 ' H ' ' HD2' ' A' ' 271' ' ' PRO . . . -94.21 -50.54 0.26 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.775 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.612 ' HG2' HG11 ' A' ' 249' ' ' VAL . 73.5 Cg_endo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.449 2.099 . . . . 0.0 112.377 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 CA-C-O 119.866 -0.139 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.08 158.75 45.34 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.947 1.765 . . . . 0.0 112.283 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo -72.5 -81.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.529 2.152 . . . . 0.0 112.126 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.486 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.5 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.558 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 184' ' ' TYR . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -96.34 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -94.84 -36.98 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -132.18 108.46 9.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.26 127.1 91.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.926 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.37 101.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.838 2.359 . . . . 0.0 112.361 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.425 HG13 ' O ' ' B' ' 39' ' ' VAL . 2.9 p -94.23 91.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' B' ' 39' ' ' VAL . 3.2 p30 44.2 28.62 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.474 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 63.5 m -72.25 130.26 40.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.759 0.314 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.8 147.64 18.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.421 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.6 18.99 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.047 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -78.85 141.99 37.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -131.94 113.11 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.603 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER -115.09 95.29 5.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.717 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 193' ' ' ARG . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.676 HG23 HG11 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.603 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' ILE . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 244' ' ' ILE . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.448 ' HB3' HD11 ' A' ' 231' ' ' LEU . 96.1 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.59 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 -178.63 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.55 85.97 1.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -173.49 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 131.46 15.59 1.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -130.47 166.34 20.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.552 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.59 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.438 ' HA ' HD21 ' A' ' 217' ' ' LEU . 24.6 p-10 -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 209' ' ' PHE . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.498 ' HG2' HG23 ' A' ' 261' ' ' VAL . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.52 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.601 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -110.78 81.37 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.5 t30 177.19 -42.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 26.7 t80 62.66 118.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.251 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -112.85 81.34 4.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.189 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.724 2.283 . . . . 0.0 112.234 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 111.154 -0.364 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.91 126.0 10.33 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.495 2.13 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.52 ' HG2' HG12 ' A' ' 261' ' ' VAL . 39.4 Cg_endo -67.33 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.371 2.047 . . . . 0.0 112.18 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.51 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.59 ' H ' ' HB2' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.526 ' H ' HE22 ' A' ' 189' ' ' GLN . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.61 99.05 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' B' ' 35' ' ' LYS . 3.8 mppt? -113.44 -23.37 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.639 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 62.6 m -80.16 -48.78 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm 63.8 119.73 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.41 98.27 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.413 2.076 . . . . 0.0 112.291 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.413 HG23 ' H ' ' B' ' 40' ' ' ASP . 0.2 OUTLIER -121.13 -53.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.413 ' H ' HG23 ' B' ' 39' ' ' VAL . 14.6 t70 59.94 90.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.632 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.8 m -60.34 -65.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.079 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.841 0.353 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.88 -113.05 2.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.7 137.6 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.344 . . . . 0.0 111.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.01 151.51 19.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -129.95 112.9 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.683 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.515 ' HB2' ' ND2' ' B' ' 34' ' ' ASN . 0.5 OUTLIER -105.32 95.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.354 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.425 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 1.2 mp0 -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.425 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.681 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.526 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.404 ' N ' HG12 ' B' ' 33' ' ' VAL . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.546 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.546 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -74.63 -165.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.4 177.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.109 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.5 m 63.54 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.082 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 162.8 51.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.665 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -138.01 159.94 40.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.477 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.546 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.3 p-10 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 217' ' ' LEU . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' MET . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -99.44 80.9 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.1 t30 174.03 134.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.438 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -143.98 99.45 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.389 . . . . 0.0 110.941 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.57 81.93 18.9 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.716 2.277 . . . . 0.0 112.209 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.484 0.935 0 N-CA-C 111.194 -0.348 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.458 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 75.0 Cg_exo -49.04 -48.04 19.62 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.639 2.226 . . . . 0.0 113.279 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo -73.83 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.935 1.757 . . . . 0.0 112.285 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HB ' ' A' ' 185' ' ' VAL . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 182' ' ' TYR . 91.2 m-20 -97.56 143.72 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.35 -30.48 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 65.5 p -70.53 -63.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.473 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 49.8 mm 60.29 104.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.224 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 9.6 Cg_endo -50.78 102.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.608 HG13 ' H ' ' B' ' 40' ' ' ASP . 1.0 OUTLIER -117.25 -63.65 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.22 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.608 ' H ' HG13 ' B' ' 39' ' ' VAL . 3.1 p30 179.89 -174.97 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.5 p -140.73 -39.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.154 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.59 78.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.399 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -141.0 128.87 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -141.09 142.25 34.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.74 113.39 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.356 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 -81.19 95.24 6.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.594 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.626 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.653 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.405 HG12 ' HD2' ' A' ' 260' ' ' LYS . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TRP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.412 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD3' HG23 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.498 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m -144.19 -179.52 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.14 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.365 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -147.53 -12.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 159.03 37.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -103.52 139.63 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.507 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.507 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.525 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.5 p-10 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 246' ' ' VAL . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.706 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.411 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.77 81.68 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 179.74 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.62 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 28.3 t80 57.96 97.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.216 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -130.16 80.9 69.9 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 C--N 1.346 0.435 0 C-N-CA 122.631 2.221 . . . . 0.0 112.305 179.747 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.101 -0.384 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.52 143.95 97.54 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.474 2.116 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.82 ' HB2' HG12 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -85.13 179.51 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.765 2.31 . . . . 0.0 112.059 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.547 ' O ' HG13 ' B' ' 31' ' ' VAL . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.57 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 199' ' ' HIS . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.42 -15.48 52.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 61.13 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -89.83 96.43 10.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.51 124.17 90.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.06 99.18 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.502 2.135 . . . . 0.0 112.281 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.69 -26.11 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.993 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.4 t -113.04 -16.78 12.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.079 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.027 0.441 . . . . 0.0 110.752 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.462 ' HB2' HG13 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.599 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.599 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.689 ' HA ' HG12 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.755 HD22 ' H ' ' A' ' 205' ' ' ARG . 10.4 t30 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.755 ' H ' HD22 ' A' ' 203' ' ' ASN . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.648 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.463 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 207' ' ' THR . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.436 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.495 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.613 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.406 0.086 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.613 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 110.262 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.539 ' H ' HD21 ' B' ' 34' ' ' ASN . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.463 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 71.7 mm-40 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.545 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.633 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.433 HG12 ' ND1' ' A' ' 199' ' ' HIS . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.709 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.428 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.751 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.441 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.428 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.495 HG12 ' H ' ' B' ' 24' ' ' GLU . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.597 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.596 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.504 0.126 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.597 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.636 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.539 HD21 ' H ' ' A' ' 184' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.655 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.7 HE22 ' HA ' ' B' ' 25' ' ' PRO . 16.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.612 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 199' ' ' HIS . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.718 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.631 HG23 HG11 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.5 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.5 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.444 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.597 ' SD ' HG23 ' A' ' 230' ' ' THR . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.597 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.56 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 241' ' ' ARG . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.418 ' HG3' ' HB ' ' A' ' 236' ' ' VAL . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.546 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 CA-C-O 120.747 0.228 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.7 ' HA ' HE22 ' A' ' 189' ' ' GLN . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.466 ' H ' ' NE2' ' A' ' 189' ' ' GLN . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.419 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.652 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.464 ' H ' HD21 ' B' ' 34' ' ' ASN . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.451 HG23 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.662 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.451 ' HD3' HG23 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 244' ' ' ILE . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.64 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.64 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 243' ' ' ILE . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.558 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.424 HD12 HG23 ' A' ' 237' ' ' VAL . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.635 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 38.1 m-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.506 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 120.456 0.107 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.635 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 189' ' ' GLN . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.464 HD21 ' H ' ' A' ' 184' ' ' TYR . 1.4 p30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.5 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.94 0.4 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.491 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.494 ' HB2' HE22 ' A' ' 189' ' ' GLN . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.621 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.0 OUTLIER -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.621 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.454 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.604 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.67 ' HA ' HG12 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.525 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 2.6 t-20 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.417 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.479 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.564 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.556 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.556 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.55 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.479 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.447 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.511 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.546 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.67 0.196 . . . . 0.0 112.234 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 261' ' ' VAL . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.511 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HE3' ' B' ' 27' ' ' TRP . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 38.4 m-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.465 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.419 ' HB3' HG22 ' A' ' 264' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 189' ' ' GLN . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.651 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.708 ' HA ' HG12 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.455 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 231' ' ' LEU . 26.1 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.482 HD12 HE21 ' A' ' 219' ' ' GLN . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.493 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 253' ' ' TRP . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.407 ' CZ3' HG11 ' A' ' 246' ' ' VAL . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 218' ' ' PRO . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.568 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 186' ' ' MET . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' A' ' 261' ' ' VAL . 52.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.515 0.131 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 199' ' ' HIS . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.641 HG23 HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.437 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.496 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.449 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.456 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.537 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.521 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 40.0 m-80 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG2' HG12 ' A' ' 261' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--O 1.23 0.1 0 CA-C-O 120.476 0.115 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.658 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.532 ' HE3' HG22 ' B' ' 30' ' ' THR . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.532 HG22 ' HE3' ' B' ' 27' ' ' TRP . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.951 0.405 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.505 ' HB2' HE22 ' A' ' 189' ' ' GLN . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.588 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.2 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.594 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 262' ' ' VAL . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.404 HG12 ' ND1' ' A' ' 199' ' ' HIS . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.738 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.448 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.602 HH11 HG21 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.405 ' HA ' HD13 ' A' ' 257' ' ' LEU . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.602 HG21 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.414 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 14.1 m120 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.527 ' HA ' HD21 ' A' ' 217' ' ' LEU . 66.4 m-20 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 218' ' ' PRO . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 197' ' ' PRO . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.513 ' HG2' HG12 ' A' ' 261' ' ' VAL . 58.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.441 0.101 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.49 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 ' HE3' ' B' ' 27' ' ' TRP . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.056 0.455 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.542 ' HB2' HE22 ' A' ' 189' ' ' GLN . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.542 HE22 ' HB2' ' A' ' 187' ' ' SER . 2.7 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.579 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.422 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.502 HG12 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.739 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.682 HG23 HG11 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.748 HD22 ' H ' ' A' ' 205' ' ' ARG . 10.3 t30 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.748 ' H ' HD22 ' A' ' 203' ' ' ASN . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.477 ' HB3' HD11 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.419 ' HB3' HD11 ' A' ' 231' ' ' LEU . 15.0 mm100 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.423 ' HA ' HD21 ' A' ' 217' ' ' LEU . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.693 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.488 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.6 ' HG2' HG12 ' A' ' 261' ' ' VAL . 35.0 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.458 0.107 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.693 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 188' ' ' GLU . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.031 0.443 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB3' HG22 ' A' ' 264' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.521 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.484 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.428 ' HA ' HG21 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.429 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.727 ' HA ' HG12 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.672 HG23 HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.489 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.538 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.653 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.451 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.653 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 233' ' ' ASN . 0.8 OUTLIER -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.48 HG23 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 240' ' ' ASN . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' A' ' 217' ' ' LEU . 2.7 p-10 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.48 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.471 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.462 HG12 HG22 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 261' ' ' VAL . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.499 0.125 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 261' ' ' VAL . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.521 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.541 ' O ' HG13 ' B' ' 31' ' ' VAL . 0.7 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 199' ' ' HIS . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.631 HD22 ' N ' ' B' ' 34' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.501 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.69 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.562 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.422 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.707 ' HA ' HD13 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.619 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.619 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.564 HD22 ' N ' ' A' ' 233' ' ' ASN . 0.8 OUTLIER -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.49 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.594 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 36.5 t30 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.624 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.535 0.139 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.594 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.471 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 0.1 OUTLIER -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.573 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.404 HG23 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.736 ' HA ' HG12 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.69 HG23 HG11 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 244' ' ' ILE . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' HG23 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.481 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 252' ' ' GLU . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' CE1' ' A' ' 211' ' ' PHE . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 223' ' ' ILE . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.574 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.579 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.717 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.439 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.579 ' HG2' HG12 ' A' ' 261' ' ' VAL . 14.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.504 0.127 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.717 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 188' ' ' GLU . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.527 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.564 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.458 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 53.4 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 199' ' ' HIS . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.602 ' HA ' HG12 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.527 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.558 HE21 HD11 ' A' ' 231' ' ' LEU . 15.4 mm100 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 252' ' ' GLU . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.558 HD11 HE21 ' A' ' 219' ' ' GLN . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HG3' ' HZ3' ' A' ' 253' ' ' TRP . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' HD11 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.57 ' H ' HG12 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.438 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.441 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.646 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.515 ' HG2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.593 0.164 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.463 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 186' ' ' MET . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.027 0.441 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.531 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.443 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.528 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.542 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.405 HG23 HG11 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.403 ' HE1' ' NE ' ' A' ' 208' ' ' ARG . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.441 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.414 ' HD2' HG13 ' A' ' 237' ' ' VAL . 43.2 t60 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.654 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.2 p30 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.654 ' HB ' HG23 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.552 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.4 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.449 0.104 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.592 HG13 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 199' ' ' HIS . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 110.709 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.676 HE21 HD21 ' A' ' 266' ' ' ASN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.51 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.421 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.646 HE22 ' HA ' ' B' ' 25' ' ' PRO . 22.1 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.707 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.696 HG23 HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 202' ' ' ASP . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 244' ' ' ILE . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.53 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.53 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 248' ' ' THR . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.404 ' H ' HG12 ' A' ' 246' ' ' VAL . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.414 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.414 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.456 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.676 HD21 HE21 ' A' ' 183' ' ' GLN . 15.7 t-20 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.538 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 120.663 0.193 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HA ' HE22 ' A' ' 189' ' ' GLN . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.456 ' N ' HE22 ' A' ' 189' ' ' GLN . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.449 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' A' ' 189' ' ' GLN . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 7.5 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.434 HG12 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.696 ' HA ' HG12 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.568 HG13 HG11 ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 243' ' ' ILE . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.642 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.642 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.424 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.507 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.3 p30 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 217' ' ' LEU . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.55 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.481 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.571 ' HG2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.484 0.118 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.55 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.441 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.479 HD22 ' N ' ' B' ' 34' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' HG23 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 212' ' ' PRO . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.413 ' HA ' HG12 ' B' ' 33' ' ' VAL . 21.2 m80 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 243' ' ' ILE . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 244' ' ' ILE . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.509 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.635 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.474 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.635 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 209' ' ' PHE . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 261' ' ' VAL . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.7 m120 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 CA-C-O 120.459 0.108 . . . . 0.0 112.126 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.486 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.558 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 184' ' ' TYR . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.603 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.606 ' H ' HD21 ' B' ' 34' ' ' ASN . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 193' ' ' ARG . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.676 HG23 HG11 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.603 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' ILE . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 244' ' ' ILE . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.448 ' HB3' HD11 ' A' ' 231' ' ' LEU . 24.8 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.59 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.552 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.59 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.752 ' H ' HD22 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 209' ' ' PHE . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.498 ' HG2' HG23 ' A' ' 261' ' ' VAL . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.52 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.601 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.52 ' HG2' HG12 ' A' ' 261' ' ' VAL . 39.4 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.476 0.115 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.51 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.59 ' H ' ' HB2' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.526 ' H ' HE22 ' A' ' 189' ' ' GLN . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.606 HD21 ' H ' ' A' ' 184' ' ' TYR . 2.4 p30 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.938 0.399 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.425 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.425 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.681 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.526 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.42 ' H ' ' ND2' ' B' ' 34' ' ' ASN . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.546 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.408 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.546 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.477 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.546 ' HA ' HD21 ' A' ' 217' ' ' LEU . 9.4 p30 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 217' ' ' LEU . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' MET . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo . . . . . 0 C--O 1.23 0.119 0 CA-C-O 120.486 0.119 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HB ' ' A' ' 185' ' ' VAL . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 199' ' ' HIS . 12.9 m120 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.594 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' MET . . . . . 0.626 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.653 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.405 HG12 ' HD2' ' A' ' 260' ' ' LYS . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.412 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD3' HG23 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.498 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.507 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.507 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.585 ' HB2' HD22 ' A' ' 242' ' ' ASN . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.585 HD22 ' HB2' ' A' ' 240' ' ' ASN . 8.3 p30 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 246' ' ' VAL . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.706 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.411 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.82 ' HB2' HG12 ' A' ' 261' ' ' VAL . 59.6 Cg_endo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 120.732 0.221 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.547 ' O ' HG13 ' B' ' 31' ' ' VAL . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.57 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 199' ' ' HIS . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.845 0.355 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.61 -152.51 6.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.505 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.83 113.01 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -101.43 165.28 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -131.41 113.09 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.94 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -120.49 95.28 4.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -115.12 103.68 11.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.22 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.26 154.92 45.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.13 0.49 . . . . 0.0 111.58 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.7 m -142.79 127.7 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.28 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.7 ptt? -122.18 146.44 47.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.417 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.6 p -55.11 131.17 44.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.462 ' HB2' HG13 ' B' ' 31' ' ' VAL . 7.2 tp10 -89.71 90.06 8.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.626 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 2.1 mp0 -127.68 123.87 23.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.398 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.15 -10.54 28.48 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.42 2.08 . . . . 0.0 112.521 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.5 pt-20 -83.19 -36.86 24.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 16.1 ptp -99.66 16.62 22.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.423 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.599 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -63.77 -26.15 68.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.064 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -52.12 -52.16 53.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.526 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.3 pt -96.83 10.58 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.342 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.599 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 60.9 tt0 -59.66 119.84 43.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.678 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.07 126.57 16.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 112.117 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -53.31 -68.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.663 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.689 ' HA ' HG12 ' B' ' 33' ' ' VAL . 76.5 m-70 -144.34 157.46 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.563 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 93.5 t -140.76 137.56 35.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.696 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.6 p90 -145.4 138.38 26.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.166 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -112.88 173.02 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.063 0.458 . . . . 0.0 111.474 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.755 HD22 ' H ' ' A' ' 205' ' ' ARG . 10.4 t30 -145.98 162.99 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -55.43 -23.52 25.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.408 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.755 ' H ' HD22 ' A' ' 203' ' ' ASN . 80.2 mtm180 -99.05 -69.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -128.81 170.83 12.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 111.35 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 91.3 m -121.07 142.05 50.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.614 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.18 124.49 43.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.243 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.07 121.8 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.451 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 94.8 m-85 -118.46 160.75 38.6 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.669 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.01 154.39 51.33 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.366 2.044 . . . . 0.0 111.961 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.13 -26.95 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -86.1 -14.89 42.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 111.094 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -98.83 168.05 10.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.161 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.41 156.56 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.7 mp -92.04 112.55 55.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.213 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.17 179.57 6.08 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -101.51 125.97 48.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -97.8 119.53 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 111.644 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.0 m-85 -93.63 177.57 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.549 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.648 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -147.63 139.13 23.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.461 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.8 mm -80.66 104.65 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.241 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.6 t -64.07 176.88 0.89 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.4 39.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.7 t -81.84 -59.23 2.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.88 -6.21 1.36 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 0.5 OUTLIER -103.28 175.17 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 110.79 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.5 mt-10 -92.74 136.58 33.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.9 m -130.35 138.38 50.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.008 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 232' ' ' PRO . 6.3 tt -92.84 106.28 18.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.739 0.304 . . . . 0.0 110.935 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.8 Cg_endo -76.28 159.26 36.81 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.963 2.442 . . . . 0.0 112.545 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.82 112.43 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.545 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.2 p -100.82 158.09 16.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 49.4 m80 -131.84 167.41 19.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.36 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.56 129.1 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 111.431 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.48 -179.62 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 167.59 22.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.486 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.05 -17.9 62.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -126.94 10.46 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 241' ' ' ARG . 8.8 mpt_? 57.98 28.0 15.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.463 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.4 p-10 -91.06 11.35 23.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.5 mt -108.06 154.55 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.7 mt -132.79 103.27 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 207' ' ' THR . 38.7 tt0 -93.21 110.64 22.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.355 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 248' ' ' THR . 82.1 t -89.68 140.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.656 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.2 tt0 -88.93 63.09 6.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.914 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 246' ' ' VAL . 7.3 t 173.36 154.31 0.1 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.974 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.4 t -125.3 124.94 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -133.19 -174.09 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.19 -7.5 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.67 123.7 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -121.63 132.52 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.436 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -116.58 105.07 12.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 220' ' ' VAL . 76.6 mt -89.66 114.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -125.17 142.19 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 111.389 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 36.3 tp -167.2 125.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.88 -115.25 7.58 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -119.44 19.05 12.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.664 0.269 . . . . 0.0 111.171 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.495 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 32.1 mmmt -127.84 150.25 49.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 111.355 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.1 p -140.46 146.46 24.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 74.4 t -131.7 112.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.434 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.613 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.69 125.42 7.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.086 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 186' ' ' MET . 74.6 t -123.14 146.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -141.64 131.89 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.361 . . . . 0.0 111.008 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -92.3 116.14 28.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -105.38 81.15 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.685 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 175.74 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 40.1 t80 59.41 98.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.024 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 271' ' ' PRO . . . -81.14 -50.46 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.062 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 270' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.38 2.053 . . . . 0.0 112.377 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.173 -0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' B' ' 23' ' ' PRO . 52.8 Cg_exo -55.13 117.19 3.75 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.237 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 43.5 Cg_endo -67.55 -79.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.343 2.028 . . . . 0.0 112.22 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.3 tt0 61.98 124.22 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.613 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.4 Cg_endo -78.73 105.04 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.303 2.002 . . . . 0.0 111.308 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.42 -7.48 59.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.594 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.613 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.79 28.74 6.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.025 0.44 . . . . 0.0 109.931 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m -34.25 -66.61 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.138 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -112.23 -0.4 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.75 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 54.5 m 40.61 89.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.312 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 188' ' ' GLU . 5.3 m -103.4 120.46 51.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.054 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 89.9 Cg_exo -50.48 169.15 0.16 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.011 2.474 . . . . 0.0 113.311 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.1 t -112.86 10.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -127.97 104.83 8.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -126.22 -38.75 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.987 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.6 p -81.79 -41.2 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.254 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.9 mm 62.22 109.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.116 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -78.89 97.65 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 112.311 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.14 -25.77 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.063 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.0 t70 61.17 101.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.094 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 58.6 m -68.26 139.74 56.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 155.32 146.96 4.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -144.95 126.38 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -144.87 133.86 22.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -114.12 113.61 24.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.9 OUTLIER -81.68 95.09 7.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.262 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -91.87 99.14 12.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.539 ' H ' HD21 ' B' ' 34' ' ' ASN . 65.4 m-85 -126.91 143.37 51.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.334 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.5 m -142.78 133.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.658 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.0 ptt? -125.4 156.87 38.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.362 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 81.1 p -66.51 125.9 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -77.41 101.78 6.54 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.818 0.342 . . . . 0.0 110.735 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.463 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 71.7 mm-40 -144.86 117.7 5.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.65 -10.75 28.5 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.552 2.168 . . . . 0.0 112.422 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -79.99 -26.3 39.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.545 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.1 ptp -110.9 20.49 17.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.8 ptt180 -67.32 -26.46 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.6 t -53.21 -52.14 59.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.355 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -97.91 8.96 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.633 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.1 tt0 -59.09 127.94 84.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.62 124.88 10.12 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.38 2.053 . . . . 0.0 112.125 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.433 HG12 ' ND1' ' A' ' 199' ' ' HIS . 47.3 t -51.11 -68.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.709 ' HA ' HG12 ' B' ' 33' ' ' VAL . 41.3 m80 -145.32 156.38 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.53 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 33' ' ' VAL . 84.0 t -139.84 136.58 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.597 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.4 p90 -148.1 136.94 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.428 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.98 167.18 10.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 0.0 111.649 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -136.45 179.74 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -70.97 -23.56 62.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -97.76 -69.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.599 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -129.39 171.11 12.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.332 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 91.2 m -121.51 141.03 51.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.418 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.54 143.0 49.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.077 0.465 . . . . 0.0 111.827 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.16 124.31 43.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.891 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.67 122.55 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -121.22 159.79 48.24 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.819 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' A' ' 198' ' ' VAL . 36.7 Cg_exo -61.07 155.81 48.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.421 2.081 . . . . 0.0 111.937 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.13 -23.73 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.1 -14.94 42.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.38 153.71 42.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -93.51 1.62 56.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 242' ' ' ASN . 9.9 mp 62.21 102.79 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.441 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.0 Cg_endo -80.35 178.61 6.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.92 2.413 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -97.8 120.25 37.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 64.3 t -92.06 116.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.684 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.445 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.4 m-85 -97.26 177.21 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.446 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 0.4 OUTLIER -143.82 140.09 29.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 252' ' ' GLU . 15.5 mm -85.84 145.09 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.975 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 76.9 p -125.66 82.23 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.53 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.88 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.212 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p -42.27 -59.32 1.85 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.617 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 145.48 -7.97 1.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.558 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -62.08 139.86 58.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.936 0.398 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.4 mt-10 -95.64 115.33 27.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.2 t -114.84 135.27 54.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -91.23 110.51 43.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.3 Cg_endo -76.64 163.27 31.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.955 2.437 . . . . 0.0 112.493 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -59.51 102.44 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.429 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.2 t -98.16 156.93 16.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.456 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -140.24 166.95 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.377 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.26 132.27 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.398 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.64 177.49 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.44 162.62 22.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.67 -29.33 70.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.83 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -114.96 8.9 15.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 57.72 28.22 15.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.519 ' HA ' HD11 ' A' ' 217' ' ' LEU . 27.8 p30 -90.82 15.3 11.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.2 157.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.8 mt -134.63 104.14 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -99.54 111.52 23.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.89 133.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.48 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.95 39.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.2 m -158.8 152.23 22.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 271' ' ' PRO . 46.8 t -123.56 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.67 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -143.74 -173.84 4.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.906 0.384 . . . . 0.0 111.331 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.751 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.62 -5.1 16.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.441 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.96 123.43 13.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -124.99 114.31 18.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.742 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.428 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.7 tpp180 -98.09 106.6 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 63.0 mt -87.11 114.75 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.515 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -130.4 142.47 50.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 111.486 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 218' ' ' PRO . 18.3 tp -165.62 118.28 1.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.4 -114.68 5.57 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.227 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.49 21.75 11.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.707 0.289 . . . . 0.0 110.979 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' B' ' 23' ' ' PRO . 1.1 tpmt? -128.13 147.81 50.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.037 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.495 HG12 ' H ' ' B' ' 24' ' ' GLU . 5.1 p -141.42 146.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.899 0.381 . . . . 0.0 111.425 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.1 t -133.39 110.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.17 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.597 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.09 126.56 9.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.197 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 186' ' ' MET . 90.5 t -128.15 141.6 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -137.87 133.2 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 111.255 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -101.09 111.84 24.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.693 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.02 81.36 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 178.43 -69.0 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.698 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 49.4 t80 57.91 97.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -80.97 -47.5 1.14 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.973 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 47.2 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.487 2.124 . . . . 0.0 112.332 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.08 -0.392 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.32 157.12 18.86 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.536 2.157 . . . . 0.0 112.236 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.596 ' HB3' ' HE2' ' A' ' 260' ' ' LYS . 53.4 Cg_endo -69.4 -78.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.457 2.105 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 40.9 tt0 61.76 122.84 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.597 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.6 Cg_endo -80.61 107.63 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.383 2.056 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -86.19 -6.31 59.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.582 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.636 ' H ' ' HB2' ' A' ' 187' ' ' SER . 63.5 m95 52.42 27.44 4.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 110.153 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -35.22 -64.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.357 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -112.05 -5.26 14.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m 43.68 88.61 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.85 121.79 48.06 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.903 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 95.9 Cg_exo -49.95 170.0 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.066 2.511 . . . . 0.0 113.515 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -116.01 14.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.539 HD21 ' H ' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -150.88 103.21 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.955 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -96.86 -45.57 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 71.4 p -101.84 90.79 4.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.96 130.51 84.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.55 98.82 1.1 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.504 2.136 . . . . 0.0 112.286 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.84 -22.01 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t70 60.94 83.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.175 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -55.85 156.35 5.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.302 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.785 0.326 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.543 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.61 116.0 21.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.771 0.319 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -100.23 130.94 46.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -123.09 113.5 19.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -90.83 94.98 9.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.658 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -100.54 97.62 8.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.3 m-85 -121.59 141.99 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.656 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.0 m -142.15 124.95 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.286 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.655 ' HB3' HG22 ' A' ' 264' ' ' VAL . 12.8 ptt? -117.08 -176.89 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.508 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 93.7 p -83.1 149.32 26.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 27.6 tt0 -98.3 104.85 16.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.568 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.7 HE22 ' HA ' ' B' ' 25' ' ' PRO . 16.1 mt-30 -149.28 108.93 3.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.36 -16.22 53.4 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.424 2.083 . . . . 0.0 111.956 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -15.0 50.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.661 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.612 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 18.3 mmt -106.68 4.47 27.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 41.4 ptt180 -59.81 -25.36 64.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -48.39 -52.38 22.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.728 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 260' ' ' LYS . 47.6 pt -108.72 1.87 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 111.52 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 34.9 tt0 -58.68 133.11 86.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.5 125.82 12.74 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.299 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 199' ' ' HIS . 13.7 t -57.27 -58.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.239 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.718 ' HA ' HG12 ' B' ' 33' ' ' VAL . 80.9 m-70 -145.86 156.88 43.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.303 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.631 HG23 HG11 ' B' ' 33' ' ' VAL . 87.9 t -144.4 136.83 22.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.524 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 29.9 p90 -146.81 141.67 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.4 p30 -115.61 173.26 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.194 0.521 . . . . 0.0 111.836 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.5 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -144.99 156.98 44.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.5 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 97.7 m-85 -52.75 -23.5 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.329 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.36 -69.09 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.443 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -127.07 170.9 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 245' ' ' GLU . 85.7 m -124.33 140.09 53.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.95 153.09 34.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.892 0.377 . . . . 0.0 111.35 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 43.1 m-85 -132.39 124.01 27.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -95.63 118.09 31.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.5 159.04 49.73 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.567 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.72 140.45 84.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.328 2.018 . . . . 0.0 112.037 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.88 -19.55 65.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.26 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -86.2 -14.79 42.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.096 0.474 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.91 154.75 29.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -87.02 5.28 38.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.613 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.2 mt 64.45 111.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.328 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.79 -177.71 3.52 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.939 2.426 . . . . 0.0 112.557 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -106.05 121.86 45.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.409 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 255' ' ' ILE . 16.1 t -93.41 115.04 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.444 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.87 177.3 6.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.655 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.597 ' SD ' HG23 ' A' ' 230' ' ' THR . 2.5 ppp? -144.15 134.16 24.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.802 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 10.6 mm -80.85 121.14 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.9 t -91.21 176.05 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.1 -21.29 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.166 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.0 m -73.37 -30.09 63.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 101.31 15.1 28.69 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.607 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.66 157.32 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.1 mt-10 -88.87 122.34 32.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.311 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.597 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -124.68 135.48 53.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.359 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 232' ' ' PRO . 58.8 tp -87.52 109.17 24.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.56 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.7 Cg_endo -76.54 163.41 31.98 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.787 2.324 . . . . 0.0 112.146 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.2 108.64 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.65 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.5 p -98.0 147.3 24.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.354 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -132.97 167.44 20.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.313 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 241' ' ' ARG . 10.9 m -128.39 125.51 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 111.574 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 243' ' ' ILE . 15.6 m -129.14 168.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.59 154.02 13.74 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.72 -34.78 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -104.67 6.78 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.418 ' HG3' ' HB ' ' A' ' 236' ' ' VAL . 79.7 ttt180 53.33 77.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.406 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.7 -7.7 4.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.053 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 209' ' ' PHE . 4.3 mp -102.33 151.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 111.757 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 217' ' ' LEU . 67.6 mt -123.72 106.24 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.816 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 207' ' ' THR . 41.8 tt0 -95.02 111.74 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.396 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.04 133.32 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.76 40.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.6 m -160.5 154.33 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 0.0 111.291 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.85 131.67 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.57 -173.89 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -104.98 -16.75 14.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.6 tt0 -134.28 123.42 24.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.47 122.02 40.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -105.87 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 220' ' ' VAL . 71.5 mt -88.32 114.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.755 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -127.47 142.17 51.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 111.562 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 27.8 tp -166.7 120.49 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.12 -116.87 6.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.205 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.44 20.2 12.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.014 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 23.8 ttmm -129.3 142.52 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 23' ' ' PRO . 5.8 p -134.87 146.47 30.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.4 t -128.58 119.35 49.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.035 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.76 119.82 4.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.783 -0.723 . . . . 0.0 113.667 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 186' ' ' MET . 65.1 t -121.02 142.88 35.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.546 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.2 ttt180 -145.11 119.18 9.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.391 . . . . 0.0 111.112 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -81.4 119.44 23.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.742 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -103.61 81.11 1.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 173.8 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 68.3 t80 56.88 95.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.187 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -127.11 80.17 71.95 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.622 2.215 . . . . 0.0 112.241 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.084 -0.391 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.1 158.18 58.8 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.485 2.123 . . . . 0.0 112.189 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HB2' HG12 ' A' ' 261' ' ' VAL . 6.8 Cg_exo -72.36 -50.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.688 2.259 . . . . 0.0 111.987 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.56 112.55 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.7 ' HA ' HE22 ' A' ' 189' ' ' GLN . 7.0 Cg_exo -70.66 97.83 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.226 1.951 . . . . 0.0 112.119 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.466 ' H ' ' NE2' ' A' ' 189' ' ' GLN . 28.3 t70 -59.6 88.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -65.78 -12.59 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.419 ' HB3' ' OD2' ' B' ' 26' ' ' ASP . 37.6 t -42.09 -35.07 0.83 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 110.6 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -129.05 100.86 5.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.009 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.3 p -87.05 116.68 25.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.024 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.58 115.04 49.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.237 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 86.8 Cg_exo -48.51 167.09 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.972 2.448 . . . . 0.0 113.64 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 199' ' ' HIS . 5.4 t -109.64 -6.57 11.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.493 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -122.59 98.15 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.972 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.38 -26.57 30.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.716 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 64.5 p -139.32 100.12 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.903 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.23 126.86 57.35 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.075 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.61 98.43 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.593 2.195 . . . . 0.0 112.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.92 -21.27 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 60.36 98.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 m -105.43 -64.51 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.785 0.326 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.54 100.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.53 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.57 135.03 21.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -103.15 139.01 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -129.11 112.95 14.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.624 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -101.68 95.25 6.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.652 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 53.5 tp60 -98.5 103.25 15.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.464 ' H ' HD21 ' B' ' 34' ' ' ASN . 69.6 m-85 -130.12 152.29 49.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.102 0.477 . . . . 0.0 111.807 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.3 m -147.54 129.8 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.2 ptt? -123.56 149.25 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.942 0.401 . . . . 0.0 111.449 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' B' ' 27' ' ' TRP . 95.9 p -58.81 128.05 35.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.08 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.96 100.12 8.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 73.0 mm-40 -145.67 118.37 5.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.81 -10.73 28.31 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.576 2.184 . . . . 0.0 112.531 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -80.25 -23.39 40.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.142 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 17.6 ptp -113.34 19.25 17.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.317 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 41.3 ptt180 -68.35 -26.58 65.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.7 t -53.72 -52.1 61.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.312 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.4 6.28 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.36 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.3 tt0 -60.53 132.42 91.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.0 130.17 15.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.333 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.451 HG23 ' HD3' ' A' ' 212' ' ' PRO . 33.3 t -56.13 -68.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.568 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.662 ' HA ' HG12 ' B' ' 33' ' ' VAL . 77.2 m-70 -145.56 157.3 44.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.77 139.32 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.492 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 34.0 p90 -147.13 134.39 20.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.21 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.88 156.45 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.468 . . . . 0.0 111.467 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -124.67 174.17 8.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.918 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 110.503 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -90.75 -68.13 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -136.57 170.04 16.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 111.207 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 44.4 m -109.69 152.3 25.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 73.1 mtp180 -133.67 147.78 51.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -126.75 129.79 49.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.396 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -103.26 120.4 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.389 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 244' ' ' ILE . 95.8 m-85 -119.03 161.19 37.73 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.451 ' HD3' HG23 ' A' ' 198' ' ' VAL . 27.8 Cg_exo -61.87 163.89 17.91 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.413 2.075 . . . . 0.0 111.928 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.86 -31.04 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -86.11 -14.94 42.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.66 170.17 9.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.238 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.17 150.53 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 244' ' ' ILE . 11.2 mp -91.89 112.67 55.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.47 -179.42 5.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.833 2.355 . . . . 0.0 112.734 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -104.91 113.8 27.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.476 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 255' ' ' ILE . 12.0 t -84.6 122.54 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.1 m-85 -102.64 176.9 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.981 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.64 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.4 ppp? -144.74 140.5 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 252' ' ' GLU . 14.7 mm -80.77 106.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.328 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -65.06 176.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.68 30.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.4 m -87.74 -34.26 18.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.14 -8.65 10.43 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -99.38 175.0 6.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -93.8 146.12 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.042 0.449 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 222' ' ' MET . 88.7 m -142.43 139.49 31.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.067 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.5 tt -93.23 107.52 26.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.64 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.6 Cg_endo -76.16 163.26 33.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.095 2.53 . . . . 0.0 112.586 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 126.31 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.6 t -127.14 159.95 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.014 0.435 . . . . 0.0 111.523 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' A' ' 245' ' ' GLU . 19.7 m80 -153.62 122.47 6.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.512 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 243' ' ' ILE . 75.7 t -86.05 133.0 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 243' ' ' ILE . 34.1 m -134.4 177.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.176 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.86 147.97 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.54 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.15 -21.82 66.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -117.97 7.96 12.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.79 77.38 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.423 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.558 ' HA ' HD11 ' A' ' 217' ' ' LEU . 29.0 p-10 -143.49 13.67 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.016 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.424 HD12 HG23 ' A' ' 237' ' ' VAL . 7.7 mt -118.19 155.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.017 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -138.86 102.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 9.4 pt-20 -93.78 128.82 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.681 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.9 t -112.44 126.55 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -81.54 48.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.254 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.0 m -157.54 144.56 18.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 51.0 t -121.85 124.67 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.571 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.89 -173.75 3.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.747 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -107.37 -3.54 19.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -147.37 123.6 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.01 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -124.56 119.13 28.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 229' ' ' GLU . 35.5 ttm180 -111.28 116.81 31.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 220' ' ' VAL . 85.4 mt -92.09 125.35 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.655 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -131.32 137.76 48.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.8 tp -165.3 125.2 1.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.486 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.4 -113.58 5.64 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.284 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.55 5.75 11.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.632 0.254 . . . . 0.0 111.371 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 46.1 mmtm -111.79 153.79 26.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.919 0.39 . . . . 0.0 111.604 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.2 p -142.18 146.54 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.2 t -130.64 108.89 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.299 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.635 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.95 115.17 4.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.342 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.5 t -117.06 142.29 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 69.2 ttt180 -128.3 116.33 19.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -78.54 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.798 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 268' ' ' ASN . 38.1 m-80 -117.13 172.26 7.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.055 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' ASN . 7.2 t30 75.92 -36.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 267' ' ' ASN . 36.5 t80 52.73 96.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.46 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.21 78.12 13.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.579 2.186 . . . . 0.0 112.34 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.438 ' HG2' ' HD3' ' B' ' 22' ' ' PRO . 5.9 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 CA-C-O 119.693 -0.211 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.438 ' HD3' ' HG2' ' B' ' 21' ' ' PRO . 62.5 Cg_exo -52.02 157.43 6.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.096 1.864 . . . . 0.0 112.214 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.506 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.8 Cg_endo -70.67 -78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.439 2.093 . . . . 0.0 112.144 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.462 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.1 tt0 61.97 124.8 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.13 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.783 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.635 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.5 Cg_endo -81.79 104.12 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.268 1.978 . . . . 0.0 111.498 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.7 -4.26 59.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.242 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 187' ' ' SER . 51.2 m95 51.89 32.14 9.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.036 0.446 . . . . 0.0 110.139 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 189' ' ' GLN . 47.8 t -33.26 -66.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.159 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -115.17 1.24 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.73 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m 39.89 89.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.418 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -104.37 123.82 39.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.094 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.1 Cg_exo -50.05 170.19 0.12 Allowed 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.173 2.582 . . . . 0.0 113.456 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -115.69 13.67 7.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.461 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.464 HD21 ' H ' ' A' ' 184' ' ' TYR . 1.4 p30 -152.88 101.1 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -91.86 -31.24 15.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -111.25 94.63 5.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.07 130.26 26.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.15 97.86 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.93 -26.55 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 64.85 151.78 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -69.73 143.53 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.939 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.7 69.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.88 121.14 40.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -89.38 138.07 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -117.67 113.5 21.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.045 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.5 m-85 -82.38 95.04 7.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 267' ' ' ASN . 7.0 tp60 -80.07 104.94 10.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.8 m-85 -135.57 143.2 45.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 111.513 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.9 m -144.03 124.57 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.261 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.491 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.7 ptt? -117.5 139.01 51.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.463 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.494 ' HB2' HE22 ' A' ' 189' ' ' GLN . 59.8 p -56.75 130.72 46.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.244 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 9.2 tp10 -94.14 102.12 14.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 111.669 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.621 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.0 OUTLIER -139.39 119.73 9.44 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.46 -11.11 15.48 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.615 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.621 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -83.17 -25.29 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.454 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 19.1 ptp -114.16 22.23 14.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.604 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -69.53 -26.31 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.024 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.0 t -53.1 -52.24 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.367 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 260' ' ' LYS . 47.4 pt -96.66 11.55 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.358 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.3 tt0 -58.59 115.54 12.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 126.91 17.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.338 2.026 . . . . 0.0 112.19 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.9 t -53.82 -64.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.67 ' HA ' HG12 ' B' ' 33' ' ' VAL . 81.4 m-70 -147.12 157.13 43.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.508 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.572 HG23 HG11 ' B' ' 33' ' ' VAL . 98.4 t -143.3 140.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 111.663 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.8 p90 -146.48 146.74 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.006 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.525 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.6 p30 -112.8 173.28 6.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 111.95 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 2.6 t-20 -133.5 -176.79 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.666 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.417 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 96.5 m-85 -69.85 -24.97 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.669 0.271 . . . . 0.0 111.208 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -119.63 -69.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -92.6 171.25 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.575 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.8 m -136.52 125.65 24.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.479 HH21 HD13 ' A' ' 243' ' ' ILE . 77.9 mtp180 -101.94 145.43 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.205 0.526 . . . . 0.0 112.287 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.43 124.61 38.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.069 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -98.98 122.29 42.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.398 . . . . 0.0 111.627 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.15 160.42 45.44 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -62.32 148.02 93.97 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.1 . . . . 0.0 111.817 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.83 -26.61 54.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -86.33 -14.85 42.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.087 0.47 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.3 172.81 7.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.256 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -94.76 153.81 17.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.564 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.2 mp -92.83 111.83 53.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 85.4 Cg_endo -79.94 175.87 10.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.718 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -94.23 143.2 26.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.063 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.44 111.72 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 111.692 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.455 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 6.1 m-85 -91.1 176.24 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.741 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.556 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.3 ptm -145.3 138.65 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.7 mm -80.9 112.64 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.166 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 62.4 m -110.42 -165.88 1.04 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.98 165.03 1.98 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.6 m 61.73 9.62 2.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.122 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.69 59.6 10.28 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 142.08 49.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 11.7 mt-10 -85.6 109.32 18.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.196 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' A' ' 222' ' ' MET . 6.9 t -105.64 140.73 38.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.367 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.06 106.73 23.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 111.019 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.556 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 72.8 Cg_endo -75.65 163.44 33.91 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.044 2.496 . . . . 0.0 112.705 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.73 139.63 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.247 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -138.81 149.03 44.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.357 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 43.4 m80 -127.84 167.2 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.98 129.19 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.339 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 243' ' ' ILE . 31.4 m -141.25 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.46 6.93 32.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.57 2.07 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -138.92 5.32 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.656 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 57.33 46.3 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.55 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.6 p-10 -114.65 1.32 14.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.479 HD13 HH21 ' A' ' 208' ' ' ARG . 9.4 mt -116.13 156.99 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.978 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 217' ' ' LEU . 53.6 mt -133.37 103.75 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -92.13 107.49 19.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.66 147.81 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.756 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.67 32.41 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.881 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 33.0 p -145.82 154.08 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 0.0 111.663 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.22 124.63 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.42 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -141.72 -174.12 3.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -99.78 -24.68 14.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -125.49 123.81 40.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.992 0.425 . . . . 0.0 111.189 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -120.01 121.42 38.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.626 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.447 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.3 tpp180 -106.5 106.7 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.862 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 77.0 mt -89.91 114.61 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -128.53 142.92 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 21.6 tp -162.55 119.86 2.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.358 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.58 -112.18 4.77 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.201 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.68 23.09 11.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.697 0.284 . . . . 0.0 111.056 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 1.8 tppp? -128.58 146.61 50.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.541 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.1 147.01 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.33 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.46 122.38 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.241 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -82.07 105.39 2.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.301 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.5 t -112.68 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.511 ' HB2' ' HH2' ' B' ' 27' ' ' TRP . 33.6 ttm180 -115.57 126.73 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -100.07 114.74 28.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 183' ' ' GLN . 82.5 m-20 -101.5 81.06 2.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.0 t30 175.05 142.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.53 115.91 13.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -142.65 75.83 18.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.346 0.425 0 C-N-CA 122.629 2.219 . . . . 0.0 112.341 179.814 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.157 -0.363 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.49 124.15 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.546 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 38.2 Cg_endo -66.2 -77.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.456 2.104 . . . . 0.0 112.234 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 261' ' ' VAL . 12.8 mm-40 61.05 128.77 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 4.3 Cg_endo -82.77 106.24 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.545 2.163 . . . . 0.0 111.138 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.38 -16.28 62.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.881 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.511 ' HH2' ' HB2' ' A' ' 265' ' ' ARG . 96.1 m95 61.93 5.98 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.872 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.35 -55.13 2.29 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.926 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 92.8 m-20 -123.22 92.23 3.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HE3' ' B' ' 27' ' ' TRP . 42.5 p -61.24 92.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 110.685 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.1 t -93.34 112.77 57.88 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.509 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 88.2 Cg_exo -49.39 170.18 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.055 2.504 . . . . 0.0 113.617 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.7 t -121.05 10.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.506 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 184' ' ' TYR . 38.4 m-80 -123.08 -38.96 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.13 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 63.29 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -119.82 129.13 54.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.41 . . . . 0.0 110.977 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.43 128.55 93.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.108 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 98.58 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.571 2.18 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 p -115.15 -26.71 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 59.75 98.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 72.3 p -111.38 146.1 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.987 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.5 157.63 28.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.545 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.38 124.22 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.26 151.48 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -120.6 113.14 19.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -114.7 95.33 5.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.465 179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -100.75 101.17 11.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 61.9 m-85 -128.14 144.12 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.137 0.494 . . . . 0.0 111.529 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.4 m -134.08 124.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.353 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.419 ' HB3' HG22 ' A' ' 264' ' ' VAL . 23.1 ptt? -117.39 137.91 52.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.747 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.2 p -58.32 135.0 57.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.962 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 8.6 tp10 -104.55 102.32 11.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.815 -178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 27.8 mp0 -137.75 137.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 189' ' ' GLN . 31.5 Cg_exo -59.07 -25.42 77.81 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.112 . . . . 0.0 112.534 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.47 6.03 21.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.248 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.651 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 41.2 mtt -132.63 13.09 4.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.677 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 13.6 ptp180 -72.14 -26.64 62.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.215 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -60.62 -52.36 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.653 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 pt -99.74 13.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 5.1 tp-100 -60.63 116.21 17.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.76 126.81 18.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 199' ' ' HIS . 21.3 t -54.45 -70.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.708 ' HA ' HG12 ' B' ' 33' ' ' VAL . 68.8 m-70 -142.57 156.57 45.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.644 HG23 HG11 ' B' ' 33' ' ' VAL . 96.8 t -142.21 132.73 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.411 . . . . 0.0 111.515 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 21.1 p90 -142.62 142.1 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.455 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -112.93 173.25 6.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.038 0.446 . . . . 0.0 111.375 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -132.36 -173.64 3.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.124 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -71.35 -23.6 61.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.434 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -118.55 -69.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -99.84 170.79 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.5 m -130.28 146.8 51.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.331 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.27 144.32 50.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.81 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -126.32 124.54 40.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.199 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -100.25 116.58 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 111.297 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -114.57 159.21 37.89 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.862 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.7 168.65 5.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.422 2.081 . . . . 0.0 112.054 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.04 -26.36 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -86.12 -14.85 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -99.48 157.1 16.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.257 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -83.09 154.64 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.1 mt -86.56 114.7 59.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 257' ' ' LEU . 98.1 Cg_endo -80.54 171.39 14.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.831 2.354 . . . . 0.0 112.73 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 231' ' ' LEU . 26.1 mt-30 -94.69 118.72 32.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 255' ' ' ILE . 40.6 t -91.41 131.1 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.517 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -112.35 177.15 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.831 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.503 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.0 OUTLIER -144.18 146.41 32.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.11 119.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.345 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 74.9 m -144.28 147.22 33.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.65 98.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.1 t 62.1 -82.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.98 72.9 0.11 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -129.18 141.57 51.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.2 mt-10 -96.79 122.06 39.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.26 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 4.4 t -135.12 136.87 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.358 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.482 HD12 HE21 ' A' ' 219' ' ' GLN . 3.3 tt -77.81 109.91 11.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.971 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 230' ' ' THR . 72.3 Cg_endo -76.23 163.43 32.65 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.677 2.251 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -50.06 104.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.788 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.0 t -112.36 156.12 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.341 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -141.97 167.03 23.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.9 m -122.09 132.35 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.339 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 243' ' ' ILE . 29.7 m -141.19 177.51 3.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.45 163.33 12.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.94 -5.22 58.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -138.58 12.55 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.773 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 55.24 75.04 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.406 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.591 ' H ' HD22 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -146.32 10.93 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.493 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -115.03 156.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.092 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 217' ' ' LEU . 60.0 mt -138.17 106.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.88 107.78 19.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 110.335 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.407 HG11 ' CZ3' ' A' ' 253' ' ' TRP . 94.1 t -99.44 127.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.512 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 248' ' ' THR . 41.0 mt-10 -74.62 159.57 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 247' ' ' GLU . 1.1 m 67.18 134.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.355 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -102.12 131.05 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -122.43 164.75 17.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.269 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.41 -25.79 22.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.951 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.41 123.73 32.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.976 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.407 ' CZ3' HG11 ' A' ' 246' ' ' VAL . 98.4 m95 -116.28 128.23 55.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.667 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -114.08 105.21 12.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.822 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 220' ' ' VAL . 72.2 mt -89.72 114.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.567 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -129.66 142.82 50.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 111.747 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 218' ' ' PRO . 19.6 tp -164.59 117.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.67 5.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.135 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.61 23.3 11.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.968 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 34.3 ttmt -132.04 137.36 47.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.041 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.568 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.8 p -133.89 146.78 31.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.262 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 192' ' ' MET . 99.6 t -129.01 122.25 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.275 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.45 111.27 3.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.276 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 186' ' ' MET . 61.8 t -119.58 116.39 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.5 ttt180 -111.27 130.25 55.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -94.64 111.71 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -102.12 80.63 2.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.795 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 173.82 141.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.85 102.07 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -134.3 78.64 57.35 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.239 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.432 ' HG2' ' HD3' ' B' ' 22' ' ' PRO . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.78 0 CA-C-O 119.789 -0.171 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 21' ' ' PRO . 59.3 Cg_exo -52.12 147.06 28.35 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.949 1.766 . . . . 0.0 112.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.568 ' HG2' HG12 ' A' ' 261' ' ' VAL . 52.9 Cg_endo -69.78 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.395 2.063 . . . . 0.0 112.402 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 32.9 mt-10 59.59 118.96 0.02 OUTLIER Pre-proline 0 CA--C 1.528 0.107 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.919 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.479 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 0.9 OUTLIER -76.5 108.57 2.69 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.135 1.89 . . . . 0.0 111.298 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 -13.99 61.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.671 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 94.0 m95 58.81 8.22 0.91 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 p -42.91 -63.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 96.4 m-20 -105.4 78.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.361 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -53.1 98.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 188' ' ' GLU . 2.4 t -105.77 114.74 62.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.924 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.6 Cg_exo -51.15 169.28 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.895 2.397 . . . . 0.0 113.069 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -111.11 1.51 9.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.46 100.59 5.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.2 p -106.25 103.74 13.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 50.6 mm -59.25 109.75 2.16 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 19.2 Cg_endo -58.54 96.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.607 2.204 . . . . 0.0 112.169 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.64 -32.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.234 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 58.8 -172.69 0.1 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -119.13 143.53 47.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.34 87.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.88 7.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -140.12 137.77 34.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -120.22 113.37 20.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 2.4 m-85 -79.47 95.16 5.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.431 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 20.9 tp60 -95.98 110.87 23.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.467 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 63.3 m-85 -137.06 152.68 50.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.069 0.461 . . . . 0.0 111.652 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -147.74 133.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.52 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.5 ptt? -127.46 147.39 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 65.6 p -54.38 129.43 35.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.056 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 24.8 tt0 -81.83 75.15 8.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.798 0.332 . . . . 0.0 111.313 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -115.72 106.42 50.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.691 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HB3' HH21 ' A' ' 193' ' ' ARG . 36.8 Cg_endo -65.07 -16.42 55.13 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 12.9 pt-20 -83.12 0.66 44.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 38.5 mtt -132.32 14.12 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 12.7 ptp180 -62.43 -26.38 68.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -50.28 -52.16 38.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.351 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.65 11.79 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.4 tt0 -67.83 132.54 92.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.38 131.68 16.67 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.396 2.064 . . . . 0.0 112.295 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 199' ' ' HIS . 18.7 t -58.81 -64.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.504 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 73.8 m-70 -143.54 158.92 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.408 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.641 HG23 HG11 ' B' ' 33' ' ' VAL . 97.7 t -143.4 138.5 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.08 0.467 . . . . 0.0 111.674 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 48.7 p90 -148.1 138.03 22.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.044 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.437 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 5.0 p-10 -116.84 159.67 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 111.726 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.7 153.52 51.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.766 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -51.92 -23.44 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 0.0 111.086 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -91.59 -67.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.278 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.19 170.94 14.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.099 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 59.6 m -122.75 143.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.516 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 95.6 mtt180 -127.34 143.41 51.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.047 0.451 . . . . 0.0 111.647 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -122.43 124.39 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.149 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -95.89 122.2 38.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.72 160.23 47.53 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.42 156.95 28.53 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.381 2.054 . . . . 0.0 111.929 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.36 -26.82 60.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -86.08 -14.85 43.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.178 0.513 . . . . 0.0 110.958 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.82 166.46 11.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.24 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -102.73 -0.04 32.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.643 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.4 mp 62.17 104.67 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.269 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.2 171.55 13.77 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.951 2.434 . . . . 0.0 112.671 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -94.5 117.2 29.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.634 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -89.12 112.1 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.496 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.7 m-85 -90.59 177.01 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.6 OUTLIER -144.01 150.69 38.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.35 123.01 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.173 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.3 p -81.83 -178.3 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.41 82.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.2 t -68.48 -52.25 34.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 130.78 45.05 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -131.05 143.68 50.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.351 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.3 mt-10 -86.36 118.48 25.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.8 t -129.26 136.89 50.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.415 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.6 tp -79.61 111.3 20.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.119 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 230' ' ' THR . 70.9 Cg_endo -75.87 161.87 35.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.679 2.252 . . . . 0.0 112.167 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.71 100.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.758 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.1 p -96.06 166.16 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 40.1 t-80 -139.38 163.86 31.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.356 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.67 126.98 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 243' ' ' ILE . 3.5 m -142.53 -179.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.266 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.29 148.76 10.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.42 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.6 -31.28 72.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -106.52 7.43 30.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.78 76.79 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.449 ' HA ' HD11 ' A' ' 217' ' ' LEU . 28.0 p30 -150.89 14.0 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 237' ' ' VAL . 5.0 mt -108.98 155.51 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.011 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.3 mt -133.24 103.28 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 35.9 tt0 -94.29 111.05 22.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.83 128.44 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -79.23 39.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 32.9 m -158.76 151.57 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.889 0.376 . . . . 0.0 111.246 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -123.01 129.47 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.75 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.27 -173.91 3.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.46 -16.95 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -135.57 123.53 22.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.24 119.92 34.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.456 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 22.0 tpp180 -104.13 106.83 17.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 220' ' ' VAL . 72.0 mt -87.33 114.64 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.651 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -127.08 141.59 51.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 111.415 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 33.8 tp -166.69 124.07 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.53 -114.26 5.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.431 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 10.9 m-20 -119.49 12.22 12.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.604 0.24 . . . . 0.0 111.326 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 5.7 mptp? -122.02 153.0 39.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.537 HG12 ' HG2' ' B' ' 23' ' ' PRO . 7.4 p -142.12 146.2 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.558 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 80.4 t -128.26 123.12 59.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.399 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -83.75 118.52 4.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.06 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.3 t -126.55 116.56 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.521 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 68.9 ttt180 -110.52 115.63 29.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.869 0.366 . . . . 0.0 110.972 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -73.52 131.53 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 40.0 m-80 -117.24 172.51 7.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.148 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.62 22.56 11.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.456 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -55.05 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.56 79.65 9.45 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.082 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.652 2.234 . . . . 0.0 112.237 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 111.069 -0.396 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.52 159.46 51.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.507 2.138 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG2' HG12 ' A' ' 261' ' ' VAL . 33.6 Cg_endo -64.75 -73.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.579 2.186 . . . . 0.0 112.176 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.3 tt0 62.27 124.39 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.658 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.2 Cg_exo -77.11 107.29 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.227 1.951 . . . . 0.0 111.625 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' SER . 10.0 m-20 -68.97 -9.5 52.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.532 ' HE3' HG22 ' B' ' 30' ' ' THR . 98.6 m95 55.66 -86.03 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.585 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.413 ' N ' ' O ' ' B' ' 26' ' ' ASP . 47.9 t 48.52 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.04 69.03 5.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.504 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.532 HG22 ' HE3' ' B' ' 27' ' ' TRP . 34.7 p -47.03 94.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.26 115.32 59.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 78.2 Cg_exo -48.08 166.86 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.232 0 C-N-CA 123.13 2.553 . . . . 0.0 113.745 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.4 t -117.36 10.05 7.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.224 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.466 ' HB3' HG12 ' B' ' 37' ' ' ILE . 7.3 m120 -90.5 -67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.078 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.79 -82.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.804 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 7.6 t -103.14 -33.91 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' B' ' 34' ' ' ASN . 59.5 mt 67.49 129.19 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.35 101.28 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.522 2.148 . . . . 0.0 112.349 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 39' ' ' VAL . 9.3 p -164.07 35.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.335 0.588 . . . . 0.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -48.25 135.94 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -69.32 -38.51 78.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.829 0.347 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.42 -44.91 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.565 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.73 147.56 22.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.37 131.65 54.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.06 113.02 25.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -118.89 95.51 4.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.628 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.46 105.98 17.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.8 137.03 44.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.303 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -129.29 127.14 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.467 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.532 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.3 ptt? -116.11 145.23 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.365 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.505 ' HB2' HE22 ' A' ' 189' ' ' GLN . 78.8 p -60.11 140.04 57.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -101.08 96.94 7.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 111.322 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.588 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 1.2 mp0 -137.04 123.96 13.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.97 -10.9 27.2 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.573 2.182 . . . . 0.0 112.684 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -82.97 -23.03 33.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.016 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -117.82 18.39 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.275 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.594 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 38.5 ptt180 -69.55 -26.56 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.055 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.2 m -53.3 -52.02 60.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.276 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 24.0 pt -97.65 16.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.364 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.5 tt0 -62.55 117.85 35.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 262' ' ' VAL . 36.4 Cg_endo -65.29 127.02 17.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.404 HG12 ' ND1' ' A' ' 199' ' ' HIS . 43.1 t -56.1 -71.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.692 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.738 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.2 m80 -140.32 151.01 44.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.419 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' B' ' 33' ' ' VAL . 21.0 m -140.47 146.01 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.634 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.448 ' NE1' ' HB3' ' A' ' 208' ' ' ARG . 45.1 p90 -148.15 166.16 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.79 172.9 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -134.87 -175.68 3.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.244 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.26 -23.31 61.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.16 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -115.93 -69.15 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.796 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.2 170.66 8.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.101 0.477 . . . . 0.0 111.904 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 51.7 m -130.81 150.37 52.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.016 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.602 HH11 HG21 ' A' ' 237' ' ' VAL . 5.7 tpp180 -127.19 152.36 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.09 0.471 . . . . 0.0 111.88 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -136.66 124.8 23.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.311 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -103.93 118.51 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 111.41 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.33 161.09 31.64 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.8 176.83 2.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 111.826 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.69 -20.56 20.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.804 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -86.31 -14.97 42.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.221 0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.35 -173.8 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -124.6 7.24 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.804 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 242' ' ' ASN . 3.9 mm? 60.08 90.93 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.405 ' HA ' HD13 ' A' ' 257' ' ' LEU . 95.2 Cg_endo -77.41 176.89 9.51 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.952 2.435 . . . . 0.0 112.804 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -99.72 121.98 42.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 255' ' ' ILE . 40.0 t -93.29 112.93 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 111.665 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -90.83 177.14 6.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.431 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.7 ppp? -145.52 144.96 30.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.83 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.62 132.23 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.271 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 59.9 m -122.23 -165.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.2 153.36 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.113 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 t 61.73 11.03 3.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.113 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.44 78.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.654 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.12 143.09 40.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 16.0 mt-10 -97.29 118.46 33.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.26 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 222' ' ' MET . 11.5 t -130.24 143.66 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.261 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.05 108.93 15.73 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.666 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 230' ' ' THR . 61.6 Cg_endo -73.01 163.09 39.29 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.724 2.283 . . . . 0.0 112.537 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.96 99.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.8 p -100.79 -176.96 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -164.12 128.32 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.709 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.59 142.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.602 HG21 HH11 ' A' ' 208' ' ' ARG . 0.0 OUTLIER -148.84 173.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.397 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.41 150.08 25.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.433 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.69 -20.48 65.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.781 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.414 ' HB2' ' ND2' ' A' ' 242' ' ' ASN . 14.1 m120 -116.81 10.82 14.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.841 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 58.14 29.65 18.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.527 ' HA ' HD21 ' A' ' 217' ' ' LEU . 66.4 m-20 -95.57 11.34 33.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 237' ' ' VAL . 8.5 mt -117.7 154.07 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 63.4 mt -139.12 109.34 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 208' ' ' ARG . 39.8 tt0 -94.55 108.47 20.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 248' ' ' THR . 89.7 t -90.75 135.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.625 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 248' ' ' THR . 38.8 tt0 -92.57 69.87 4.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 246' ' ' VAL . 10.0 t 171.07 152.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.41 124.94 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -129.96 -176.99 4.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.028 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -102.85 -16.73 15.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.84 123.57 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -115.91 141.78 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.5 tpp180 -129.26 104.58 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 110.83 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 220' ' ' VAL . 67.4 mt -88.69 114.62 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.744 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -124.59 142.9 51.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.394 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 218' ' ' PRO . 29.6 tp -166.17 125.06 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 61.07 -112.64 4.88 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.385 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -119.46 23.14 11.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.643 0.258 . . . . 0.0 111.195 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.423 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.2 mmtt -131.37 149.0 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 111.453 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' B' ' 23' ' ' PRO . 8.4 p -141.29 146.37 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.754 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 197' ' ' PRO . 87.7 t -129.72 116.47 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.404 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.71 110.47 3.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.172 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 186' ' ' MET . 64.0 t -116.92 116.89 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.474 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 65.5 ttt180 -111.05 141.47 44.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 111.298 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -100.58 111.98 24.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.795 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -103.86 81.08 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.966 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.613 HD21 ' HB2' ' A' ' 270' ' ' ALA . 4.7 t30 175.19 -56.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 t80 57.25 96.04 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.613 ' HB2' HD21 ' A' ' 268' ' ' ASN . . . -120.66 80.75 32.0 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.621 2.214 . . . . 0.0 112.255 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.484 ' HA ' ' HD2' ' B' ' 22' ' ' PRO . 2.6 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' B' ' 21' ' ' PRO . 2.8 Cg_endo -43.3 -48.74 7.95 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.902 2.401 . . . . 0.0 113.343 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.513 ' HG2' HG12 ' A' ' 261' ' ' VAL . 58.5 Cg_endo -71.4 -78.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.847 1.698 . . . . 0.0 112.235 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.49 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.6 tt0 60.22 120.76 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 1.8 Cg_endo -78.13 108.46 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.184 1.922 . . . . 0.0 111.305 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.99 -15.57 60.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.1 m95 58.7 10.15 1.36 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.754 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 50.8 m -37.76 -71.04 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 55.5 m-20 -108.85 75.23 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.063 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 ' HE3' ' B' ' 27' ' ' TRP . 59.8 p -46.13 95.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.926 0.393 . . . . 0.0 111.158 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 188' ' ' GLU . 3.7 m -97.14 114.75 65.21 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.444 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 93.3 Cg_exo -48.9 167.34 0.13 Allowed 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.014 2.476 . . . . 0.0 113.672 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.1 t -118.33 10.8 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.174 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -98.87 -78.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.276 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.02 -71.39 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 57.2 m -49.98 -76.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.939 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 46.6 mm 66.6 129.06 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 37' ' ' ILE . 6.1 Cg_exo -78.96 110.44 2.77 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.804 2.336 . . . . 0.0 112.017 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.0 -34.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.232 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.18 98.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -93.26 -16.87 24.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.739 0.304 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.4 174.13 34.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.535 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 59.42 -177.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 0.0 111.257 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 180' ' ' LYS . 10.1 mptt -120.43 173.92 6.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -104.35 113.01 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.3 OUTLIER -130.18 95.16 3.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.98 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 6.1 tp-100 -123.26 93.97 4.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.965 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.73 153.34 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 22.2 m -138.34 124.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.907 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB3' HG22 ' A' ' 264' ' ' VAL . 17.5 ptt? -116.71 146.44 42.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.498 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.542 ' HB2' HE22 ' A' ' 189' ' ' GLN . 31.8 p -56.1 127.17 29.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.008 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 7.6 tp10 -88.84 90.3 8.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.542 HE22 ' HB2' ' A' ' 187' ' ' SER . 2.7 mp0 -123.94 118.83 26.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.492 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 -10.81 29.0 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.336 2.024 . . . . 0.0 112.68 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.16 -28.14 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.6 ptp -114.09 16.96 18.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.579 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.3 ptm180 -60.88 -25.92 67.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 m -50.28 -52.02 39.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.477 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.71 7.62 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.588 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 8.5 tt0 -59.85 122.58 66.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.422 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 28.8 Cg_endo -62.82 127.17 19.8 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.403 2.069 . . . . 0.0 112.206 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.502 HG12 ' ND1' ' A' ' 199' ' ' HIS . 28.9 t -54.29 -68.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.739 ' HA ' HG12 ' B' ' 33' ' ' VAL . 43.9 m80 -143.46 157.45 44.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.467 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.682 HG23 HG11 ' B' ' 33' ' ' VAL . 94.0 t -140.4 139.67 35.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 31.6 p90 -147.74 142.3 26.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -117.25 173.08 6.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.173 0.511 . . . . 0.0 111.618 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.748 HD22 ' H ' ' A' ' 205' ' ' ARG . 10.3 t30 -145.07 158.95 43.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.079 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -53.01 -23.31 7.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.482 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.748 ' H ' HD22 ' A' ' 203' ' ' ASN . 40.8 mmt180 -99.82 -69.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.704 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -124.44 170.79 10.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.5 m -124.52 140.65 52.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.331 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 97.8 mtt180 -120.86 147.28 45.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.016 0.436 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -126.32 124.41 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.191 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -99.88 119.5 38.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 0.0 111.476 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -116.04 160.33 35.88 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.92 158.74 19.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.425 2.083 . . . . 0.0 111.859 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.93 22.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -86.1 -14.89 42.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.181 0.515 . . . . 0.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -102.07 155.5 18.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.24 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.81 153.65 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.477 ' HB3' HD11 ' A' ' 244' ' ' ILE . 91.3 mt -84.64 117.31 68.46 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.37 176.76 8.37 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.85 2.367 . . . . 0.0 112.661 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.419 ' HB3' HD11 ' A' ' 231' ' ' LEU . 15.0 mm100 -103.02 125.11 49.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.362 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.83 131.2 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 0.0 111.62 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.8 m-85 -109.03 177.59 4.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.453 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -145.47 140.07 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.91 132.36 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.286 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.2 t -125.07 -171.73 2.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.612 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -53.89 155.68 3.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 37.1 t 61.86 11.48 4.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.056 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.16 76.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.684 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -136.29 141.55 43.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.7 mt-10 -99.46 118.8 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.208 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 222' ' ' MET . 8.9 t -128.4 144.77 51.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.134 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.2 tt -85.7 108.9 18.33 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.075 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 230' ' ' THR . 73.5 Cg_endo -75.38 162.99 35.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.808 2.339 . . . . 0.0 112.239 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -55.58 135.91 50.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 246' ' ' VAL . 82.2 p -146.41 151.49 37.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -138.05 123.1 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.705 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.36 135.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.404 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.93 -177.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.099 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.54 150.34 16.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.576 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.42 -33.38 75.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -99.56 3.3 45.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.8 78.51 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.515 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.423 ' HA ' HD21 ' A' ' 217' ' ' LEU . 26.3 p30 -154.98 18.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.987 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.08 156.74 13.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.7 mt -136.41 102.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 36.4 tt0 -97.06 107.81 20.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.069 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 234' ' ' SER . 73.9 t -89.86 131.14 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.547 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -79.21 43.7 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.2 m -160.64 147.7 15.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.8 0.334 . . . . 0.0 111.305 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -119.27 124.89 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.41 -175.17 3.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.271 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -104.42 -25.74 12.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.4 tt0 -128.84 123.8 33.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -116.86 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.435 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 20.2 tpp180 -117.32 103.97 10.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 262' ' ' VAL . 37.4 mt -88.53 114.65 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -125.97 138.48 53.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.521 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 44.1 tp -165.58 127.55 2.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.335 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.1 -115.86 8.42 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.12 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.47 14.67 12.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.972 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -121.24 148.02 44.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.054 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.9 p -142.42 131.41 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 255' ' ' ILE . 5.4 m -123.32 112.98 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 110.573 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.693 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.59 119.17 4.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.157 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.583 HG22 ' HB3' ' A' ' 186' ' ' MET . 87.3 t -112.16 115.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.488 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 65.4 ttt180 -106.29 124.38 49.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.392 . . . . 0.0 111.045 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -80.35 111.86 17.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -100.94 81.41 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 183' ' ' GLN . 13.4 t-20 175.36 -64.7 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 2.4 t80 59.14 96.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.562 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . . . -77.12 -47.79 2.62 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.899 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 270' ' ' ALA . 33.5 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.432 2.088 . . . . 0.0 112.317 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.484 0.938 0 N-CA-C 111.191 -0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 156.98 61.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.221 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.6 ' HG2' HG12 ' A' ' 261' ' ' VAL . 35.0 Cg_endo -65.73 -74.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.445 2.097 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.2 tt0 62.95 123.72 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.693 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.3 Cg_endo -78.22 86.14 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.294 1.996 . . . . 0.0 112.18 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -65.4 93.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 110.141 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 92.3 m95 -63.09 0.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.635 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -44.98 -48.93 11.45 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.827 0.346 . . . . 0.0 110.64 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.7 m-20 -93.43 -73.65 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.304 0.573 . . . . 0.0 110.586 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 188' ' ' GLU . 58.6 m 64.93 110.08 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.772 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 188' ' ' GLU . 16.7 m -117.82 131.07 24.3 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 77.1 Cg_exo -48.11 167.19 0.11 Allowed 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 123.116 2.544 . . . . 0.0 113.732 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 199' ' ' HIS . 2.8 t -112.49 9.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.544 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -124.08 114.45 19.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -136.91 -39.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.975 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 87.8 m -74.1 -52.69 11.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm 64.07 117.62 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.97 98.93 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.461 2.107 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.52 -37.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.033 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 57.09 96.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -104.3 130.68 52.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -165.35 155.89 27.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.564 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -148.19 173.39 13.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -111.01 178.52 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -130.26 113.14 14.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.2 OUTLIER -125.69 95.24 4.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.84 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 183' ' ' GLN . 4.6 pm0 -108.62 106.95 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 89.2 m-85 -144.33 137.27 27.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.284 0.564 . . . . 0.0 112.06 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.1 m -138.38 124.7 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.766 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB3' HG22 ' A' ' 264' ' ' VAL . 19.1 ptt? -117.61 146.06 43.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.102 0.477 . . . . 0.0 111.846 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.521 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 93.4 p -58.36 145.94 36.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.302 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 29' ' ' ASN . 9.2 tt0 -99.31 95.16 6.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 0.0 111.869 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 24.6 mp0 -137.48 110.45 8.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HB3' HH21 ' A' ' 193' ' ' ARG . 19.9 Cg_endo -59.85 -14.51 27.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.63 2.22 . . . . 0.0 112.873 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.1 pt-20 -83.2 5.39 23.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.484 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 29.4 mtt -132.1 6.14 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.364 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 190' ' ' PRO . 15.1 ptp180 -61.25 -26.17 67.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.053 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -49.07 -52.2 27.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.8 pt -110.15 9.4 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.713 0.292 . . . . 0.0 111.462 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.428 ' HA ' HG21 ' A' ' 262' ' ' VAL . 58.5 tt0 -56.84 132.06 79.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.786 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.429 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 55.3 Cg_endo -69.48 123.8 10.56 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.382 2.055 . . . . 0.0 112.339 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 212' ' ' PRO . 38.2 t -57.02 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.727 ' HA ' HG12 ' B' ' 33' ' ' VAL . 33.7 m80 -138.99 153.26 48.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.25 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.672 HG23 HG11 ' B' ' 33' ' ' VAL . 90.2 t -142.52 139.02 29.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.097 0.475 . . . . 0.0 111.721 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 14.0 p90 -144.45 152.09 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.861 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.489 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.8 p-10 -134.54 158.18 44.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.305 0.574 . . . . 0.0 112.089 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.66 174.97 7.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.524 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.34 -23.15 61.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.728 0.299 . . . . 0.0 110.809 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -94.78 -63.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.43 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -129.15 170.99 12.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.38 . . . . 0.0 111.138 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 94.5 m -127.1 141.56 51.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 98.9 mtt180 -122.27 145.35 48.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 111.556 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.72 124.73 42.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.273 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -97.02 119.7 35.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 111.56 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.82 161.08 41.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 198' ' ' VAL . 48.5 Cg_exo -56.43 163.8 6.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.317 2.012 . . . . 0.0 112.054 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -79.04 -30.24 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.204 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -86.06 -14.86 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.108 0.48 . . . . 0.0 111.023 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.24 147.74 46.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.249 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -85.76 2.93 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.606 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 244' ' ' ILE . 86.6 mt 62.84 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.276 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.86 165.47 11.69 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.979 2.453 . . . . 0.0 112.607 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -90.92 116.73 28.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 255' ' ' ILE . 19.3 t -88.39 112.32 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.538 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.6 m-85 -93.48 177.28 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.653 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -143.83 142.14 30.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 252' ' ' GLU . 21.9 mm -80.46 101.17 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.0 111.37 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.1 m -76.36 -164.93 0.44 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.724 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -63.97 176.54 0.95 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t 62.28 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 165.63 51.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.606 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -138.19 141.61 40.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 14.1 mt-10 -71.79 146.18 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 222' ' ' MET . 90.4 m -140.77 138.35 34.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.451 HD12 ' HD2' ' A' ' 232' ' ' PRO . 64.6 tp -93.82 107.69 29.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.272 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.653 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.6 Cg_endo -76.98 163.24 31.23 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.963 2.442 . . . . 0.0 112.368 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 233' ' ' ASN . 0.8 OUTLIER -60.24 145.16 48.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.237 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 t -152.68 170.31 20.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -140.73 167.11 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.21 127.75 73.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.261 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.48 HG23 ' HB ' ' A' ' 243' ' ' ILE . 30.4 m -138.7 -179.39 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.181 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 243' ' ' ILE . . . 83.72 157.73 25.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.348 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.48 143.36 57.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 110.833 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 240' ' ' ASN . 2.5 t-20 62.44 11.37 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 52.27 79.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.888 0.375 . . . . 0.0 110.214 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' A' ' 217' ' ' LEU . 2.7 p-10 -128.59 5.97 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.216 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.48 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.4 mt -117.32 154.66 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 111.317 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 217' ' ' LEU . 63.4 mt -136.43 106.05 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 37.1 tt0 -97.35 108.46 21.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.79 130.82 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.613 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.07 44.2 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.152 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 38.5 m -159.29 151.01 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 111.424 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.7 t -126.53 126.46 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -137.41 -173.83 3.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.379 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -106.93 -4.63 18.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.471 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.2 tt0 -144.47 123.42 12.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -124.68 115.58 21.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.714 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.8 tpp180 -100.13 103.85 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.692 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.462 HG12 HG22 ' A' ' 220' ' ' VAL . 79.5 mt -86.4 114.72 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.607 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -128.35 141.75 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.094 0.473 . . . . 0.0 111.612 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.9 tp -166.8 122.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.442 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.11 -114.09 6.1 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.341 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.49 23.15 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.161 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -131.29 146.04 52.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 111.306 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.9 p -140.9 146.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.698 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 196' ' ' GLN . 74.4 t -129.91 118.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -81.68 109.97 3.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.049 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 186' ' ' MET . 54.5 t -113.19 142.72 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.618 0.247 . . . . 0.0 110.408 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -139.19 156.54 47.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.037 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 251' ' ' LYS . 3.0 m-20 -111.01 126.42 54.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.227 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 82.5 m-20 -117.57 80.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.117 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 63.7 t30 161.62 26.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.807 0.692 . . . . 0.0 110.466 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -53.49 106.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.189 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.99 69.86 6.33 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.031 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.711 2.274 . . . . 0.0 112.511 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.16 -0.361 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.36 153.31 41.37 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 112.253 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.536 ' HG2' HG12 ' A' ' 261' ' ' VAL . 43.9 Cg_endo -68.3 -75.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.552 2.168 . . . . 0.0 112.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 261' ' ' VAL . 9.8 tp10 60.4 119.66 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.677 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.543 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.3 Cg_exo -75.89 111.13 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.274 1.983 . . . . 0.0 111.373 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 9.7 m-20 -77.56 -12.05 59.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.892 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.521 ' H ' ' HB2' ' A' ' 187' ' ' SER . 90.6 m95 54.29 15.42 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.651 0.262 . . . . 0.0 110.624 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -37.69 -72.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.192 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.541 ' O ' HG13 ' B' ' 31' ' ' VAL . 0.7 OUTLIER -111.89 73.29 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.3 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 29' ' ' ASN . 61.3 m -35.11 104.14 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.464 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 29' ' ' ASN . 2.8 m -110.59 115.33 53.94 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.2 Cg_exo -51.17 168.42 0.25 Allowed 'Trans proline' 0 CA--C 1.52 -0.212 0 C-N-CA 122.853 2.369 . . . . 0.0 113.208 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 199' ' ' HIS . 10.4 t -103.5 -5.14 9.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.631 HD22 ' N ' ' B' ' 34' ' ' ASN . 0.8 OUTLIER -108.03 126.3 52.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.614 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.02 -38.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.206 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 10.5 t -105.36 -25.51 12.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.181 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.8 mm 67.11 132.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.84 104.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.921 2.414 . . . . 0.0 112.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.98 -22.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 60.26 -176.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -125.75 -51.23 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.748 0.309 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.95 77.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.43 172.04 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -98.62 167.5 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.76 113.33 14.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.4 OUTLIER -108.19 95.45 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.81 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -101.55 103.33 14.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 67.0 m-85 -127.73 151.31 49.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.476 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.8 m -144.0 125.07 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.662 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 264' ' ' VAL . 15.3 ptt? -117.31 149.24 40.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.327 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 90.3 p -58.24 129.36 41.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.224 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -79.34 89.5 4.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.862 0.363 . . . . 0.0 110.488 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -133.69 118.44 14.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.634 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.501 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 57.6 Cg_endo -70.64 -10.77 28.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.576 2.184 . . . . 0.0 112.743 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.35 -21.64 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.849 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 18.5 ptp -113.68 26.49 10.33 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 190' ' ' PRO . 80.4 mtp180 -72.19 -26.59 62.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.915 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.1 m -53.23 -52.27 59.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.501 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.7 pt -96.76 -0.36 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.366 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -59.05 127.12 83.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 128.68 13.98 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.2 t -54.79 -60.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.155 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.69 ' HA ' HG12 ' B' ' 33' ' ' VAL . 38.4 m80 -146.51 153.78 40.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.404 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.562 HG23 HG11 ' B' ' 33' ' ' VAL . 86.9 t -140.04 127.87 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 111.697 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 28.4 p90 -134.89 143.93 47.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.289 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.422 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.25 170.77 8.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 0.0 111.589 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -143.12 161.57 37.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -56.41 -23.48 38.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -98.13 -69.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.565 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.83 171.15 11.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 84.8 m -122.86 143.34 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.503 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 140.28 52.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.528 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -120.62 124.84 46.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.707 ' HA ' HD13 ' A' ' 243' ' ' ILE . 19.6 tt0 -101.89 117.62 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -115.41 158.81 40.53 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.715 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.0 165.73 4.76 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.417 2.078 . . . . 0.0 112.094 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.07 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.16 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.0 -14.9 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.136 0.493 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.63 150.63 41.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.03 7.11 36.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 242' ' ' ASN . 87.0 mt 62.92 107.31 0.03 OUTLIER Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.18 -173.2 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.928 2.419 . . . . 0.0 112.784 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.25 103.51 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 255' ' ' ILE . 27.5 t -73.04 109.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.1 m-85 -90.89 177.06 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.819 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.619 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.6 ppp? -144.07 143.92 31.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.952 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 252' ' ' GLU . 28.5 mm -80.34 95.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -79.59 -172.46 3.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.547 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.54 171.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.104 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.2 m 62.56 9.84 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.232 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.07 52.99 50.11 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.821 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -138.04 140.92 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.3 mt-10 -69.08 149.12 49.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.201 0.524 . . . . 0.0 111.178 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 222' ' ' MET . 94.6 m -148.72 140.56 23.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.059 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 232' ' ' PRO . 65.4 tp -95.16 107.45 32.16 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.771 0.319 . . . . 0.0 111.325 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.619 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 72.2 Cg_endo -76.75 163.28 31.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.915 2.41 . . . . 0.0 112.298 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.564 HD22 ' N ' ' A' ' 233' ' ' ASN . 0.8 OUTLIER -56.85 126.32 26.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 246' ' ' VAL . 81.0 p -137.92 153.2 49.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.095 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -136.53 160.7 37.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.35 133.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 243' ' ' ILE . 35.1 m -139.13 169.87 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.04 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 166.53 17.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.75 -50.83 31.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.347 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.36 6.27 43.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 54.58 76.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 p-10 -137.97 3.37 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 210' ' ' GLU . 13.1 mm -104.11 151.16 6.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.7 mt -134.93 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.41 109.1 20.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.291 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 234' ' ' SER . 76.0 t -90.92 129.65 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.52 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.84 40.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -155.34 149.41 25.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 41.7 t -123.45 129.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -140.13 -173.88 3.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.255 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.743 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -108.85 -5.34 16.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.49 ' HB3' HG12 ' A' ' 223' ' ' ILE . 2.3 tt0 -143.14 123.39 13.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -124.25 114.28 19.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.453 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.34 104.61 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 220' ' ' VAL . 13.8 mm -76.25 114.89 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.152 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -129.11 135.84 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.076 0.465 . . . . 0.0 111.791 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.2 tp -167.36 119.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 -115.27 6.87 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.235 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.58 23.15 11.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 13.8 tppt? -126.06 147.71 49.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' B' ' 23' ' ' PRO . 4.7 p -142.07 146.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 92.6 t -132.7 120.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.328 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.594 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -84.84 112.19 3.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.268 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 186' ' ' MET . 88.5 t -114.74 145.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -139.35 126.57 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 0.0 111.143 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 251' ' ' LYS . 36.5 t30 -91.92 111.87 23.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 2.3 m-20 -103.05 80.84 1.9 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.877 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 3.0 t-20 172.61 -25.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.716 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.79 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.415 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 50.74 54.81 15.97 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.253 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.512 0 C-N-CA 122.504 2.136 . . . . 0.0 112.251 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 111.105 -0.383 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.51 156.94 60.36 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.539 2.159 . . . . 0.0 112.263 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.624 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 36.9 Cg_endo -65.68 -76.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.528 2.152 . . . . 0.0 112.305 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.6 tt0 62.23 124.19 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.989 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.594 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -78.11 108.26 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.391 2.061 . . . . 0.0 111.247 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.99 -8.38 59.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.147 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 74.4 m95 51.01 25.48 2.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.034 0.445 . . . . 0.0 110.264 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -32.11 -63.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.338 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.471 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 74.8 m-20 -118.21 0.48 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.838 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m 41.43 91.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.18 121.98 45.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.083 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 99.5 Cg_exo -50.44 169.01 0.17 Allowed 'Trans proline' 0 CA--C 1.52 -0.189 0 C-N-CA 123.133 2.555 . . . . 0.0 113.496 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.4 t -114.84 14.7 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.324 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -143.62 114.38 7.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.014 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -106.93 -33.94 7.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 38.6 p -58.64 -74.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.349 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.5 mm 64.36 131.55 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.369 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 37' ' ' ILE . 5.9 Cg_exo -77.91 110.62 2.95 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.753 2.302 . . . . 0.0 112.128 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 41' ' ' THR . 13.1 t -98.49 -70.39 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 56.53 24.86 9.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.454 ' H ' HG12 ' B' ' 39' ' ' VAL . 62.9 m 59.94 99.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -155.96 68.19 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -150.29 113.42 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 203' ' ' ASN . 67.4 mttm -135.75 144.99 46.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -99.39 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' TRP . 2.3 p90 -116.74 95.41 5.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.682 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -82.17 111.45 18.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.849 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -138.4 144.11 40.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.084 0.468 . . . . 0.0 111.553 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 20.8 m -142.82 129.54 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.413 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 264' ' ' VAL . 18.7 ptt? -122.43 146.94 46.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.37 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 p -59.35 124.22 19.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.06 98.83 8.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.781 0.324 . . . . 0.0 111.245 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.536 ' NE2' ' HB2' ' B' ' 26' ' ' ASP . 0.1 OUTLIER -137.7 110.85 8.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.561 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.69 -18.22 39.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.568 2.179 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.0 4.51 25.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.573 ' HG2' ' HD2' ' A' ' 260' ' ' LYS . 36.6 mtt -132.24 7.25 4.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.251 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -60.43 -26.36 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -53.56 -52.19 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.441 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.6 pt -103.31 5.07 10.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.364 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.84 130.78 88.74 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.03 127.63 12.3 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.392 2.061 . . . . 0.0 112.297 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.404 HG23 ' HD3' ' A' ' 212' ' ' PRO . 46.1 t -55.34 -72.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.443 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.736 ' HA ' HG12 ' B' ' 33' ' ' VAL . 27.8 m170 -135.89 153.66 51.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.403 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.69 HG23 HG11 ' B' ' 33' ' ' VAL . 96.9 t -139.94 138.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.38 . . . . 0.0 111.39 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 31.3 p90 -148.04 159.5 43.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -148.03 173.16 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 180' ' ' LYS . 4.0 p30 -153.53 -171.67 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.54 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -71.06 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.633 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.6 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -143.64 170.41 15.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.935 0.398 . . . . 0.0 111.304 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 202' ' ' ASP . 82.8 m -111.69 149.27 31.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.654 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 99.1 mtt180 -134.52 147.88 50.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.931 0.396 . . . . 0.0 111.549 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.39 127.61 44.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.393 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -101.83 116.16 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 111.218 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 244' ' ' ILE . 80.4 m-85 -114.79 159.69 36.37 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' HG23 ' A' ' 198' ' ' VAL . 31.5 Cg_exo -59.57 164.55 11.07 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.74 -27.7 55.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.333 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.04 -14.92 42.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 111.219 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.19 145.37 55.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.368 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -84.13 1.2 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.497 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 244' ' ' ILE . 82.0 mt 62.54 100.55 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.57 166.24 12.04 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.129 2.553 . . . . 0.0 112.719 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.96 123.47 33.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 42.4 t -93.92 111.93 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.654 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.481 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.75 175.25 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -142.97 143.07 31.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 252' ' ' GLU . 21.6 mm -85.81 120.65 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.176 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 47.0 t -143.68 139.86 29.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 60.58 102.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.225 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t 63.07 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.11 51.36 0.2 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.452 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -104.37 141.39 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.981 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 17.8 mt-10 -100.07 119.03 37.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 222' ' ' MET . 3.7 t -129.21 134.21 47.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.489 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 232' ' ' PRO . 52.0 tp -78.4 110.45 13.85 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.4 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.8 Cg_endo -76.3 163.48 32.41 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.717 2.278 . . . . 0.0 112.009 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -50.19 105.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.75 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -102.09 157.45 16.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.313 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -144.73 167.16 23.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.532 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.33 135.19 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.49 176.0 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.63 157.86 12.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.542 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.03 -36.1 82.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.41 10.27 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 54.71 72.8 0.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.512 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -135.48 15.43 3.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 8.4 mt -114.5 149.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.411 HD12 ' CE1' ' A' ' 211' ' ' PHE . 52.4 mt -131.11 103.82 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.2 pt-20 -99.85 132.49 45.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.25 132.05 59.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.66 40.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.137 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.9 m -156.85 144.04 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.178 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.4 t -108.93 136.63 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.804 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -150.06 177.13 10.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 265' ' ' ARG . 42.4 tttm -94.11 -64.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.708 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 223' ' ' ILE . 2.8 tt0 -90.11 123.36 33.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.71 119.37 36.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.46 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.863 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 72.1 mt -90.28 114.68 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -130.38 144.68 51.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 111.647 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.72 120.05 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.451 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 71.08 -115.74 5.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.319 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.39 17.98 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.574 ' HD3' ' HB3' ' B' ' 23' ' ' PRO . 14.0 tppt? -127.65 141.75 51.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.866 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.579 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.4 p -135.2 146.35 30.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.998 0.428 . . . . 0.0 111.368 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.0 t -129.9 116.34 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.147 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.717 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -78.06 129.69 9.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.224 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 186' ' ' MET . 86.6 t -129.36 144.63 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.439 ' HE ' ' NZ ' ' A' ' 251' ' ' LYS . 60.4 ttt180 -137.02 153.04 50.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.792 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.16 124.29 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 37.2 m-80 -117.1 80.32 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 267' ' ' ASN . 55.0 t30 173.06 28.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.71 108.36 0.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.944 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.89 80.93 9.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.722 2.281 . . . . 0.0 112.305 179.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.404 ' N ' ' HD2' ' B' ' 22' ' ' PRO . 43.9 Cg_exo . . . . . 0 N--CA 1.485 1.021 0 CA-C-O 119.872 -0.137 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.495 ' HA ' ' HD2' ' B' ' 23' ' ' PRO . 73.9 Cg_endo -75.55 114.35 3.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.936 1.757 . . . . 0.0 112.281 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.579 ' HG2' HG12 ' A' ' 261' ' ' VAL . 14.7 Cg_endo -57.2 -67.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 61.99 120.51 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.578 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.717 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.0 Cg_exo -73.65 101.27 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.414 2.076 . . . . 0.0 112.308 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -73.45 89.99 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.373 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.35 -0.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.567 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 26' ' ' ASP . 79.6 p -43.09 -47.31 6.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 3.2 m-20 -94.23 -71.02 0.68 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 188' ' ' GLU . 90.8 m 63.82 108.2 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.933 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -120.85 130.39 24.87 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.818 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 67.1 Cg_exo -46.66 161.99 0.16 Allowed 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.915 2.41 . . . . 0.0 113.517 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 199' ' ' HIS . 4.3 t -99.18 -2.11 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.467 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -95.58 150.73 20.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.775 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -135.38 -45.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -123.55 97.18 5.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.052 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.24 128.41 57.64 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.072 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.88 98.16 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.534 2.156 . . . . 0.0 112.188 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.5 -28.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.009 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.0 t70 59.27 98.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.6 m -67.26 112.36 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 108.46 54.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.46 32.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -151.09 153.34 34.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -123.3 113.35 18.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.02 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.527 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 3.6 p90 -105.78 95.3 5.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.613 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.16 106.45 15.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.603 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 49.7 m-85 -132.07 147.21 52.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.611 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 17.4 m -149.74 124.86 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.961 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.564 ' HB3' HG22 ' A' ' 264' ' ' VAL . 14.8 ptt? -126.8 170.6 12.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.4 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.661 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 83.2 p -77.48 125.87 30.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -80.72 95.74 6.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.845 0.355 . . . . 0.0 110.581 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.458 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 26.0 mm-40 -128.95 115.26 18.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 -21.97 29.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.621 2.214 . . . . 0.0 112.246 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.42 -11.29 57.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 15.9 mmt -112.12 4.22 17.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.931 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 196' ' ' GLN . 15.4 ptm180 -55.13 -26.38 38.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -51.4 -52.05 49.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.585 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.9 pt -103.19 -4.44 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.564 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 193' ' ' ARG . 53.4 tt0 -61.97 130.89 93.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.36 126.11 11.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.449 2.1 . . . . 0.0 112.345 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 199' ' ' HIS . 4.3 t -55.51 -57.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.602 ' HA ' HG12 ' B' ' 33' ' ' VAL . 97.8 m-70 -144.43 155.93 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.129 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.407 HG23 HG11 ' B' ' 33' ' ' VAL . 98.9 t -145.43 140.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.514 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 182' ' ' TYR . 23.3 p90 -148.14 151.13 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.527 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 4.7 p-10 -122.67 173.04 7.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 111.463 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -133.86 -173.64 3.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.066 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -71.37 -23.73 61.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.234 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.43 -69.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.877 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.04 170.59 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.133 0.492 . . . . 0.0 111.906 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -137.08 144.33 43.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 76.9 mtp180 -123.84 149.3 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.0 111.838 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -127.71 124.78 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.197 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -96.68 122.82 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 111.442 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.64 160.45 44.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.759 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.63 166.08 10.48 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.364 2.043 . . . . 0.0 111.982 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.92 -30.08 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.175 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.1 -14.88 42.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.47 174.31 7.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.84 155.8 16.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.7 mp -93.43 112.33 56.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.095 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HA ' HD13 ' A' ' 257' ' ' LEU . 88.6 Cg_endo -79.89 174.52 11.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.896 2.397 . . . . 0.0 112.678 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.558 HE21 HD11 ' A' ' 231' ' ' LEU . 15.4 mm100 -98.84 125.17 44.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.287 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 255' ' ' ILE . 25.6 t -92.92 135.01 28.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.98 0.419 . . . . 0.0 111.558 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.81 177.05 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.45 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -142.52 134.44 27.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.466 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 252' ' ' GLU . 11.5 mm -80.8 132.77 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.28 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 79.9 p -124.53 -164.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.697 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.11 157.5 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.196 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.9 m 62.04 10.25 3.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.36 74.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -138.23 141.85 39.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -89.38 134.97 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.3 t -138.1 133.54 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.534 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.558 HD11 HE21 ' A' ' 219' ' ' GLN . 1.8 tt -87.05 111.16 38.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.438 ' HG3' ' HZ3' ' A' ' 253' ' ' TRP . 68.8 Cg_endo -75.09 163.1 35.8 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.85 2.367 . . . . 0.0 112.483 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -57.65 98.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.6 p -100.61 150.13 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -137.26 126.93 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.73 141.76 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -146.68 158.88 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 111.58 151.49 11.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.381 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.68 -54.16 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 110.791 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.64 12.61 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.571 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.02 68.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' HD11 ' A' ' 217' ' ' LEU . 30.1 p-10 -127.55 15.67 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.964 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.6 mt -129.19 149.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.5 mt -133.38 109.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 40.3 tt0 -99.9 110.73 23.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.326 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 248' ' ' THR . 37.9 t -90.32 134.73 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.98 39.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.25 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.57 ' H ' HG12 ' A' ' 246' ' ' VAL . 35.3 m -156.39 150.5 25.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.138 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.66 130.05 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -136.81 -173.94 3.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.345 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -105.08 -21.69 13.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.7 tt0 -133.27 123.26 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.438 ' HZ3' ' HG3' ' A' ' 232' ' ' PRO . 96.3 m95 -117.32 122.05 42.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.441 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 21.0 tpp180 -107.99 106.3 16.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.625 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 220' ' ' VAL . 69.0 mt -90.0 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -126.4 137.89 53.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.552 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 218' ' ' PRO . 32.4 tp -157.48 123.61 4.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.479 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 65.54 -111.8 4.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.206 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -119.45 8.83 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.318 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -115.16 153.6 30.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.438 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' B' ' 23' ' ' PRO . 5.0 p -142.09 146.44 22.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.932 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -131.75 113.63 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.115 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.646 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.2 130.34 12.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.475 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 186' ' ' MET . 49.4 t -131.93 146.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 58.9 ttt180 -144.58 123.42 12.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -101.24 112.11 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -97.97 80.91 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 174.81 137.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.524 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.24 98.92 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.815 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -126.14 80.52 68.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.143 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--N 1.346 0.431 0 C-N-CA 122.562 2.175 . . . . 0.0 112.278 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 111.171 -0.357 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.28 156.17 55.3 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.422 2.081 . . . . 0.0 112.262 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.515 ' HG2' HG12 ' A' ' 261' ' ' VAL . 41.0 Cg_endo -67.82 -74.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.506 2.137 . . . . 0.0 112.285 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.0 tt0 62.71 126.77 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 3.1 Cg_exo -79.04 113.75 3.27 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.569 2.179 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.81 -7.69 59.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.941 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.661 ' H ' ' HB2' ' A' ' 187' ' ' SER . 78.3 m95 51.9 27.66 4.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.292 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.2 t -32.62 -78.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.359 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.463 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 66.5 m-20 -102.23 0.48 34.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 111.679 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 186' ' ' MET . 25.1 m 41.38 87.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.713 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 186' ' ' MET . 3.4 m -90.09 117.13 67.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.9 0.381 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 85.9 Cg_exo -52.56 -1.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.849 3.033 . . . . 0.0 114.884 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 199' ' ' HIS . 19.3 t 69.94 -18.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' B' ' 32' ' ' PRO . 6.6 m120 -105.27 -59.93 1.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.219 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 66.13 -4.69 0.64 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.077 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.432 ' H ' ' C ' ' B' ' 34' ' ' ASN . 40.0 p -148.59 95.58 2.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.839 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.44 128.33 28.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.51 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.732 2.288 . . . . 0.0 112.257 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.28 -30.76 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 59.43 99.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 66.0 m -73.3 -38.74 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.56 73.67 0.3 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -139.21 17.95 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.65 145.87 24.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.64 113.42 14.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 95.11 7.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -99.91 115.17 29.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.496 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 66.4 m-85 -137.0 154.24 50.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.532 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.6 m -144.19 124.82 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.718 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 12.0 ptt? -108.93 143.33 38.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.716 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -61.19 117.83 6.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.38 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -77.17 98.85 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 111.177 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.77 121.64 10.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.153 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.23 -17.94 55.65 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.63 2.22 . . . . 0.0 112.72 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 192' ' ' MET . 13.0 pt-20 -83.09 4.19 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.012 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.531 ' HG3' ' HG3' ' A' ' 191' ' ' GLU . 30.6 mtt -132.15 6.87 4.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.353 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 35.8 ptt180 -58.54 -26.59 63.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 80.2 p -60.34 -47.4 86.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.1 pt -104.85 14.1 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.504 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 4.6 tp-100 -58.3 121.09 49.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.443 ' HD2' ' OE1' ' A' ' 196' ' ' GLN . 40.9 Cg_endo -67.56 126.24 14.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.27 1.98 . . . . 0.0 112.192 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.528 HG12 ' ND1' ' A' ' 199' ' ' HIS . 15.9 t -54.66 -67.41 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.542 ' HA ' HG12 ' B' ' 33' ' ' VAL . 46.9 m80 -144.37 160.46 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.35 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.405 HG23 HG11 ' B' ' 33' ' ' VAL . 94.5 t -145.04 132.08 15.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.403 ' HE1' ' NE ' ' A' ' 208' ' ' ARG . 36.5 p90 -142.92 143.2 31.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.332 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.441 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.7 p-10 -119.84 173.06 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 111.42 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -144.36 159.3 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.143 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -53.77 -23.38 11.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -98.27 -69.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.61 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -126.15 170.94 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.953 0.406 . . . . 0.0 111.469 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 86.4 m -124.77 144.34 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.424 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 245' ' ' GLU . 90.7 mtm180 -126.35 145.28 50.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.23 124.55 43.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -99.04 119.67 38.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.49 160.41 38.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.65 163.34 11.08 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.425 2.083 . . . . 0.0 112.044 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.44 -23.98 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.16 -14.87 42.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.91 167.28 10.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.264 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.87 153.73 20.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 244' ' ' ILE . 87.6 mt -85.51 117.89 69.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.68 176.98 7.28 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.824 2.349 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -104.93 108.9 20.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.459 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 255' ' ' ILE . 37.6 t -79.32 111.57 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.531 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.5 m-85 -90.75 177.23 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.601 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 230' ' ' THR . 0.4 OUTLIER -144.17 150.76 38.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 18.8 mm -94.17 129.09 44.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.6 m -91.23 -178.37 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.54 -22.5 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.4 t -85.74 -21.01 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.23 4.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -122.59 142.96 50.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.32 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.6 mt-10 -88.65 118.19 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.32 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 222' ' ' MET . 5.4 t -133.1 138.33 46.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.382 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 232' ' ' PRO . 49.6 tp -77.71 110.4 12.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.273 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 231' ' ' LEU . 73.7 Cg_endo -76.29 163.24 32.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.714 2.276 . . . . 0.0 112.247 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.46 126.87 25.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 246' ' ' VAL . 80.3 p -130.3 163.67 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.147 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.414 ' HD2' HG13 ' A' ' 237' ' ' VAL . 43.2 t60 -146.27 122.94 11.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.93 135.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.351 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.654 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -146.33 177.55 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.221 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 108.73 153.95 16.37 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.53 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.2 10.24 22.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.51 78.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.381 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.2 p30 -151.74 15.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.654 ' HB ' HG23 ' A' ' 237' ' ' VAL . 3.3 mt -112.12 155.75 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.071 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 217' ' ' LEU . 57.9 mt -134.89 103.63 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.764 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 208' ' ' ARG . 36.5 tt0 -96.25 107.99 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.143 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' SER . 81.5 t -90.04 127.5 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.5 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.51 40.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.543 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 53.3 m -156.12 145.98 21.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.08 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.12 128.23 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.71 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -132.81 -174.57 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -101.4 -25.52 13.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.095 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -130.1 123.7 31.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 0.0 111.208 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -117.03 118.22 31.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.53 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 25' ' ' PRO . 19.5 tpp180 -106.11 104.08 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 220' ' ' VAL . 73.2 mt -83.36 114.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -124.84 140.82 52.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.957 0.408 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.6 tp -167.69 126.71 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.56 -114.86 7.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.392 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.42 20.97 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.631 0.253 . . . . 0.0 111.276 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 74.7 mmtt -131.29 149.56 52.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.991 0.424 . . . . 0.0 111.542 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.552 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -141.18 146.28 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.486 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.95 136.66 59.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.469 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -96.46 103.81 2.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.126 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 186' ' ' MET . 59.4 t -115.48 116.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.407 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 67.7 ttt180 -106.68 120.82 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 111.007 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.95 125.35 26.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.115 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.59 172.14 7.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.998 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 61.11 29.59 18.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.53 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.87 107.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.062 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -123.88 81.55 55.93 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.179 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.72 2.28 . . . . 0.0 112.211 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 111.092 -0.388 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.52 156.01 58.66 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.467 2.111 . . . . 0.0 112.225 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 261' ' ' VAL . 55.4 Cg_endo -69.76 -77.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.513 2.142 . . . . 0.0 112.341 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.4 tt0 59.88 119.0 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.738 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG2' ' NH1' ' A' ' 254' ' ' ARG . 3.1 Cg_exo -74.97 108.79 2.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.08 1.853 . . . . 0.0 111.049 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -73.31 -13.77 61.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.908 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 93.7 m95 56.65 11.36 0.87 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.61 0.243 . . . . 0.0 110.72 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -37.82 -64.9 0.36 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.857 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 56.4 m-20 -113.54 79.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.124 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -49.78 92.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.227 0.537 . . . . 0.0 110.768 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.592 HG13 ' HD2' ' B' ' 32' ' ' PRO . 2.4 t -93.39 145.43 29.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.982 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 73.5 Cg_endo -66.14 -160.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.472 0.217 0 C-N-CA 122.548 2.166 . . . . 0.0 111.615 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 199' ' ' HIS . 85.9 t -134.23 -49.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.172 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -94.49 102.28 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' B' ' 35' ' ' LYS . 3.6 mptp? -79.41 -63.95 1.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 69.5 p -96.72 102.41 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.04 124.91 88.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.48 100.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.686 2.257 . . . . 0.0 112.223 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.7 -30.8 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.225 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 59.4 -173.58 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 60.0 m -129.86 -49.05 1.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -153.01 58.13 0.42 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.546 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.49 -172.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.859 0.362 . . . . 0.0 111.218 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 180' ' ' LYS . 0.4 OUTLIER -146.91 163.59 35.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.36 113.64 25.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.577 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -106.21 95.24 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.709 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.676 HE21 HD21 ' A' ' 266' ' ' ASN . 3.3 pm0 -111.5 95.03 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.934 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.51 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 93.3 m-85 -139.9 129.54 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.271 0.558 . . . . 0.0 112.293 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 16.8 m -126.21 124.63 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.802 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.421 ' HB3' HG22 ' A' ' 264' ' ' VAL . 20.5 ptt? -116.41 139.13 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.058 0.456 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.2 p -51.69 144.19 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 189' ' ' GLN . 1.5 tm-20 -90.28 97.0 10.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.635 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.646 HE22 ' HA ' ' B' ' 25' ' ' PRO . 22.1 mt-30 -149.62 106.61 3.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 58.5 Cg_endo -70.75 -10.81 28.51 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.512 2.141 . . . . 0.0 113.009 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.8 pt-20 -62.29 -38.49 89.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.375 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.34 29.18 8.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.808 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -55.13 -26.67 39.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -55.01 -52.02 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -84.74 -15.52 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.69 122.65 66.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.67 132.29 21.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.477 2.118 . . . . 0.0 112.595 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.21 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.419 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.707 ' HA ' HG12 ' B' ' 33' ' ' VAL . 37.0 m80 -139.77 153.61 47.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.696 HG23 HG11 ' B' ' 33' ' ' VAL . 89.2 t -143.28 141.98 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.213 0.53 . . . . 0.0 111.851 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 18.3 p90 -147.8 163.85 35.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.783 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 3.9 p30 -140.69 173.25 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.251 0.548 . . . . 0.0 112.05 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -139.8 164.27 30.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.846 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -57.38 -23.31 48.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.381 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -102.18 -69.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -117.28 171.15 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 202' ' ' ASP . 86.4 m -126.37 148.57 49.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.288 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.45 145.7 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -127.63 124.5 38.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.311 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -98.31 119.58 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.522 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 244' ' ' ILE . 93.7 m-85 -116.53 160.1 37.58 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.78 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 167.51 5.37 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.346 2.031 . . . . 0.0 111.936 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -94.51 -28.07 15.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -86.24 -14.84 42.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.088 0.471 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -95.78 173.45 7.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.335 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -97.07 156.36 16.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.654 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.8 mp -92.24 110.52 45.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.183 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.01 167.26 18.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.939 2.426 . . . . 0.0 112.653 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -86.96 139.18 30.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.335 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 255' ' ' ILE . 17.6 t -111.44 111.1 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 111.532 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.497 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -90.86 175.81 6.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.53 ' HG2' ' HD3' ' A' ' 232' ' ' PRO . 18.1 ptm -143.89 137.55 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 12.7 mm -81.13 124.39 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.088 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.1 t -140.1 175.82 9.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.77 -84.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.4 m -147.57 -14.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.716 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 161.52 30.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 228' ' ' LYS . 13.5 mptt -101.7 109.12 20.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.4 mt-10 -68.17 108.9 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 222' ' ' MET . 5.9 t -110.32 140.22 44.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 232' ' ' PRO . 62.8 tp -94.17 107.71 30.7 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.53 ' HD3' ' HG2' ' A' ' 222' ' ' MET . 61.4 Cg_endo -74.24 163.17 37.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.869 2.379 . . . . 0.0 112.509 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.98 102.8 0.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.4 p -94.93 158.49 15.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 66.8 m80 -133.06 167.27 20.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.543 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.62 129.87 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.414 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 243' ' ' ILE . 35.7 m -139.66 175.54 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.05 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.45 157.89 22.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.362 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.81 -12.9 57.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -129.24 20.24 5.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 39.32 37.72 0.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 217' ' ' LEU . 3.3 p-10 -96.77 6.66 48.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 237' ' ' VAL . 7.5 mt -105.27 153.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 217' ' ' LEU . 55.6 mt -131.47 102.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.01 109.72 21.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 248' ' ' THR . 71.5 t -89.79 141.04 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.72 32.46 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.404 ' H ' HG12 ' A' ' 246' ' ' VAL . 23.6 p -148.5 155.94 41.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.012 0.434 . . . . 0.0 111.824 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.414 ' HA ' ' HZ2' ' A' ' 253' ' ' TRP . 23.3 t -132.65 124.55 51.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.394 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.93 -173.76 3.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 111.577 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -101.68 -11.93 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.178 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.87 123.85 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.0 110.81 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.414 ' HZ2' ' HA ' ' A' ' 249' ' ' VAL . 98.4 m95 -118.91 130.46 55.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -115.87 104.01 11.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 220' ' ' VAL . 76.9 mt -89.77 114.69 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -124.99 142.66 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.457 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 22.4 tp -165.71 120.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.489 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.92 -115.34 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.303 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -119.42 21.05 12.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 111.029 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.9 mmtt -130.27 142.67 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.287 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' B' ' 23' ' ' PRO . 8.8 p -134.58 146.2 31.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.075 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.22 133.62 68.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.056 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -95.39 102.07 2.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.545 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 186' ' ' MET . 84.2 t -107.66 116.78 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.456 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 54.9 ttp180 -113.85 150.92 32.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.1 0.476 . . . . 0.0 111.734 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.676 HD21 HE21 ' A' ' 183' ' ' GLN . 15.7 t-20 -101.59 125.31 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 268' ' ' ASN . 84.6 m-20 -117.54 82.59 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.579 ' HB3' ' HG3' ' A' ' 183' ' ' GLN . 7.0 t30 163.51 -47.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.257 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 65.8 t80 57.03 98.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.311 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -138.16 78.46 34.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.975 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.346 0.402 0 C-N-CA 122.597 2.198 . . . . 0.0 112.297 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 N-CA-C 111.148 -0.366 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' B' ' 23' ' ' PRO . 58.4 Cg_endo -71.71 157.25 55.98 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.498 2.132 . . . . 0.0 112.248 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.538 ' HB2' HG12 ' A' ' 261' ' ' VAL . 4.7 Cg_exo -78.43 -57.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.884 2.389 . . . . 0.0 112.005 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 62.16 121.02 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.646 ' HA ' HE22 ' A' ' 189' ' ' GLN . 6.1 Cg_exo -75.66 88.37 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.266 1.977 . . . . 0.0 112.221 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.456 ' N ' HE22 ' A' ' 189' ' ' GLN . 11.2 m-20 -57.8 92.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.52 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 91.6 m95 -64.85 -0.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.39 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 56.1 m -47.41 -26.35 1.3 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.449 ' CG ' ' HB3' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -139.39 93.83 2.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.421 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -76.07 121.0 22.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 111.585 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.61 111.64 34.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.417 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 80.5 Cg_exo -51.38 169.72 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.914 2.409 . . . . 0.0 113.392 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 199' ' ' HIS . 3.5 t -110.61 -2.08 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -107.46 97.25 7.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -99.14 -34.59 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -127.72 98.66 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -63.8 130.11 94.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.74 99.22 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.529 2.153 . . . . 0.0 112.337 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.89 -30.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.9 t70 59.33 98.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.3 t -95.18 -5.63 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -163.43 -171.92 30.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.588 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.434 ' C ' ' HZ3' ' A' ' 180' ' ' LYS . . . -138.96 -176.91 4.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.332 . . . . 0.0 111.08 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.659 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -131.24 157.36 43.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -95.81 113.83 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.1 OUTLIER -80.54 94.7 6.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.181 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 267' ' ' ASN . 48.5 tp60 -87.16 102.44 14.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 71.7 m-85 -137.34 129.66 29.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.451 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 30.8 m -128.71 129.45 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.421 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.4 ptt? -118.28 138.97 52.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.43 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.3 m -52.78 130.2 32.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.991 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -86.07 102.13 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.778 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 191' ' ' GLU . 72.7 mm-40 -144.64 123.74 6.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.51 -10.65 28.4 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.58 2.187 . . . . 0.0 112.543 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 12.7 pt-20 -82.71 -22.51 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' A' ' 189' ' ' GLN . 19.1 ptp -117.09 14.28 14.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.7 ptm180 -65.76 -26.45 67.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.001 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.8 m -52.54 -52.47 54.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.8 pt -96.66 8.99 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 7.5 tt0 -59.94 125.63 81.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.752 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.9 130.31 20.16 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.458 2.105 . . . . 0.0 112.313 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.434 HG12 ' ND1' ' A' ' 199' ' ' HIS . 40.6 t -57.39 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.397 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.696 ' HA ' HG12 ' B' ' 33' ' ' VAL . 36.3 m80 -142.36 151.15 41.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.164 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.568 HG13 HG11 ' B' ' 33' ' ' VAL . 17.5 m -141.66 148.06 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.041 0.448 . . . . 0.0 111.68 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 41.0 p90 -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.324 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.476 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.9 p-10 -129.25 173.22 10.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -140.24 -177.23 4.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -71.33 -23.53 61.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.338 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -111.52 -69.19 0.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -109.5 170.51 8.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.985 0.422 . . . . 0.0 111.672 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 92.3 m -134.06 134.99 43.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 208' ' ' ARG . 9.3 mpt_? -112.58 150.15 31.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.422 ' O ' HG23 ' A' ' 243' ' ' ILE . 48.7 m-85 -128.65 124.53 36.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.3 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -98.41 116.39 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.544 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -114.49 160.7 32.02 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.08 172.49 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.076 . . . . 0.0 112.123 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -101.57 -25.33 13.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -86.14 -14.92 42.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.44 155.78 17.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.32 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.19 150.41 31.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 242' ' ' ASN . 94.0 mt -81.77 120.12 76.97 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.2 Cg_endo -82.97 -171.84 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.883 2.388 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -117.68 110.91 18.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 255' ' ' ILE . 13.1 t -80.84 121.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.2 m-85 -98.38 177.49 5.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.766 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.642 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.3 ppp? -145.98 137.51 24.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.428 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 252' ' ' GLU . 19.7 mm -80.51 102.34 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 39.9 t -60.87 172.29 1.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -67.33 -14.42 62.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.1 m -77.25 -62.34 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 141.5 31.56 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -137.86 145.84 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.831 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 20.3 mt-10 -68.69 118.4 11.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.223 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 222' ' ' MET . 85.0 m -117.78 138.21 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.318 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.6 tp -93.14 107.8 28.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.716 0.293 . . . . 0.0 111.234 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.642 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.7 Cg_endo -76.94 163.26 31.28 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.908 2.406 . . . . 0.0 112.442 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.6 141.35 55.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.499 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.7 p -139.93 167.26 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.371 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -149.98 124.53 9.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.447 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.59 136.81 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.243 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -140.75 172.29 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.339 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.01 147.83 16.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.424 ' HG3' ' OD1' ' A' ' 240' ' ' ASN . 10.4 pt-20 -61.57 -39.09 89.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 239' ' ' GLU . 20.1 m120 -95.68 7.17 47.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 53.49 74.12 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.49 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.507 ' HA ' HD21 ' A' ' 217' ' ' LEU . 8.3 p30 -141.36 5.89 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 237' ' ' VAL . 9.0 mt -106.7 148.28 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 217' ' ' LEU . 59.2 mt -126.32 103.68 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.574 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.75 109.66 21.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.4 t -92.09 132.54 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.96 36.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.422 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.6 m -153.99 152.98 31.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.316 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.7 t -128.47 125.83 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.601 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -134.51 -173.72 3.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -105.17 -10.72 16.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -141.55 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.985 0.422 . . . . 0.0 111.009 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -118.47 139.58 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.555 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -122.24 103.52 8.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 220' ' ' VAL . 76.4 mt -82.94 114.51 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -122.09 135.95 54.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.456 . . . . 0.0 111.697 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 59.7 tp -167.38 125.63 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.304 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 66.89 -117.05 8.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.981 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.2 m-20 -119.8 16.46 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 14.5 mptt -123.28 154.22 39.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.0 0.429 . . . . 0.0 111.825 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.3 p -140.94 146.38 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.9 t -128.04 114.65 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.533 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.55 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -79.66 111.8 3.33 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.907 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 47.3 t -117.52 116.36 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.481 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 67.9 ttt180 -111.4 132.32 54.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.958 0.409 . . . . 0.0 111.163 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.752 HD21 ' H ' ' A' ' 269' ' ' PHE . 6.4 t30 -98.2 127.78 44.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 183' ' ' GLN . 37.2 m-80 -117.06 81.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.08 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -179.86 -60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.728 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.752 ' H ' HD21 ' A' ' 266' ' ' ASN . 51.0 t80 57.97 95.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.206 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -117.1 81.78 13.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.683 2.256 . . . . 0.0 112.249 179.751 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.403 ' N ' ' HD2' ' B' ' 22' ' ' PRO . 45.0 Cg_exo . . . . . 0 N--CA 1.485 0.996 0 CA-C-O 119.834 -0.152 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' B' ' 21' ' ' PRO . 73.6 Cg_endo -75.5 155.4 40.64 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.933 1.756 . . . . 0.0 112.307 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.571 ' HG2' HG12 ' A' ' 261' ' ' VAL . 64.0 Cg_endo -74.5 -80.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.459 2.106 . . . . 0.0 112.251 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.498 ' H ' HG12 ' A' ' 261' ' ' VAL . 3.5 tm-20 62.1 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.608 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.55 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.6 Cg_endo -80.29 103.58 1.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.131 1.887 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.0 -5.61 56.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.007 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . . . . . . . . . 67.2 m95 53.36 24.6 3.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.022 0.439 . . . . 0.0 110.203 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -34.04 -68.17 0.12 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.8 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 79.3 m-20 -108.53 -17.07 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.362 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.441 HG22 ' HB ' ' A' ' 185' ' ' VAL . 35.9 m 43.63 96.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.526 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.4 128.63 25.27 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.95 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 91.9 Cg_exo -49.27 170.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.149 2.566 . . . . 0.0 113.547 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 199' ' ' HIS . 6.4 t -116.47 10.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.425 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.479 HD22 ' N ' ' B' ' 34' ' ' ASN . 0.9 OUTLIER -95.61 -72.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.34 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' B' ' 33' ' ' VAL . 0.0 OUTLIER 61.12 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 76.7 p -102.78 103.78 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mm -73.54 126.75 89.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.021 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.54 102.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.834 2.356 . . . . 0.0 112.305 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 -32.36 35.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.183 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 60.68 104.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 75.3 p -59.25 -53.83 53.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.191 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.9 2.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.494 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -91.57 144.3 25.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.345 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -129.81 149.64 51.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.45 113.48 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 0.0 OUTLIER -90.87 95.19 10.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 267' ' ' ASN . 49.0 tp60 -95.84 112.7 24.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.417 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' B' ' 33' ' ' VAL . 61.8 m-85 -136.61 155.18 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.108 0.48 . . . . 0.0 111.696 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.5 m -148.12 125.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.388 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.515 ' HG3' HG23 ' B' ' 31' ' ' VAL . 10.2 ptt? -105.89 159.09 16.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -75.31 120.06 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.318 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -79.18 99.86 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -143.06 112.8 5.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.5 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.06 -10.87 13.68 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.529 2.153 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.14 -24.79 32.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.186 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 17.2 ptp -114.06 15.31 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 39.4 ptt180 -64.23 -26.28 68.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 53.9 m -52.38 -49.41 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.43 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 pt -100.54 14.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 64.6 tt0 -56.56 129.34 75.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.687 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.52 131.83 11.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.433 2.088 . . . . 0.0 112.314 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 212' ' ' PRO . 30.6 t -56.73 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.413 ' HA ' HG12 ' B' ' 33' ' ' VAL . 21.2 m80 -137.82 162.67 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.325 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.88 133.84 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 111.28 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 36.2 p90 -142.74 146.01 33.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 207' ' ' THR . 4.9 p-10 -137.6 173.17 11.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.974 0.416 . . . . 0.0 111.191 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.97 -171.46 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.683 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -71.16 -23.65 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.612 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -85.55 -69.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -143.46 170.35 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.95 0.405 . . . . 0.0 111.351 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 202' ' ' ASP . 76.1 m -110.84 152.13 27.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.67 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 80.4 mtp180 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.026 0.441 . . . . 0.0 111.474 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 243' ' ' ILE . 41.0 m-85 -127.42 133.84 49.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.404 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.13 119.39 39.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.275 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 244' ' ' ILE . 96.1 m-85 -118.46 160.98 37.66 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 198' ' ' VAL . 35.2 Cg_exo -61.46 168.3 8.33 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.367 2.044 . . . . 0.0 111.907 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.65 -27.31 34.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.17 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.97 -14.83 43.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.83 156.9 31.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.09 -2.13 56.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 242' ' ' ASN . 10.4 mp 61.8 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.388 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.24 158.91 17.6 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.051 2.501 . . . . 0.0 112.7 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -78.52 139.74 38.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.353 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 t -110.48 110.38 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 0.0 111.292 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.509 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 4.0 m-85 -90.96 176.99 6.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.635 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -144.04 141.66 30.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.161 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 22.9 mm -80.53 105.86 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.366 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.5 t -67.86 177.5 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.737 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.57 4.47 24.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.099 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -95.2 -22.6 17.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 104.34 13.08 27.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -128.6 147.0 50.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.772 0.32 . . . . 0.0 110.729 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 15.3 mt-10 -67.89 144.34 55.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 222' ' ' MET . 86.0 m -140.6 139.39 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.474 HD12 ' HD2' ' A' ' 232' ' ' PRO . 60.3 tp -93.39 108.35 32.91 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 111.395 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.635 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.5 Cg_endo -76.43 163.51 32.07 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.861 2.374 . . . . 0.0 112.347 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -51.23 111.07 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.6 p -109.74 159.88 16.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.283 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.36 167.09 28.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.6 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.89 135.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 111.532 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.78 178.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.116 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.09 157.23 23.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.411 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.45 142.21 49.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 110.764 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 63.29 7.69 3.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 51.23 80.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 217' ' ' LEU . 8.9 p30 -125.31 6.56 7.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 209' ' ' PHE . 7.7 mt -114.78 147.12 18.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' A' ' 217' ' ' LEU . 51.3 mt -129.9 103.03 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.1 pt-20 -96.58 134.43 39.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.73 127.8 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -82.58 43.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 55.0 m -154.39 144.03 21.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.612 HG11 ' HG2' ' A' ' 271' ' ' PRO . 20.0 t -114.84 125.56 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -135.23 171.41 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.222 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -95.39 -24.58 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.3 tt0 -128.34 123.49 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -116.93 121.76 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.066 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -109.44 105.84 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 65.2 mt -86.61 114.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.975 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 261' ' ' VAL . 93.9 mtt180 -123.02 140.58 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.0 111.713 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 23.1 tp -165.91 122.37 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.53 -112.97 5.37 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.228 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.59 17.67 12.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 2.2 mptm? -121.94 150.05 42.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.885 0.374 . . . . 0.0 111.429 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' B' ' 23' ' ' PRO . 9.7 p -142.18 146.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.9 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.0 t -129.68 121.75 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.458 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -85.98 111.59 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 186' ' ' MET . 97.8 t -123.27 116.57 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.557 0.218 . . . . 0.0 110.471 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.8 ttt180 -107.29 113.79 27.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.867 0.365 . . . . 0.0 110.707 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -66.51 134.48 52.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.151 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 183' ' ' GLN . 18.7 m120 -117.1 171.9 7.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.6 t30 59.18 17.95 6.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.074 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -53.14 98.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.44 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.513 ' H ' ' HD2' ' A' ' 271' ' ' PRO . . . -94.21 -50.54 0.26 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.775 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.612 ' HG2' HG11 ' A' ' 249' ' ' VAL . 73.5 Cg_endo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.449 2.099 . . . . 0.0 112.377 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 CA-C-O 119.866 -0.139 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.08 158.75 45.34 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.947 1.765 . . . . 0.0 112.283 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 60.4 Cg_endo -72.5 -81.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.529 2.152 . . . . 0.0 112.126 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.486 ' H ' HG12 ' A' ' 261' ' ' VAL . 41.0 tt0 61.24 121.14 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 9.7 Cg_endo -83.98 101.73 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.278 1.985 . . . . 0.0 111.323 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.57 -6.18 56.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.376 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 78.4 m95 56.04 18.25 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 47.5 t -40.22 -52.01 2.65 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.926 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -127.63 72.97 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.094 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.6 m -49.37 94.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.558 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 11.9 m -90.71 163.17 31.27 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 48.1 Cg_endo -77.77 -163.83 0.24 Allowed 'Trans proline' 0 N--CA 1.47 0.126 0 C-N-CA 122.659 2.24 . . . . 0.0 111.906 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 184' ' ' TYR . 59.7 t -139.27 -32.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -96.34 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.764 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -94.84 -36.98 11.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -132.18 108.46 9.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.26 127.1 91.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.926 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.37 101.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.838 2.359 . . . . 0.0 112.361 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.425 HG13 ' O ' ' B' ' 39' ' ' VAL . 2.9 p -94.23 91.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' B' ' 39' ' ' VAL . 3.2 p30 44.2 28.62 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.474 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 63.5 m -72.25 130.26 40.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.759 0.314 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.8 147.64 18.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.421 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.6 18.99 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.047 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -78.85 141.99 37.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -131.94 113.11 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.603 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER -115.09 95.29 5.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.717 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -107.23 105.48 15.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.437 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.606 ' H ' HD21 ' B' ' 34' ' ' ASN . 71.4 m-85 -128.84 140.7 51.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 18.9 m -134.03 128.71 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.678 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.539 ' HB3' HG22 ' A' ' 264' ' ' VAL . 16.1 ptt? -119.37 146.61 45.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.427 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' B' ' 27' ' ' TRP . 84.2 p -54.76 126.88 25.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.038 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -78.85 86.25 4.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.696 0.284 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.577 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 2.1 mp0 -133.22 114.28 13.63 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 193' ' ' ARG . 25.4 Cg_exo -63.04 -13.83 37.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.523 2.149 . . . . 0.0 112.291 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.51 -9.11 59.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 16.2 mmt -109.87 -1.25 17.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.32 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 14.6 ptm180 -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.164 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -48.96 -52.15 26.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.1 pt -114.3 12.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.34 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 193' ' ' ARG . 33.0 tt0 -60.74 134.32 92.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.53 132.29 20.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.496 2.13 . . . . 0.0 112.278 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 12.2 t -57.69 -65.69 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.347 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.698 ' HA ' HG12 ' B' ' 33' ' ' VAL . 78.7 m-70 -144.56 157.15 44.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.466 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.676 HG23 HG11 ' B' ' 33' ' ' VAL . 89.1 t -141.58 138.28 32.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.369 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 182' ' ' TYR . 36.0 p90 -148.03 138.56 22.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.66 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.603 ' H ' ' HB3' ' A' ' 182' ' ' TYR . 3.6 p30 -113.28 173.16 6.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.11 0.481 . . . . 0.0 111.303 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -147.27 156.65 43.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.27 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -52.14 -23.7 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 205' ' ' ARG . 10.4 mpt_? -91.8 -68.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -138.04 170.23 16.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.815 0.341 . . . . 0.0 111.318 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 62.3 m -116.37 151.25 36.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.864 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 83.5 mtm180 -137.32 148.93 46.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.003 0.43 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' ILE . 35.1 m-85 -123.85 132.47 53.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.588 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.84 116.03 31.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.82 159.94 35.44 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.95 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.37 162.53 20.16 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.481 2.121 . . . . 0.0 112.047 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.41 -25.33 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.17 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.1 -14.95 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.088 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -100.29 152.56 20.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.306 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.85 154.84 38.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 244' ' ' ILE . 88.8 mt -90.63 117.08 67.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.254 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.6 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.383 . . . . 0.0 112.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.448 ' HB3' HD11 ' A' ' 231' ' ' LEU . 24.8 mt-30 -120.14 111.92 18.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 255' ' ' ILE . 15.2 t -82.47 112.71 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 5.7 m-85 -91.0 177.09 6.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.717 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.59 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 2.8 ppp? -146.94 161.41 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.864 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.1 mm -107.33 119.56 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.301 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.2 m -104.4 -178.63 3.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.55 85.97 1.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -173.49 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 131.46 15.59 1.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -130.47 166.34 20.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 12.4 mt-10 -90.82 141.37 28.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.552 HG23 ' SD ' ' A' ' 222' ' ' MET . 0.5 OUTLIER -136.2 136.14 39.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.498 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 219' ' ' GLN . 3.1 tt -86.73 110.01 28.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.631 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.59 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 73.8 Cg_endo -75.28 163.06 35.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.797 2.332 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.47 105.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 79.9 p -107.06 166.02 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.381 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -151.59 167.2 28.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.564 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 16.7 m -124.8 131.07 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.489 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.22 -175.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.081 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.19 169.61 44.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.466 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.5 138.48 58.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.46 12.44 3.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 52.28 79.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.427 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.752 ' H ' HD22 ' A' ' 242' ' ' ASN . 0.1 OUTLIER -129.73 14.97 5.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.142 -179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 209' ' ' PHE . 8.3 mt -117.8 148.89 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 217' ' ' LEU . 49.7 mt -130.65 102.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 11.8 pt-20 -97.38 135.39 39.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.1 t -115.6 132.7 64.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.71 41.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.085 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.3 m -157.14 147.18 20.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.322 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 49.3 t -121.31 128.27 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.63 -173.94 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.287 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.64 -23.86 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.036 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 265' ' ' ARG . 4.7 tt0 -125.29 123.68 39.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.87 138.06 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.269 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -131.09 110.62 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 220' ' ' VAL . 85.1 mt -83.04 114.99 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.628 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.498 ' HG2' HG23 ' A' ' 261' ' ' VAL . 79.5 mtp180 -119.5 135.72 54.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -165.5 126.72 1.94 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.569 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 62.6 -115.54 8.14 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.181 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 260' ' ' LYS . 9.7 m-20 -119.41 18.17 12.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.691 0.282 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 259' ' ' ASP . 14.4 mptt -123.54 150.86 43.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.569 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.52 HG12 ' HG2' ' B' ' 23' ' ' PRO . 6.1 p -142.2 146.46 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.693 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 192' ' ' MET . 88.0 t -129.82 116.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.601 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -80.67 109.51 2.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.015 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 186' ' ' MET . 48.5 t -118.28 116.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.635 0.255 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 252' ' ' GLU . 51.4 mtp180 -114.59 131.74 56.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -89.2 124.2 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.74 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -110.78 81.37 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.5 t30 177.19 -42.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 26.7 t80 62.66 118.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.251 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -112.85 81.34 4.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.189 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.724 2.283 . . . . 0.0 112.234 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 N-CA-C 111.154 -0.364 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.91 126.0 10.33 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.495 2.13 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.52 ' HG2' HG12 ' A' ' 261' ' ' VAL . 39.4 Cg_endo -67.33 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.371 2.047 . . . . 0.0 112.18 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 41.7 tt0 61.89 125.48 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.601 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 2.6 Cg_endo -79.04 111.38 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.455 2.104 . . . . 0.0 111.313 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.51 ' HB2' ' NE2' ' A' ' 189' ' ' GLN . 10.3 m-20 -83.24 -8.22 59.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.914 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.59 ' H ' ' HB2' ' A' ' 187' ' ' SER . 76.5 m95 51.14 25.43 2.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.704 0.288 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.526 ' H ' HE22 ' A' ' 189' ' ' GLN . 46.9 t -24.1 -63.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.373 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -124.58 1.62 8.26 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.626 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 45.1 m 45.62 87.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.152 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 m -104.97 123.23 40.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 81.4 Cg_exo -49.22 169.39 0.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 123.142 2.562 . . . . 0.0 113.677 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 199' ' ' HIS . 14.0 t -111.51 -10.0 11.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.606 HD21 ' H ' ' A' ' 184' ' ' TYR . 2.4 p30 -131.61 99.05 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' B' ' 35' ' ' LYS . 3.8 mppt? -113.44 -23.37 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.639 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 62.6 m -80.16 -48.78 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm 63.8 119.73 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.41 98.27 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.413 2.076 . . . . 0.0 112.291 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.413 HG23 ' H ' ' B' ' 40' ' ' ASP . 0.2 OUTLIER -121.13 -53.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.413 ' H ' HG23 ' B' ' 39' ' ' VAL . 14.6 t70 59.94 90.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.632 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.8 m -60.34 -65.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.079 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.841 0.353 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.88 -113.05 2.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.7 137.6 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.344 . . . . 0.0 111.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.01 151.51 19.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -129.95 112.9 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.683 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.32 95.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.354 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.6 96.52 5.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 57.3 m-85 -129.76 143.83 51.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.162 0.506 . . . . 0.0 111.7 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' B' ' 32' ' ' PRO . 14.0 m -146.88 124.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.263 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.1 ptt? -103.77 155.92 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 111.175 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 96.0 p -73.34 114.38 11.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.133 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 4.9 tp10 -75.99 99.8 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.4 . . . . 0.0 111.326 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.425 ' HB3' ' HG2' ' A' ' 192' ' ' MET . 0.0 OUTLIER -139.6 116.07 8.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.38 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 193' ' ' ARG . 31.4 Cg_exo -59.57 -13.35 20.92 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.608 2.206 . . . . 0.0 112.755 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.63 -21.62 32.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.87 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.425 ' HG2' ' HB3' ' A' ' 189' ' ' GLN . 18.6 ptp -116.54 24.03 11.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.681 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 82.8 mtm180 -72.23 -25.91 61.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.736 0.303 . . . . 0.0 111.067 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.5 t -49.35 -46.0 46.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.428 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 pt -107.9 18.81 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 111.217 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 34.8 tt0 -54.97 128.11 63.95 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.777 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 125.38 8.93 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.365 2.043 . . . . 0.0 112.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.5 t -53.88 -71.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.386 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.526 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.3 m-70 -142.25 157.29 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.3 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.42 ' H ' ' ND2' ' B' ' 34' ' ' ASN . 94.2 t -144.16 128.12 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.868 0.366 . . . . 0.0 111.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.546 ' HE1' ' HD2' ' A' ' 208' ' ' ARG . 45.5 p90 -132.47 153.89 50.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.5 p30 -112.83 173.14 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 0.0 111.249 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 204' ' ' TYR . 3.1 t-20 -154.6 153.14 30.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.408 ' H ' ' ND2' ' A' ' 203' ' ' ASN . 95.2 m-85 -55.43 -23.84 27.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -91.22 -69.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.322 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -139.98 163.01 33.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.037 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.4 m -92.9 151.96 19.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.59 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.546 ' HD2' ' HE1' ' A' ' 201' ' ' TRP . 99.4 mtt180 -133.8 144.0 48.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.449 . . . . 0.0 111.785 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -126.81 131.12 51.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.484 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -106.57 118.94 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.43 160.85 38.15 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.96 175.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.514 2.143 . . . . 0.0 112.117 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -100.46 -27.89 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.24 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -86.07 -14.94 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.162 0.506 . . . . 0.0 111.122 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -96.93 147.81 23.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.57 150.29 44.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 242' ' ' ASN . 97.7 mt -85.16 117.66 69.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 257' ' ' LEU . 96.7 Cg_endo -83.25 -174.44 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.807 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -115.5 112.62 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.201 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 255' ' ' ILE . 39.4 t -80.88 123.04 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.817 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.517 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.9 m-85 -98.57 177.68 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.711 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.612 ' HG3' ' HD3' ' A' ' 232' ' ' PRO . 3.2 ppp? -145.78 139.39 26.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.993 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.2 mm -80.24 99.86 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.996 0.426 . . . . 0.0 111.426 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -74.63 -165.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.557 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.4 177.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.109 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 49.5 m 63.54 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.082 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 162.8 51.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.665 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -138.01 159.94 40.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 18.2 mt-10 -86.31 144.62 27.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.015 0.436 . . . . 0.0 111.275 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.52 ' O ' ' HG3' ' A' ' 222' ' ' MET . 72.0 m -139.94 136.94 34.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.072 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.477 HD12 ' HD2' ' A' ' 232' ' ' PRO . 61.7 tp -93.5 108.6 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 0.0 111.362 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.612 ' HD3' ' HG3' ' A' ' 222' ' ' MET . 71.5 Cg_endo -76.64 163.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.001 2.468 . . . . 0.0 112.391 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.72 96.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.526 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 17.7 m -95.01 169.87 9.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.173 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 22.2 m80 -149.24 167.24 26.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.683 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.1 134.43 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 243' ' ' ILE . 31.0 m -140.72 173.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.124 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.9 152.77 10.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.1 -42.5 99.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -99.69 9.86 42.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 53.98 78.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.399 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.546 ' HA ' HD21 ' A' ' 217' ' ' LEU . 9.4 p30 -143.9 14.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.773 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 237' ' ' VAL . 2.0 mt -119.48 147.68 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.363 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 217' ' ' LEU . 47.1 mt -131.44 111.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.53 131.89 47.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 110.575 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.9 t -106.84 132.59 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.03 43.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.4 m -158.81 149.59 20.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.32 124.76 69.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.518 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -139.45 -173.63 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.344 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -104.68 -17.02 14.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 265' ' ' ARG . 2.2 tt0 -130.88 124.06 30.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -124.87 161.28 26.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.1 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 220' ' ' VAL . 48.4 mtt180 -146.49 148.47 32.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.249 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HB ' ' HB ' ' A' ' 262' ' ' VAL . 87.9 mt -120.82 114.36 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.975 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 261' ' ' VAL . 61.6 mtp180 -121.89 137.72 54.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 111.833 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 218' ' ' PRO . 50.9 tp -167.93 122.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.191 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.5 -115.52 6.38 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.098 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -119.83 23.18 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.502 0.192 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' B' ' 23' ' ' PRO . 75.8 mmtt -127.47 149.52 50.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.894 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' B' ' 23' ' ' PRO . 11.7 p -136.89 146.3 28.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 255' ' ' ILE . 61.2 t -127.9 124.74 63.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -89.25 108.42 3.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.943 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' MET . 66.1 t -119.38 116.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.547 0.213 . . . . 0.0 110.445 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 252' ' ' GLU . 70.1 ttt180 -110.42 126.83 54.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.209 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -96.52 111.78 23.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -99.44 80.9 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.784 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 14.1 t30 174.03 134.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.438 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -143.98 99.45 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.389 . . . . 0.0 110.941 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.57 81.93 18.9 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.716 2.277 . . . . 0.0 112.209 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.484 0.935 0 N-CA-C 111.194 -0.348 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.458 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 75.0 Cg_exo -49.04 -48.04 19.62 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.639 2.226 . . . . 0.0 113.279 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 260' ' ' LYS . 68.9 Cg_endo -73.83 -83.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.935 1.757 . . . . 0.0 112.285 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' B' ' 23' ' ' PRO . 41.1 tt0 60.77 119.31 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 24' ' ' GLU . 10.1 Cg_endo -84.29 99.42 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.327 2.018 . . . . 0.0 111.366 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.89 -7.94 56.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.459 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 86.8 m95 58.05 14.74 2.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.885 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -40.86 -50.41 3.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 188' ' ' GLU . 95.9 m-20 -126.28 75.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.45 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.404 HG22 ' HB ' ' A' ' 185' ' ' VAL . 46.9 m -55.68 91.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.565 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 13.5 m -89.27 163.03 35.44 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 65.9 Cg_endo -75.13 -161.75 0.13 Allowed 'Trans proline' 0 N--CA 1.471 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 111.598 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' HIS . 43.7 t -139.12 -34.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 0.0 111.249 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 199' ' ' HIS . 12.9 m120 -97.56 143.72 27.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.35 -30.48 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 65.5 p -70.53 -63.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.473 ' HA ' ' HD2' ' B' ' 38' ' ' PRO . 49.8 mm 60.29 104.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.224 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' B' ' 37' ' ' ILE . 9.6 Cg_endo -50.78 102.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.952 2.435 . . . . 0.0 112.275 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.608 HG13 ' H ' ' B' ' 40' ' ' ASP . 1.0 OUTLIER -117.25 -63.65 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.22 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.608 ' H ' HG13 ' B' ' 39' ' ' VAL . 3.1 p30 179.89 -174.97 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.5 p -140.73 -39.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.154 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.59 78.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.399 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -141.0 128.87 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -141.09 142.25 34.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 181' ' ' ASN . 0.2 OUTLIER -123.74 113.39 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.356 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 201' ' ' TRP . 1.4 m-85 -81.19 95.24 6.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -90.44 106.49 18.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 202' ' ' ASP . 65.7 m-85 -135.46 149.21 49.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.501 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' B' ' 32' ' ' PRO . 15.7 m -145.59 124.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.465 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' B' ' 32' ' ' PRO . 11.0 ptt? -106.76 147.91 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.186 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.594 ' HB2' HE22 ' A' ' 189' ' ' GLN . 82.9 p -59.96 124.26 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.853 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 8.1 tp10 -86.87 106.24 17.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' A' ' 187' ' ' SER . 24.5 mp0 -146.41 120.43 5.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.039 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.83 -22.4 45.23 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.746 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.7 -18.67 37.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.626 ' HA ' ' HD3' ' A' ' 260' ' ' LYS . 13.2 mmt -104.44 12.21 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.406 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.653 ' HA ' ' HB2' ' A' ' 196' ' ' GLN . 16.4 ptm180 -72.14 -26.33 62.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.4 p -51.29 -52.57 43.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.56 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.405 HG12 ' HD2' ' A' ' 260' ' ' LYS . 33.9 pt -103.59 17.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 193' ' ' ARG . 35.4 tt0 -59.58 127.44 84.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.765 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 127.28 12.92 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 199' ' ' HIS . 14.3 t -54.15 -70.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' B' ' 33' ' ' VAL . 34.0 m-70 -142.15 161.07 38.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.89 129.0 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.943 0.401 . . . . 0.0 111.371 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 182' ' ' TYR . 44.2 p90 -136.12 148.05 48.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.27 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.412 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 4.3 p30 -125.29 164.31 20.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.374 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -134.11 179.74 6.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.398 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -71.21 -23.54 62.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -102.76 -68.15 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.679 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -122.05 170.76 9.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 111.549 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.3 m -127.23 144.04 51.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.205 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 245' ' ' GLU . 74.1 mtp180 -125.47 146.9 49.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.152 0.501 . . . . 0.0 111.915 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.64 124.69 43.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.19 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -96.07 123.24 39.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 111.397 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 244' ' ' ILE . 95.4 m-85 -122.85 160.89 47.17 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.825 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD3' HG23 ' A' ' 198' ' ' VAL . 32.0 Cg_exo -58.71 162.0 13.82 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.407 2.071 . . . . 0.0 111.98 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.05 50.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.179 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.07 -14.93 42.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.071 0.463 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.16 152.07 46.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.271 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.09 0.09 56.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 244' ' ' ILE . 10.6 mp 62.78 104.77 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.409 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.28 163.39 19.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -86.48 121.12 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 255' ' ' ILE . 44.2 t -92.03 113.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.498 ' HD2' ' HB3' ' A' ' 229' ' ' GLU . 3.2 m-85 -90.88 177.24 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.333 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 230' ' ' THR . 1.0 OUTLIER -142.29 149.5 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.28 129.01 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 69.1 m -144.19 -179.52 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 62.14 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.365 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.3 t -147.53 -12.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 159.03 37.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -103.52 139.63 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 221' ' ' TYR . 19.3 mt-10 -101.42 113.33 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 222' ' ' MET . 6.9 t -127.7 138.16 52.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.406 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.507 HD12 ' HD2' ' A' ' 232' ' ' PRO . 51.3 tp -80.97 110.59 18.21 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.072 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.507 ' HD2' HD12 ' A' ' 231' ' ' LEU . 66.8 Cg_endo -75.54 161.48 37.12 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.701 2.267 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -63.95 106.28 1.0 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 246' ' ' VAL . 29.5 t -116.21 173.86 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.083 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -143.51 167.23 22.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.57 131.08 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.262 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.12 -178.97 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.26 165.83 19.42 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.96 -24.0 66.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.585 ' HB2' HD22 ' A' ' 242' ' ' ASN . 35.0 m-80 -126.18 14.51 7.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.993 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 58.37 34.97 24.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.987 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.585 HD22 ' HB2' ' A' ' 240' ' ' ASN . 8.3 p30 -97.84 19.03 14.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 244' ' ' ILE . 6.6 mt -116.77 157.38 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 217' ' ' LEU . 56.0 mt -137.11 102.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.784 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 208' ' ' ARG . 38.1 tt0 -96.29 110.99 23.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 111.178 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 234' ' ' SER . 53.7 t -90.01 134.95 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.702 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -82.81 39.27 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 246' ' ' VAL . 29.9 m -158.21 154.16 26.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.25 126.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -138.94 162.76 34.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.706 ' H ' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -88.24 -3.88 58.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.71 123.49 11.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.752 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -121.6 120.44 34.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 229' ' ' GLU . 4.7 tpp180 -102.18 103.93 14.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 220' ' ' VAL . 74.3 mt -83.37 114.82 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -127.03 141.65 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.398 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.2 tp -166.1 125.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.562 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.82 -114.83 7.21 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -119.54 20.09 12.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 192' ' ' MET . 22.0 ttmm -130.01 145.26 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.35 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' B' ' 23' ' ' PRO . 3.9 p -134.12 146.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 192' ' ' MET . 95.6 t -133.96 115.05 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.221 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' B' ' 25' ' ' PRO . . . -74.55 134.98 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.162 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.2 t -135.5 139.57 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.411 ' HB2' ' CH2' ' B' ' 27' ' ' TRP . 64.8 ttt180 -132.09 161.01 34.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.815 0.34 . . . . 0.0 110.832 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.721 HD21 ' H ' ' A' ' 269' ' ' PHE . 7.2 t30 -129.69 115.14 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.77 81.68 2.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.968 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.522 HD21 ' HB2' ' A' ' 270' ' ' ALA . 3.2 t30 179.74 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.721 ' H ' HD21 ' A' ' 266' ' ' ASN . 28.3 t80 57.96 97.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.216 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 268' ' ' ASN . . . -130.16 80.9 69.9 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 C--N 1.346 0.435 0 C-N-CA 122.631 2.221 . . . . 0.0 112.305 179.747 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 111.101 -0.384 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.52 143.95 97.54 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.474 2.116 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.82 ' HB2' HG12 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -85.13 179.51 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.765 2.31 . . . . 0.0 112.059 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 179.32 122.76 0.21 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.112 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' H ' ' A' ' 263' ' ' GLY . 4.8 Cg_exo -76.59 105.11 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.235 1.957 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.33 -12.16 59.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.917 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 265' ' ' ARG . 88.0 m95 54.61 16.58 1.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.618 0.247 . . . . 0.0 110.623 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.9 m -35.25 -66.38 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.547 ' O ' HG13 ' B' ' 31' ' ' VAL . 12.7 m-20 -113.05 56.48 0.68 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.113 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.422 ' C ' ' O ' ' B' ' 29' ' ' ASN . 63.1 m -30.7 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.553 0.533 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.57 ' HB ' ' HD2' ' B' ' 32' ' ' PRO . 6.8 m -92.51 163.72 25.35 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.298 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' B' ' 31' ' ' VAL . 64.6 Cg_endo -75.64 -159.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.471 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 111.497 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 199' ' ' HIS . 61.1 t -141.54 -37.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.138 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -82.42 -15.48 52.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 61.13 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.6 p -89.83 96.43 10.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.51 124.17 90.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.06 99.18 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.502 2.135 . . . . 0.0 112.281 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.69 -26.11 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.993 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.4 t -113.04 -16.78 12.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.079 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.993 . . . . . . . . 0 0 . 1 stop_ save_